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With the improvement of sequencing protocols and decreasing sequencing costs,
single-cell RNA sequencing has become widely accessible. Cells, once thought
to be of the same type based on their location or morphology, are increasingly
found to be heterogeneous with respect to gene expression levels. Computational
analysis of single cell transcriptome data allows the identification of novel
and rare cell populations and cell states, as well as the comparison of cell
populations across tissues and conditions. However, resolving cell types and
comparison of scRNA-seq data across datasets are challenging due to technical
factors such as sparsity, low numbers of cells and batch effects. To address
these challenges, I developed scID, which uses the Fisher’s Linear Discriminant
Analysis-like framework to identify transcriptionally related cell types between
scRNA-seq datasets. I demonstrate the accuracy and performance of scID relative
to existing methods on several published datasets. By increasing power to
identify transcriptionally similar cell types across datasets showing batch effects,
scID enhances an investigator’s ability to integrate and reveal development-,
disease- and perturbation-associated changes in scRNA-seq data. Using scID
and other methods for data alignment, unsupervised clustering and differential
gene expression analysis, I explored the heterogeneity within γδ-T cells from
human peripheral blood and breast tumour samples from three healthy donors
and two breast cancer patients. Two δ1 and three δ2 subtypes of γδ-T cells
were identified in blood and one δ1 and two δ2 subtypes of γδ-T cells in breast
v
tumour. These subtypes differed in antigen presentation, cytotoxicity, and IL17
and IFNγ production. Compared to blood γδ-T cells, breast tumour-infiltrating
γδ-T cells were more activated and expressed higher levels of cytotoxic genes, yet
were immunosuppressed. A breast tumour subtype that was δ1 and IFNγ positive
had no obvious similarity to any subtype observed in blood γδ-T cells and was the
only subtype associated with improved overall survival of breast cancer patients.
An additional method for overcoming batch effects and enabling comparison of
cell populations across donors and conditions is to pool cells from multiple donors
within a single scRNA-seq experiment. Experimental methods that enable the
tracking of donor identity of each cell require heavy manual processing and are
costly. Computational methods, on the other hand, can determine donor identities
of cells based on genetic variants. Technical factors, such as sparsity and gene
fragment capture, as well as biological factors, such as cell-type-specific gene
expression, can present challenges. In the last chapter I explored the use of deep
learning to implement a Non-negative matrix factorization method that clusters
cells based on genetic variants and identifies donor-specific genetic variants that
can be used for validation.
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Lay Summary
A single cell is the smallest and fundamental unit of life. Even though all
human cells carry the same DNA, they differ in morphology and function between
tissues and conditions. A new experimental approach, called single-cell RNA-
sequencing, enables researchers to measure the expressed genes in individual
cells. This information can be used to group cells based on common gene
expression patterns and define different cell types in complex tissues. Cancer
research can take advantage of such information to study how our immune cells
function in the presence of tumour cells. To understand how our immune system
is affected by the presence of cancer cells, we need to compare equivalent cell
populations across healthy and diseased samples. During my PhD I worked on
the development of computational methods to enable such analysis. I developed
a method, called scID, to identify cells that express the same sets of genes across
different datasets. I then used scID and other published methods to identify
subtypes of an immune cell type called γδ-T cells in blood from healthy donors
and breast tumour samples. This showed five different subtypes of γδ-T cells
in blood and three different subtypes of γδ-T cells in breast tumour. Two of
the subtypes were common between the two conditions while the other breast
tumour γδ-T cell subtype was not observed in blood samples. Interestingly this
subtype was associated with better survival rates of patients with breast tumour.
An alternative way of comparing cells between different conditions or individuals
is to pool cells from multiple donors together before the experiment. Then we
vii
need to know the donor identity of each cell in order to ask questions such as
whether all donors have the same cell types or whether there is a difference in
the proportion of each cell type between the donors. However, tracking the donor
identity of the cells in the single cell RNA-sequencing experiment is inefficient
and expensive. Here I present a method to computationally label the cells. To
achieve this I extract information on genetic variants of each cell. These are
positions on the genome whether the genomic sequence of a cell differs from a
reference genome. Some of them are donor-specific, thus cells that have the same
variants are expected to be from the same donor.
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1.1 Flowchart of common analysis steps of single-cell RNA-sequencing
data. The pipeline starts with the alignment of fastq files and
counting of reads per cell corresponding to each gene, resulting
in a counts gene expression matrix where rows represent genes
and columns cells. Raw counts are then normalised to correct for
technical differences between cells and allow comparison of gene
expression across cells. The next aim is to cluster the data to
identify groups of transcriptionally distinct cell populations, which
also involves feature extraction and dimensionality reduction.
Clusters of cells can then be visualised and finally, differentially
expressed genes can be found for the identified clusters of cells. . . 8
2.1 Graphical abstract of scID. scID can label the cells of a given
scRNA-seq target dataset either based on the labels of a given
labelled reference scRNA-seq dataset or identify cells enriched for
a given list of genes. . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.2 Overview of scID steps. The three main steps involved in mapping
cells across scRNA-seq data with scID are as follows: In Step 1,
gene signatures are extracted from the reference data (shown as
clustered groups on a reduced dimension). In Step 2, discriminative
weights are estimated from the target data for each reference
cluster-specific gene signature. Finally, in Step 3, every target
cell is scored for each feature and is assigned to the corresponding
reference cluster. . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.3 Fisher’s Linear Discriminant Analysis for binary classification (LDA). 34
2.4 Projection of mouse retinal cells in the precision-recall space for the
Rod Photoreceptor gene signature (Shekhar et al., 2016). Each
dot represents a cell coloured based on its cell type label. Rod
photoreceptors lie in the first quadrant of the precision-recall space
with recall close to 1 and precision much lower than 1 but still
higher than non rod photoreceptor cells. . . . . . . . . . . . . . . 36
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2.5 Projection of mouse retinal cells in the precision-recall space for
the BC7 upregulated gene signature (Shekhar et al., 2016). Each
dot represents a cell coloured based on its cell type label. Due
to transcriptionally similar cell types being present in the dataset,
BC7 cells do not cluster separately from the other cell using only
positive markers.. . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.6 Projection of mouse retinal cells in the precision-recall space for
the BC7 downregulated (negative) gene signature (Shekhar et al.,
2016). Each dot represents a cell coloured based on its cell type
label. BC7 cells are expected to be close to (0, 0) since they should
not express any negative markers. . . . . . . . . . . . . . . . . . . 38
2.7 Projection of mouse retinal cells in the differential precision-
differential recall space for the BC7 gene signature (Shekhar et al.,
2016). Each dot represents a cell coloured based on its cell type
label. BC7 lie in the first quadrant of the precision-recall space
with recall close to 1 and precision much lower than 1 but still
higher than other cell types. . . . . . . . . . . . . . . . . . . . . . 40
2.8 Illustration of the four different categories of instances of binary
classification. True instances are indicated by green circles and
false instances are indicated by red circles. All selected instances
lie in the grey circle. True instances that lie in the grey circle are
true positives (TP), true instances that lie outside the grey circle
are false negatives (FN), false instances that lie in the grey circle
are false positives (FP) and false instances that lie outside the grey
circle are true negatives (TN). . . . . . . . . . . . . . . . . . . . . 47
2.9 Quantification of accuracy of DPR classification (Step 2 of scID).
(A) Boxplot shows interquartile range for TPR for all the cell types
in each published dataset listed in the x- axis. (B) Boxplot shows
interquartile range for FPR for all the cell types in each published
dataset listed in the x- axis. . . . . . . . . . . . . . . . . . . . . . 54
2.10 Quantification of TPR and FPR of Step 2 (black) and Step 3
(white) of scID. Significance was computed using a two-sided paired
Kruskal-Wallis test for difference in TPR or FPR between Step 2
and Step 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
2.11 scID scores of mouse retinal bipolar cells (Shekhar et al. (2016)) for
different gene sets using positive and negative markers. (A) scID
scores for the RBC (Rod Bipolar Cell) gene signature including
only positive markers. Since this population is abundant and
transcriptionally distinct from the other cell types in the data,
positive markers are sufficient to distinguish them. (B) scID scores
for the MG (Müller Glia) gene signature including only positive
markers. (C) scID scores for the BC1B gene signature including
only positive markers. (D) scID scores for the BC1B gene signature
including positive and negative markers. . . . . . . . . . . . . . . 56
xvi
2.12 (A) Extent of batch effect between the reference (10X) and each
of the target datasets (Drop-seq and CEL-seq2) as measured by
kBET (Büttner et al. (2019)) is shown on the y-axis. (B) t-SNE
projection of the cells belonging to each of the three cell lines of
the 10X dataset that was used as reference. (C) Expression of top
20 genes (rows) specifically expressed in each cell line (columns) in
the 10X data. Yellow represents enrichment and purple represents
depletion of the gene’s expression. (D) Adjusted Rand Index of
scID for mapping across datasets, compared to the true labels. . . 58
2.13 Assessment of accuracy of scID via self-mapping of published
datasets. The indicated published data (x-axis labels) were self-
mapped, i.e. used as both reference and target, by scID and the
assigned labels were compared to the published cell labels. . . . . 59
2.14 (A) Extent of batch effect between the reference and each of the
target datasets as measured by kBET (Büttner et al. (2019)) is
shown on the y-axis. (B) Adjusted Rand Index of scID and other
methods for mapping across the two datasets, compared to the
labels from CCA alignment. . . . . . . . . . . . . . . . . . . . . . 60
2.15 (A) Extent of batch effect between the reference and each of
the target datasets as measured by kBET (Büttner et al 2019,
Nature Methods) is shown on the y-axis. (B) Accuracy of final
classification of scID and other methods for the two target datasets,
calculated using the Adjusted Rand Index. (C) Scatter plot of
weights estimated from pancreas scRNA-seq CEL-Seq data on the
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and gene signature. . . . . . . . . . . . . . . . . . . . . . . . . . . 62
2.16 (A) t-SNE plot showing clusters in Drop-seq (reference) data
of mouse retinal bipolar cells from Shekhar et al. (Shekhar
et al., 2016). Cluster membership of the cells was taken from
the publication. (B) t-SNE plot showing clusters in Smart-Seq2
(target) data of mouse retinal bipolar cells from Shekhar et al.
(Shekhar et al., 2016). Data were clustered using Seurat and cluster
names assigned arbitrarily. (C) Extent of batch effect between
the reference (Drop-seq) and the target (Smart-Seq2) datasets as
measured by kBET (Büttner et al., 2019) is shown on the y-axis. 64
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2.17 Heatmap showing row-scaled average expression of gene signatures
(rows) in the reference Drop-seq (A) and the target Smart-seq2 (B)
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2.18 Identification of target (Smart-seq2) cells equivalent to reference
(Drop-seq) clusters using a biomarker-based approach. Bars
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2.19 Batch correction by CCA and MNN alters the grouping of reference
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2.21 (A) t-SNE plot showing clusters in mouse brain cells (reference)
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A single cell is the smallest and fundamental unit of life, often called the
“building block of life”. In complex multicellular organisms, such as the human,
cells are specialised into different cell types with distinct morphological and
functional characteristics. Understanding the different functions of our cells is
key to studying human biology. However, all cells essentially carry the same
Deoxyribonucleic Acid (DNA). So what causes this heterogeneity between tissues
and cells?
Initial attempts to identify distinct cell types were focusing on defining them
based on their location, morphology and interactions with other cells, as observed
under the microscope. The development of immunohistochemistry (Coons
et al., 1941) and Fluorescence-Activated Cell Sorting (FACS) (Fulwyler, 1965)
enabled measurement of specific cell surface proteins and revealed transcriptional
differences between cells with the same morphology. Although the human genome
has 20,000 to 25,000 genes (Collins et al., 2004), only a small fraction of them are
expressed in each cell. Genes and their variable expression levels can explain the
observed heterogeneity between cell types and tissues.
1
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Ribonucleic Acid (RNA)-sequencing enabled researchers to study the differences
in gene expression levels that explain the specialised functions of different cell
types. However, RNA is a much more unstable molecule compared to DNA,
thus RNA-sequencing became possible only after the development of reverse
transcription polymerase chain reaction (RT-PCR) that enabled the synthesis of
complementary DNA (cDNA) from RNA making PCR analysis of RNA molecules
possible (Freeman et al., 1999). Another limitation of RNA-sequencing compared
to DNA-sequencing, is the low amount of input material to the sequencer. For
example, a human cell contains less than 1 pg of mRNA (Kawasaki, 2004),
while most RNA sequencing kits require between 10 and 400 ng of input mRNA
material. Thus, RNA-sequencing was first used to measure gene expression levels
in samples consisting of a collection of cells, known as bulk RNA-sequencing.
Bulk RNA-seq data can be used to identify differentially expressed genes between
different samples or cell types by comparing the average gene expression levels
from a homogeneous set of cells. This leads to loss of information on the intra-
sample variance of gene expression, assuming all cells have similar transcriptional
patterns. Additionally, this requires availability of known markers for isolation of
cells of a specific type, thus it does not allow identification of novel subpopulations.
Advances in DNA sequencing and the development of single-cell Quantitative
Polymerase Chain Reaction (qPCR) (Bengtsson et al., 2008), have enabled
the measurement of gene expression at the single cell level, allowing for the
characterisation of genetic variability of heterogeneous samples. Single-cell RNA-
sequencing can unravel the heterogeneity of cell populations, especially rare
ones, that was masked until now in bulk RNA-sequencing studies. Discovery
of previously unknown cell types can be unbiased without requiring prior
knowledge of markers. Gene expression differences between populations can
now be identified based on comparisons of the distributions of gene expression
between samples, allowing for better identification of biomarkers and functional
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annotation. Additionally, single-cell RNA-sequencing allows identification of
transitioning states of cell types during development.
The most promising application of single-cell RNA-sequencing is The Human
Cell Atlas (Regev et al., 2017). Several labs around the world are collaborating
by generating good quality single-cell RNA-sequencing data from different tissues
and providing annotated cell types along with their gene expression profiles. By
combining such information with existing location and morphological information
of the different cell types this can serve as a valuable public resource for the
whole scientific community for improving our understanding of the heterogeneity
of human cells and tissues in health and disease. A similar effort to map the
heterogeneity of mouse tissues is the Mouse Cell Atlas (Han et al., 2018).
4 1.1 Experimental Protocols for single-cell RNA-sequencing
1.1 Experimental Protocols for single-cell RNA-
sequencing
Since the first single-cell RNA-sequencing data were obtained in 2009 (Tang
et al., 2009), several improvements in protocols have led to broadly accessible
and robust methods. There are two main categories of protocols for single-cell
RNA-sequencing, plate-based and bead-based. The main difference between these
two lies in the cell capturing method. Plate-based methods, such as CEL-Seq
(Hashimshony et al., 2012), Smart-Seq2 (Picelli et al. (2013), Picelli et al. (2014)),
MARS-Seq (Jaitin et al., 2014) and CEL-Seq2 (Hashimshony et al., 2016), require
manual pipetting of the cells in multi-well plates. On the other hand, with
bead-based technologies thousands of cells can be processed in one experiment
by encapsulating them into droplets (Klein et al. (2015), Macosko et al. (2015),
Zheng et al. (2017)) or into wells (Han et al. (2018), Gierahn et al. (2017)) with
barcoded beads. The best choice of protocol depends on the research questions
investigated.
Bead-based methods can yield thousands of cells as they require less manual
handling, whereas plate-based methods are restricted to hundreds of cells sorted
into 96- or 384-well plates. The difference in the number of cells processed leads
to a significant difference in the library sizes, with plate-based methods detecting
more genes per cell and allowing the identification of more subtle differences
between cell subpopulations compared to bead-based. Thus, for uncovering
unknown heterogeneity in cell populations or studying rare populations bead-
based methods can be more suitable resulting in a sufficient number of cells to
improve accuracy of unsupervised clustering (Kiselev et al., 2019). For identifying
differentially expressed genes and subtle differences between cell populations,
plate-based methods can be more appropriate by capturing more genes expressed
in each cell.
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Table 1.1 summarizes the main characteristics of all experimental protocols used
to generate the datasets presented in this thesis. These protocols will be further
discussed in the following sections.
Table 1.1: Summary of main features of single-cell RNA-sequencing experimental
protocols. UMI, Unique Molecular Identifier; UTR, Untranslated Region
Protocol Publication Platform Genomic region UMI
Smart-Seq2 Picelli et al. (2013) Plate-based full-length No
CEL-Seq Hashimshony et al. (2012) Plate-based 3’ UTR Yes
CEL-Seq2 Hashimshony et al. (2016) Plate-based 3’ UTR Yes
Chromium 10X Zheng et al. (2017) Bead-based 3’ UTR Yes
Drop-seq Macosko et al. (2015) Bead-based 3’ UTR Yes
1.1.1 Plate-based methods
In this thesis I will be using data generated with three different plate-based
protocols: Smart-Seq2 (Picelli et al., 2013), CEL-Seq (Hashimshony et al., 2012)
and CEL-Seq2 (Hashimshony et al., 2016). Smart-Seq2 is a low-throughput
method that requires little special equipment but intense manual work. Cells are
placed into 96- or 384-well plates and lysed. To increase the amount of RNA, the
extracted RNA is reverse transcribed to complementary DNA (cDNA) and cDNA
is then amplified by Polymerase Chain Reaction (PCR). The amplified cDNA of
each cell/well is fragmented and adaptors are added to each fragment to prepare
the libraries for sequencing. The main advantage of Smart-Seq2 is the ability to
capture the full-length messenger RNA (mRNA), offering good coverage of the
transcriptome, including rare transcripts, while all other methods mentioned here
only capture the 3’ Untranslated Region (UTR). Thus, Smart-Seq2 is a suitable
approach to study gene isoforms and genetic variants.
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The CELSeq (Hashimshony et al., 2012) flowchart is very similar to that of Smart-
Seq2 but it additionally integrates the use of unique molecular identifiers (UMIs)
into the primer to enable identification of PCR amplification bias. CEL-Seq2
(Hashimshony et al., 2016) is an improved protocol over CEL-Seq with increased
sensitivity, decreased hands-on time and lower price.
1.1.2 Bead-based methods
Chromium 10X (Zheng et al., 2017) was used in our lab to generate the datasets
in Chapter 3. In the 10X platform, cells mixed with barcoded beads and
reagent are encapsulated in partitioning oil to form single nanoliter droplets,
called Gel Beads in Emulsion. Cell capturing with Drop-seq (Macosko et al.,
2015) is similar to the 10X workflow, however in 10X reverse transcription is
carried out within the droplets, while in Drop-seq reverse transcription is carried
out after demulsification. Although 10X has higher sensitivity than Drop-seq, the
significantly lower cost of Dropseq makes it a preferred approach for processing
very high numbers of cells (Zhang et al., 2019a).
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1.2 Computational methods for the analysis of
single-cell RNA-sequencing data
The most common analysis of single-cell RNA-sequencing data follows the
flowchart of Figure 1.1. The first step involves sequence alignment to a reference
genome and count of the expressed genes in each cell. This returns a raw counts
gene expression matrix with genes in rows and cells in columns. Each value
indicates the number of reads mapped to a specific gene in a specific cell. To
correct for gene expression bias and differences in library depths between different
cells, gene counts are normalised with different methods. This normalised data
is used for clustering, which also involves feature extraction and dimensionality
reduction, to identify transcriptionally distinct populations in the data. The
identified clusters of cells are visualised in a two dimensional projection and
differential expression analysis is used to identify cluster-specific genes.
1.2.1 Alignment and counts
Depending on the type of protocol used to generate the data, different alignment
methods can be more appropriate. Commonly used methods are the Burrows-
Wheeler Aligner (BWA) (Li and Durbin, 2009) and STAR (Dobin et al.,
2013), although not specifically developed for single-cell RNA-sequencing data.
Alternatively, faster but accurate quantification of gene expression can be
obtained using kallisto (Bray et al., 2016) that performs pseudoalignment of
reads identifying the transcript origin of each read without the specific genomic
positions.
When UMIs are available, they can be used to collapse duplicated reads due to
amplification bias into a single read. Throughout my PhD I have been using the
CellRanger pipeline from 10X Genomics (Zheng et al., 2017) to demultiplex the
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countingFASTQ files
Gene Expression Matrix (GEM)









Figure 1.1: Flowchart of common analysis steps of single-cell RNA-sequencing data.
The pipeline starts with the alignment of fastq files and counting of reads per cell
corresponding to each gene, resulting in a counts gene expression matrix where rows
represent genes and columns cells. Raw counts are then normalised to correct for
technical differences between cells and allow comparison of gene expression across cells.
The next aim is to cluster the data to identify groups of transcriptionally distinct
cell populations, which also involves feature extraction and dimensionality reduction.
Clusters of cells can then be visualised and finally, differentially expressed genes can be
found for the identified clusters of cells.
raw base call files from Illumina sequencers to fastq files and align the reads and
obtain the gene counts matrix. CellRanger uses STAR (Dobin et al., 2013) to
align the data and additionally incorporates methods to filter low quality cells
based on the number of reads and UMIs.
1.2.2 Multiplet detection
One of the disadvantages of high-throughput isolation and barcoding methods is
the generation of multiplets which arise when two or more cells are co-captured
and encapsulated in a single bead or well with the same cell barcode. These
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libraries, called multiplets, represent hybrid gene expression profiles and can
affect the computational analysis of the data as well as the interpretation of the
results. Multiplets often form separate clusters which can be interpreted as an
intermediate biological state between the actual states of the cells that comprise
them. Additionally, they can affect the results of differential expression analysis
by reducing the gene expression difference and statistical significance of truly
differentially expressed genes. Some technical characteristics of multiplets are the
high number of transcripts and the co-expression of markers of different cell types.
The latter however, can not be applied to any project, since it requires availability
and knowledge of highly expressed and exclusive markers for the cell types that
comprise the multiplets. Filtering libraries based on the observed number of
genes is also not a robust and systematic methods as it is highly dependent on
the manual inspection of the distribution of genes per library in the data and is
highly subjective.
Computational methods have been developed for the automatic identification of
multiplets from single-cell RNA-sequencing data. Scrublet (Wolock et al., 2019)
is focusing on the identification of doublets, i.e. libraries consisting of two cells,
since these make up the majority of multiplets. Artificial doublets are calculated
as linear combinations of random pairs of cells from the data and K-Nearest
Neighbours (KNN) graphs are constructed to calculate the similarity of each
cell to the simulated doublets, which is used for the classification of the cells
as doublets or singlets, i.e. libraries that represent a single cell. A very similar
approach is implemented in DoubletFinder (McGinnis et al., 2019). Artificial
doublets are generated by averaging the gene expression profiles of random pairs
of cells from the data and again doublets are selected based on their similarity to
the artificial doublets.
All methods identify an expected number of doublets based on the experimental
design. This however, can be overly stringent or too relaxed based on the quality
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of each data set. It is thus advised that the labelled doublets are only removed
from the data after clustering and differential expression analysis, if they are found
to separate from the other cells or confound downstream analysis.
1.2.3 Normalisation
Normalisation of raw count data is essential to eliminate cell-specific bias and
decrease false detection rates when comparing gene expression across different
cells. The read counts of all genes in a cell are expected to be proportional to the
expression levels of the genes and stochastic cell-specific factors. Two common
approaches for normalisation are Counts Per Million mapped reads (CPM) and
Transcripts Per Million mapped reads (TPM) mapped reads that have been
developed for bulk RNA-sequencing data. CPM is used with edgeR for bulk
RNA-sequencing data analysis where the read count Xi of a gene i in a cell is
scaled by the total number of reads N in the cell times one million, assuming all






While CPM is a between-samples normalisation method where gene expression
is normalised by the library depth of each cell and allows comparison of
gene expression across cells, TPM (Li and Durbin, 2009) is a within-sample
normalisation allowing comparison of different genes’ expression within a cell.
TPM normalizes the gene counts by the gene’s and transcript’s length. The
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where l̃i is the effective length of gene i given by:
l̃i = li + µFLD + 1 (1.3)
where µFLD is the mean fragment length.
CPM and TPM are linear normalisation methods developed for bulk RNA-
sequencing data. However, single-cell specific technical bias, such as zero-inflation
and dropouts, are not accounted for in these approaches. Some methods proposed
for the normalisation of single cell RNA-seq data apply cell-specific normalisation
based on estimated size factors. Brennecke et al (Brennecke et al., 2013) use a
cell-specific normalisation factor calculated as follows. The geometric mean of
each gene across all cells is calculated and for each cell the median of the ratio of
the cell’s gene counts to these geometric means defines a cell-specific size factor.
Finally, the gene expression counts of each cell are normalised by dividing the
read counts by the cell-specific size factor. BASiCS (Vallejos et al., 2015) uses
a Bayesian hierarchical model to normalize the data by estimating the cell size
factors from External RNA Controls Consortium (ERCC) molecules, also known
as spike-ins. Spike-ins are synthetic RNA molecules inserted in the cells and
used to measure the detection rate of RNA-seq experiments (Jiang et al., 2011).
Instead of spike-ins, Linnorm (Yip et al., 2017) utilizes a set of automatically
detected stably expressed genes to estimate the technical bias between cells.
Alternative methods use probabilistic models to apply not only cell-specific but
also gene-specific normalisation of read counts. scVI (Lopez et al., 2018) models
the read counts of a gene as a sample drawn from a Zero-Inflated Negative
Binomial (ZINB) distribution. Hafemeister and Satija (Hafemeister and Satija,
2019) on the other hand show that Negative Binomial (NB) and ZINB models
lead to overfitting of single-cell RNA-seq data and suggest a regularised negative
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binomial regression. The regularisation is achieved by pooling information
(geometric mean) across genes with similar average expression. Finally, log
transformation is applied to reduce skewness when downstream analysis methods
assume normally distributed data.
Cole et al (Cole et al., 2019) show that different datasets require different
normalisation methods and suggest a method called scone for identifying the
most suitable normalisation method for a given single-cell RNA-seq dataset.
1.2.4 Imputation
Up to 80% of the expression values of the data can be zeros, which causes
challenges in using standard normalisation methods and similarity metrics. The
term “dropout” is used to describe the case where no reads corresponding to a
gene are observed in a cell leading to a zero value. There are two cases that lead
to dropouts: either a gene is not expressed in a cell (biological zero) or a gene is
expressed in a cell but due to poor RNA capture efficiency or technical variation
it is not captured and measured (technical zero). Methods have been developed
to impute values for technical zeros.
One approach for imputation is to use generative models to determine whether
an observed zero is biological or technical and impute values for technical zeros
from the other cells in the data. Examples of these approaches are BISCUIT
(Prabhakaran et al., 2016), CIDR (Lin et al., 2017) and scImpute (Li and Li,
2018). Other methods, such as MAGIC (van Dijk et al., 2017), apply a smoothing
of gene expression for all genes (dropouts and non-dropouts) based on pooled
gene expression from a set of “similar” cells. Finally, scImpute (Li and Li, 2018),
EnImpute (Zhang et al., 2019b) and scVAE (Grønbech et al., 2019) are examples
of methods that attempt to reconstruct the data using machine learning.
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The main concern regarding imputation is the circularity of the problem that
might lead to overimputation (Lähnemann et al., 2019). Imputation of gene
expression values for biological zeros can lead to wrong clustering of the data and
false positives in differential gene expression analysis. Thus, it is suggested that
imputation is avoided when possible and account for sparsity with appropriate
statistical models instead (Lähnemann et al., 2019).
1.2.5 Feature Extraction
According to the Human Genome Project, the human genome has 20,000 to
25,000 genes (Collins et al., 2004). However, only a small fraction of them are
expressed in a cell, depending on its cell type. Of those expressed genes, only a
small fraction of genes can distinguish the different cell types, since many genes
that are involved in generic cell functions are shared between cells of different
cell types (housekeeping genes). Thus, single-cell analysis methods that aim to
identify and characterize the different cell populations within a single-cell RNA-
seq dataset start by extracting those informative features in order to reduce the
dimensionality of these highly sparse datasets.
The most common approach of feature extraction is selection of highly variable
genes. Highly variable genes are selected based on the relationship between
average expression and variance for analysis with Seurat (Hoffman et al., 2018).
It is known that variance depends on average expression level of a gene, with
variance increasing for lowly expressed genes (Grün et al., 2014). To account for
this mean-variance relationship, Stuart et al. (2019) apply a variance-stabilizing
transformation prior to fitting a linear regression between average expression and
variance. Hao et al. (2019) suggest a similar approach but the genes are first
categorised into bins based on their average expression levels and a bin-specific
linear regression is fitted between the coefficient of variation and the mean gene
expression. Other methods, such as M3Drop (Andrews and Hemberg, 2019) and
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scmap (Kiselev et al., 2018), select features based on the relationship between
average expression and dropout rate.
All the above methods select a user-defined number of top highly variable genes
(HVGs). However this number is not intuitive and there is no systematic way to
estimate a suitable number according to each dataset. Systematic evaluation of
several methods of selection of highly variable genes has shown very small overlap
between HVGs selected with different methods and unstable performance across
different datasets as evaluated by the result of unsupervised clustering (Yip et al.,
2018).
1.2.6 Dimensionality Reduction
Even though feature extraction can reduce the dimensions of the data for
clustering or other downstream analysis, dimensionality reduction methods are
additionally used to obtain a low-dimension representation of the data that can
uncover the underlying biological characteristics and reduce the noise. It has
been shown that fewer dimensions than the total number of genes measured in a
single-cell RNA-seq dataset are sufficient to describe the transcriptional programs
of the cell populations (Heimberg et al., 2016).
The reduced dimensions are linear or non-linear combinations of the original
features (genes). Principal Component Analysis (PCA) is the most commonly
used linear dimensionality reduction method (Butler et al. (2018), Kiselev et al.
(2017)). Principal components are selected based on their contribution to the
variation of the data, selecting those components with highest contribution. A
heuristic method to identify the number of principal component required is the
use of an “elbow” plot, where components are plotted against the percentage
of variance they explain. The number of principal components is selected near
the “elbow” of the curve, where the variance becomes stably low for any new
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component included. Another method, called jackstraw, uses a permutation
test. Permuted subsets of the data are used to run PCA and construct a null
distribution of principal components scores and test whether a gene is significantly
associated to a principal component as well as determine the number of sufficient
components (Macosko et al. (2015), Chung and Storey (2015)).
1.2.7 Clustering
Clustering is a typical step in single-cell RNA-seq data analysis. Organizing
the cells based on shared transcriptional patterns helps identify biologically
and functionally distinct populations in a sample. There are several different
clustering methods and tools available. SC3 (Kiselev et al., 2017) and SIMLR use
k-means clustering to group the cells into k clusters by minimizing the distance of
each cell to the centroid of the cluster it is assigned to and optimizing the centroids
to be distant from each other. SC3 (Kiselev et al., 2017) uses a combination
of Euclidean, Pearson and Spearman distance metrics to measure the similarity
between cells. SIMLR on the other hand uses Gaussian kernels based on the
Euclidean distance between cells to construct the similarity matrix for clustering.
A graph-based approach is implemented in Seurat (Butler et al., 2018). Graph-
based clustering, such as the KNN and the Shared Nearest Neighbours (SNN)
graphs (Xu and Su, 2015), represent the data as graphs with cells being the nodes
connected by weighted edges, with weights representing a measure of similarity
between two cells. In Seurat, a graph is constructed based on Euclidean distance
in PCA space and the weight between two cells is calculated based on the overlap
of the sets of their neighbours (Jaccard distance). Clusters are identified in the
constructed neighbourhood using the Louvain method for community detection
(Blondel et al., 2008), where communities are detected so that the density of the
network within a community is maximised compared to the density of a random
network.
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1.2.8 Visualisation
Visual inspection of the data can be achieved by projection of the cells onto two
dimensions. Due to the high dimensionality of the data, dimensionality reduction
is again required to identify the underlying manifold of the data in order to place
transcriptionally similar cells closer together.
t-distributed Stochastic Neighbour Embedding (tSNE) has been shown to preserve
the local structure of high-dimensional data data (Van Der Maaten and Hinton,
2008). The low-dimensional space resulting from tSNE represents pairwise
similarities between cells, where the similarity between a cell ci and a cell cj
represents the probability of cj being selected as a neighbour of ci if neighbours of
ci were selected from a probability density function under a Student-t distribution
centred at ci.
A modification of t-SNE is the Uniform Manifold Approximation and Projection
(UMAP) that computes a fuzzy topological representation of the original data
(McInnes et al., 2018). The set of cells is represented as a graph network and
cells (nodes) are connected to their nearest neighbours via edges with weights
representing the similarity between them. Becht et al. (2019) claim that UMAP
can better capture the global structure of the data compared to t-SNE. This means
that while projection of cells with both t-SNE and UMAP shows information on
the homogeneity of the cells within a cluster by their closeness in a two dimensional
space, between-cluster distances are better reflected by UMAP compared to t-
SNE. However, comparison of the two algorithms showed that they both preserve
the global structure of the data equally well and both algorithms’ performance is
highly dependent on the initialisation parameters (Kobak and Linderman, 2019).
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1.2.9 Differential gene expression analysis
Differential gene expression analysis can reveal cluster-specific changes in gene
expression between different cell types or states across different conditions. This
can help understand the role of specific cell types in development (Karaiskos
et al., 2017), disease (Stubbington et al., 2017) and drug response (Kang et al.
(2018), Kim et al. (2015)). Methods such as DESeq2 (Love et al., 2014), edgeR
(Robinson et al., 2009), and limma (Wu et al., 2015) developed for bulk RNA-
seq data, identify differentially expressed genes between two groups of samples
by comparing the average gene expression between them. Although systematic
evaluation of accuracy has shown these methods do not perform worse than
methods that have been developed for single-cell RNA sequencing data, their
accuracy depends highly on suitable filtering of the data prior to the analysis
(Soneson and Robinson, 2018).
While distributions of gene expressions over bulk samples are often unimodal,
single-cell gene expressions are often multimodal, even when all cells represent a
homogeneous population (Korthauer et al., 2016). This is due to both biological
and technical variability between cells. Methods developed specifically for single-
cell RNA-seq data can account for high levels of noise and dropouts. Such methods
additionally test for differences in how a gene’s expression is distributed as well
as differences in proportions of zeros between groups of cells, rather than just
differences in average expression (Vallejos et al., 2016).
scDD (Korthauer et al., 2016) uses Bayesian modelling to test whether a gene’s
expression is differentially distributed under different biological conditions. The
log-transformed non-zero expressions of a gene under two conditions are used to
test the null hypothesis that the data arise from two equal distributions modelled
as a Dirichlet process mixture of normal distributions. The zeros that are excluded
from the above test are used to test for differential proportion of zeros between the
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two conditions using a χ2 test. scDE (Kharchenko et al., 2014) uses raw counts
and models the gene expression as a mixture of Negative Binomial distributions,
for detected reads of a gene similar to methods developed for bulk RNA-seq data
(Love et al. (2014), Robinson et al. (2009)), and a Poisson distribution to account
for the dropout events.
Extensive comparison of various methods for differential gene expression analysis
from Soneson and Robinson (2018) showed that MAST (Finak et al., 2015)
outperformed other methods developed for single-cell RNA-sequencing data.
Details of this method will be discussed in Chapter 2, where MAST was selected
for differential gene expression analysis.
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1.3 Computational challenges of scRNA-seq
data analysis
1.3.1 Technical variability and dropouts
Single-cell RNA-seq analysis poses several computational and statistical
challenges (Stegle et al., 2015). Unlike bulk RNA-sequencing data, the low
amounts of mRNA available and the amplification bias lead to unbalanced relative
gene expressions between the cells (Kharchenko et al., 2014). Technical variability
between cells causes expression levels of genes being overdispersed. Additionally,
for a high number of genes no corresponding reads are observed in many cells
(dropout events). Even if two cells are of the same cell type, many genes expressed
in one of the cells are not detected in the other cell (Kharchenko et al., 2014).
The resulting high levels of dropouts and outliers pose challenges for normalisation
and use of traditional similarity metrics used in clustering of bulk RNA-seq data
(Kharchenko et al., 2014).
The variance measured reflects both the biological and the technical variation,
which can be split into technical noise due to sampling and technical noise due
to library depth differences between cells. While the latter can be corrected by
normalizing the data as explained above, the sampling noise depends on the gene
expression, with noise increasing with decreased gene expression (Grün et al.,
2014). It has been shown that as the expression of a gene (x -axis) increases,
the percentage of zero values across the cells (y-axis) decreases (Bacher and
Kendziorski, 2016). While this is observed in both bulk and single-cell data,
moderately expressed genes that are captured in bulk experiments have high
dropout rates in single cell RNA-seq.
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1.3.2 Batch effect
An additional challenge is technical variability that exists between data that have
been processed separately, known as a batch effect. Data that have been generated
in different labs or at different times show systematic technical differences that
confound biological variation of gene expression. Such differences in single cell
data can lead to both differences in the dynamic range of gene expression, as well
as to differences in dropout rates.
Batch effect correction methods developed for bulk RNA-sequencing data (Wu
et al. (2015), Johnson et al. (2007)) assume samples within each batch are
biological replicates, thus they have similar cell composition and normally
distributed gene expression. Systematic differences in average gene expression
between samples of different batches are identified as technical variation due to
batch and regressed out.
Single cell RNA-sequencing data, on the other hand, consists of a heterogeneous
mixture of cells. A single cell theoretically does not have a replicate. This absence
of biological replicates poses computational challenges in integrating data that
have been generated separately using existing methods.
However, data integration is important for several reasons. Increase of cells
representing a population leads to more accurate results in unsupervised clustering
and provides computational power to resolve transcriptionally similar and rare
cell types (Kiselev et al., 2019). The vast amount of publicly available data
(Regev et al., 2017) enables such analysis, assuming that it is able to overcome
batch effects. Finally, in order to understand the role and altered states of cell
populations in disease, cross-condition comparison is required.
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1.4 Aims and outline of thesis
During my PhD, I worked towards the development of computational methods
and pipelines for the analysis of single-cell RNA-sequencing data to enable the
study of immune cell populations and their states and role within the tumour
microenvironment. My main interest was to identify novel subpopulations,
cell state changes across conditions that are associated with survival and
immunotherapy response, as well as to discover biomarkers that could be
potentially used for targeted therapies. In this thesis I present the results from
this work.
The first challenge I encountered for the comparison of equivalent populations
across datasets and conditions was the presence of batch effects. In Chapter
2 I discuss the effect of technical variance due to batch in combining multiple
datasets and present a new method, called scID, that allows identification of
transcriptionally equivalent cell populations between datasets. Through extensive
validation with several datasets and comparison to other existing methods, I
show that scID is outperforming other methods in cases of datasets with strong
imbalances in numbers of cells and sequencing depth.
In Chapter 3, I use scID and other published methods to analyse two datasets
of γδ-T cells from peripheral blood mononuclear cells (PBMCs) of three healthy
donors and two datasets of immune cells from two breast tumour patients. My
aim is to identify what subpopulations exist, what are the gene signatures that
define them and what are their putative functions. I also seek to compare the
identified subpopulations between Peripheral Blood Mononuclear Cell (PBMC)
and breast tumour and test whether any of the subtypes correlates with clinical
phenotypes, such as survival rate, metastasis or immunotherapy response.
An alternative method to overcome batch effects allowing the comparison of cell
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populations across donors and conditions is to pool cells from multiple donors in
a single scRNA-seq experiment, while simultaneously decreasing the per-sample
library cost. Experimental methods that enable tracking of donor identity of each
cell require heavy manual processing and are costly. Computational methods,
on the other hand, can enable identification of donor identities of cells based
on genetic mutations. Technical factors, such as sparsity and gene fragment
capturing, as well as biological factors, such as cell-type-specific gene expression,
can be challenging. In Chapter 4 of this thesis I explore deep learning to
demultiplex donor identities in pooled single-cell RNA-seq datasets using genetic
variation.
Finally, in Chapter 5 I discuss how these methods can improve the analysis of
single-cell data and how our understanding of γδ-T cells has improved based on
the results from these four datasets. Moreover, I discuss future improvements




equivalent cells across datasets
with scID
2.1 Introduction
Single cell RNA-sequencing enables the study of cell type specific changes
in development and disease (Regev et al., 2017). As deeply characterised,
extensively validated and annotated tissue, organ and organism level atlases
are increasingly being generated (Han et al., 2020), it is worthwhile to reuse
such high-quality information to identify known populations of cells in new
datasets obtained from equivalent tissues across different conditions in order to
study condition specific changes in cell populations. Identification of condition-
specific transcriptional changes of cell populations can help understand their role




There are various computational challenges in comparing cells across datasets,
with the most important being batch effect. Technical variation between samples
that have been processed separately interferes with biological variability (Hoffman
et al. (2018), Haghverdi et al. (2018), Kiselev et al. (2019)). Batch effect can
lead to different dynamic range of gene expression and different dropout rates
between datasets. Thus, genes that can separate cell populations in one dataset
might be noisy or completely absent from another. Such technical variation is
difficult to separate from biological variation, especially in cases when pairs of data
include equivalent cell types but examined under different biological conditions,
e.g. control and stimulated or healthy and disease. Additional challenges are
introduced when there is only partial overlap between the cell types present in
each dataset. Finally, the presence of transcriptionally similar cell subtypes in
the dataset poses an additional challenge as biological variability between them
is even lower and closer to technical noise levels.
2.1.1 Batch effect correction
Batch effect correction methods have been developed to disentangle the biological
from the technical variance across datasets and enable combined analysis such
as clustering and identification of differentially expressed genes (Hoffman et al.
(2018); Haghverdi et al. (2018)). One approach for batch effect correction is
to model the gene expression variation that is due to technical bias between two
datasets and alter the measured gene expression values to remove it. On the other
hand, alignment approaches aim to combine two datasets using common gene
expression patterns in order the equivalent cell types to overlap in a transformed
reduced-dimensional space but without quantifying the effect of batch in each
specific gene that is measured.
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Canonical Correlation Analysis
One approach for alignment of two or more single-cell RNA-seq datasets uses
canonical correlation analysis (CCA) to identify a shared correlation structure
that can be used to model the common sources of variation between the datasets
(Hoffman et al. (2018), Butler et al. (2018), Stuart et al. (2019)). Similar
to Principal Component Analysis (PCA), CCA returns vectors that represent
’metagenes’ defined as a weighted linear combination of the highly correlated
genes. Next, the cells of the different datasets are aligned in this conserved low-
dimensional space of CCA vectors, using dynamic time warping to account for
imbalanced cluster sizes between the datasets. The aligned data can then be
clustered to identify subpopulations.
Highly variable genes, i.e. genes with higher variance than expected based on
their average expression, are selected for CCA. This is expected to capture cluster-
specific genes that are highly expressed in one cluster and lowly expressed in the
rest of the cells. However, for genes that can identify rare populations in the data
both the mean expression and the variance are expected to be very close to zero,
since these genes will be zero in almost all cells of the dataset, thus they might
not be selected. This might lead to rare populations being misaligned. Another
limitation of CCA is that rare populations that are unique to each dataset and
cannot be described by the shared correlation structure, are withdrawn from any
further analysis such as clustering and identification of differentially expressed
genes. However, it is still very informative to know and include populations that
are specific to one dataset/condition and study of rare populations is one of the
strengths of single-cell RNA-sequencing.
Mutual Nearest Neighbours
Haghverdi et al. (2018) on the other hand developed a batch effect correction
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method by matching mutual nearest neighbours (MNN). Assuming there is at
least one common cell population between the datasets, MNN applies cluster-
specific batch effect correction. As a first step, MNN identifies equivalent cells
across the two datasets using Euclidean distance. More specifically, for each cell in
each dataset, MNN the k nearest cells from the other dataset based on Euclidean
distance. Then two cells, each from one of the two datasets, are expected to be
equivalent if they are both in each other’s k nearest neighbours. For each pair of
equivalent cells any systematic difference in the gene expression is regarded as a
batch effect and is then removed from the data. Given the merged, batch-effect-
corrected gene expression matrix of the two datasets, downstream analysis can
cluster the cells to identify subpopulations.
Another assumption of MNN is that the batch effect is orthogonal to the biological
variation. However, in cases where the two datasets consist of equivalent cell
populations under different conditions, for example control and treatment or
normal and tumour, the batch effect is confounded by actual biological differences
that will be treated as technical variance and removed by this method.
Finally, MNN assumes that the technical variance is much smaller than the true
biological variance. However, it is unclear whether this is the case when comparing
different scRNA-sequencing methods, e.g. plate-based versus droplet-based, or
datasets with strong imbalances in sequencing depth.
A general observation from using these two methods is that cluster identities
of the cells differ between clustering the data separately and after batch effect
correction, even for datasets with a number of cells per cell type that is sufficient
to lead to stable and trustworthy clustering with unsupervised methods. This
was also the case for some of the datasets analysed in this chapter (see Figure
2.19 and Figure 2.22), especially when there were strong batch effects between
the reference and the target datasets.
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2.1.2 Mapping
A different approach for identifying transcriptionally equivalent cells across
datasets without the need for batch effect correction is mapping. Assuming one
dataset has known clusters (curated or trustworthy due to high number of cells),
features (genes) can be extracted from these reference clusters and used to identify
equivalent cells in other datasets. Such dataset with known cell type classification
is referred to as reference. Any new dataset we seek to label using a mapping
method is referred to as target.
The most intuitive method is a biomarker-based approach that is the
computational equivalent of Fluorescence activated cell sorting (FACS). In this
approach, we expect that each defined reference cluster has a uniquely and highly
expressed gene that can be used as a biomarker to identify equivalent cells in a
different (target) dataset. Although simpler than FACS, since it does not require
the biomarkers to be surface proteins, there are several computational challenges.
The most important of these is the dropout problem of scRNA seq data (Bacher
and Kendziorski (2016); Stegle et al. (2015); Vallejos et al. (2017)). Due to the
dropout events, the probability of a biomarker being detected in all cells of the
respective population is very low, even in very deeply sequenced data. Thus,
computational identification of such a gene that is specifically expressed in all
cells of a reference cluster is challenging, leading to methods failing to label many
target cells, especially in ultra-sparse datasets.
This situation becomes even more challenging when similar subpopulations exist
in the dataset. In such cases biomarkers are not categorical, i.e. they don’t
have distinct absence/presence state in the cells but they might be shared or
expressed at lower levels. In order to distinguish between transcriptionally similar
cell populations a longer list of genes is required. Classifying cells based on
the collective expression of a set of genes requires, however, a more systematic
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approach that can take into account the probability of gene being dropped out
and its biological significance for defining a cell type.
scmap
To map cells from target scRNA-seq data to a reference data, scmap (Kiselev
et al., 2018) extracts features from each reference cluster and uses a combination
of distance and correlation-based metrics to quantify the closeness between each
reference cluster’s centroid and the cell in the target data and then to assign
target cells to reference clusters. To reduce the effect of scale difference in
gene expression between the reference and the target data, scmap uses cosine
similarity and correlation metrics that range [-1, 1]. However, distance metrics in
high dimensional space may not work as expected, as the contrast between the
distances to different data points does not exist (Aggarwal et al., 2001).
In scmap, features are extracted based on the relationship between the average
expression and the dropout rate as measured by the number of zeros. More
specifically, a linear model is fitted between the mean expression and the number
of zeros of each gene and genes that have higher number of zeros than expected
based on their average expression are selected as cluster-specific features (Andrews
and Hemberg, 2019). Markers of rare clusters, however, are expected to have
high number of zeros and low mean expression, since zeros are included in the
calculation, which will be the same as the behaviour of noisy genes. It is thus
expected that genes of rare clusters will not be included in the extracted features
and that small clusters will thus be missed.
CaSTLe
CaSTLe (Lieberman et al., 2018) classifies target cells using gradient tree boosting
(XGBoost), a machine learning classification method that consists of an ensemble
of regression trees (Chen and Guestrin, 2016) whose results are combined to
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provide the final classification. Features are selected based on average expression
and mutual information with the reference cluster identities and highly correlated
features, with Pearson correlations greater than 0.9, being removed. The XGBoost
classifier is then trained using the selected features and the reference data and
subsequently used to classify the target cells.
CaSTLe was shown to outperform majority vote and linear regression classifiers
but has not been assessed systematically against published single-cell RNA-seq
mapping methods. Feature selection using highly expressed genes is expected to
miss markers of rare clusters but this could potentially be corrected by including
genes with high mutual information with the reference cluster identities. On the
other hand, using both reference and target datasets combined to calculate the
average expression is expected to perform poorly when pairs of data have different
sequencing depths. Finally, CaSTLe arbitrarily selects without justification,
at maximum, 200 features; the union of the top 100 highly expressed genes
and the top 100 based on mutual information, which might overlap without
any justification. However, the number of features required for a multi-class
classification is expected to depend on the number of classes and the similarity
between them. Consequently, 200 features might not always suffice.
2.1.3 Aim of this Chapter
In this chapter I present a new method called scID for identifying transcriptionally
related groups of cells across datasets by exploiting information from both the
reference and the target datasets without making any assumptions regarding
the nature of technical and biological variation in these datasets. Unlike the
previously mentioned mapping methods, i.e. scmap and CaSTLe, that use
highly variable and highly expressed genes, scID uses cluster-specific differentially
expressed genes extracted from the reference to label the cells in the target
dataset. Alternatively, scID can use any user-specified list of genes that can
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identify a population, for example from bulk RNA-seq data or manually curated,
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Figure 2.1: Graphical abstract of scID. scID can label the cells of a given scRNA-seq
target dataset either based on the labels of a given labelled reference scRNA-seq dataset
or identify cells enriched for a given list of genes.
I provide an extensive analysis of published datasets with batch effect and strong
asymmetry in cell number and library sizes per cell for which the independent
clustering of the target data via an unsupervised method is not obviously similar
to that of the reference. Through this analysis I show that scID has increased
classification accuracy compared to the above-mentioned alignment and mapping
methods, i.e. CaSTLe, CCA, MNN and scmap. Thus, scID helps uncover hidden
biological variation present between scRNA-seq datasets that often vary greatly
in batch effect and quality (i.e. different numbers of cells, dropout levels and
dynamic ranges of gene expression).




Given a reference and a target gene expression matrix with rows representing genes
and columns cells, and the cluster identities of the reference cells, scID identifies
target cells equivalent to the reference clusters in 3 steps (Figure 2.2). scID splits
this multiclass labelling problem into multiple binary classification problems, one
for each reference cluster. Thus, for a reference cluster C = {ri|L(ri) = C}
consisting of all cells r with class label L() equal to C , in the first step, scID
identifies a set of k = kp + kn features/genes (signature) that are positive (kp)
and negative (kn) markers for this cluster, hereon referred to as a gene signature.
In the second step a weight is assigned to each gene of the signature (wi, for
i = 1, 2, ...k) that represents its power to discriminate the cells of cluster C from
all other cells in the dataset. In the last step, scID selects target cells equivalent to
reference cluster C based on their score sCj . The term “equivalent” here on refers
to transcriptionally equivalent cell populations with respect to the given gene
signature. Given a homogeneous reference cell population with specific functions
defined by the extracted gene signature, the target cells selected by scID are
expected to be also biologically equivalent.













for j = 1, ..., n, where n is the total number of cells in the target, g̃ji ∈ [0, 1] is
















































For each target cell j
calculate score
for each gene signature
Step 3
Assign cell j to 
reference cluster
by fitting Gaussian 





































































Figure 2.2: Overview of scID steps. The three main steps involved in mapping cells
across scRNA-seq data with scID are as follows: In Step 1, gene signatures are extracted
from the reference data (shown as clustered groups on a reduced dimension). In Step
2, discriminative weights are estimated from the target data for each reference cluster-
specific gene signature. Finally, in Step 3, every target cell is scored for each feature
and is assigned to the corresponding reference cluster.
reflects the discriminatory power of gene i, defined as the distance between the
mean expression or the centroids of the C and C− = {ri|L(ri) 6= C} populations
on the projected dimension of that gene.
To reduce sensitivity of outliers and unequal contribution of genes due to
differences in expression levels, the gene expression values are scaled to [0, 1]
by the 99th percentile instead of the maximum, i.e. g̃ji = min(
gji
P99
, 1), where gji
is the library-depth normalised expression of gene i in cell j and P99 is the 99
th
percentile of its expression across all target cells. For genes that are zero in more
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than 99% of the cells, the maximum can be used instead to avoid division with
zero.









where µCi , σ
C
i represent the mean and standard deviation, respectively, of




i represent the mean and
standard deviation, respectively, of gene i in all other clusters (C−). Each term





































where lC is the number of cells in cluster C and N is the total number of cells in
the reference data.
This definition of the weights is using the framework of Linear Discriminant
Analysis (LDA) (Fisher, 1936) to define a measure of the signal-to-noise ratio
as the ratio of the variance between the classes to the variance within the classes
(Figure 2.3). Based on Fisher’s LDA, this metric is quantifying the distance




















Figure 2.3: Fisher’s Linear Discriminant Analysis for binary classification (LDA).
full covariance matrix would better capture the relationships between clusters,
especially in presence of similar cell types. However, we have chosen to
approximate the covariance matrix as diagonal for computational efficiency, but
also due to limitations posed by the nature of scRNA-seq data. When datasets
have sparse coverage, the covariance matrix is not full rank and cannot be inverted.
Additionally, when the list of genes is long, computing the full covariance matrix
is not just computationally inefficient but also error prone due to insufficient
number of samples (cells).
Choosing the weights in this way penalises high variability and low mean
expression of positive markers within the cluster of interest in order to account
for the following cases:
1. When a positive marker is not expressed uniquely in the cluster of interest,
µC
−
i will increase hence reducing the weight, as it does not provide sufficient
evidence for classification.
2. When a positive marker is expressed only in a subpopulation of the cluster
of interest, σCi will increase hence reducing the weight, so that a cell’s score
does not drop sharply when this gene’s expression is zero. This also accounts
for genes with a high dropout rate even though they might be specific and
sensitive markers.
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3. Finally, non-discriminative genes that are also present in other cell
populations will be down-weighted, as the numerator µCi −µC
−
i will be low.
Similarly, negative markers are expected to have negative weights since µCi < µ
C−
i
penalizing cells that express these genes.
Although we can compute the weights from the reference data, estimating them
from the target data can lead to improved accuracy, due to adjustments to
the technical (e.g. library depth) and the biological (e.g cell composition)
characteristics of the target data. However, to do this we need to select target
cells that are likely equivalent to the reference cluster C. The target cells (denoted
as c) that express the kp set of signature genes precisely and specifically and do
not express the kn set of genes are selected as equivalent to the reference cluster C
by clustering the target cells in the differential precision - differential recall space,
metrics motivated from precision and recall (Figure 2.4).
In general, the precision of a cell expressing a set of genes is defined as the total
number of expressed genes that belong to the given set divided by the total number
of expressed genes; and recall is defined as the number of expressed genes that
belong to the set divided by the total number of genes in the set. So, for the set






where npme: number of positive markers expressed npm: total number of positive
markers ne: total number of expressed genes
A cell expressing all positive markers will have recallp = 1 and a cell expressing
only positive markers (and no other genes) will have precisionp = 1. However,
since the majority of genes expressed in a cell will not be markers (there are
















































































































































































































































































































































































































































































































































































































































BC7 (Cone Bipolar cell 7)
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Figure 2.4: Projection of mouse retinal cells in the precision-recall space for the Rod
Photoreceptor gene signature (Shekhar et al., 2016). Each dot represents a cell coloured
based on its cell type label. Rod photoreceptors lie in the first quadrant of the precision-
recall space with recall close to 1 and precision much lower than 1 but still higher than
non rod photoreceptor cells.
one. Cells equivalent to the reference cluster C will be in the first quadrant of the
(precisionp, recallp) space, close to (1, 1), and other cells not expressing positive
markers will be close to (0, 0) (Figure 2.4).
However, when transcriptionally close cell types exist in the dataset, positive
markers are not sufficient to distinguish between them as some of the markers
will be shared across more than one cell type (Figure 2.5).
For this reason, scID takes into account negative markers as well, i.e. genes that
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Figure 2.5: Projection of mouse retinal cells in the precision-recall space for the BC7
upregulated gene signature (Shekhar et al., 2016). Each dot represents a cell coloured
based on its cell type label. Due to transcriptionally similar cell types being present in
the dataset, BC7 cells do not cluster separately from the other cell using only positive
markers..








where nnme: number of negative markers expressed nnm: total number of negative
markers ne: total number of expressed genes
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Similar to precision-recall for the positive markers, a cell expressing all negative
markers will have recalln = 1 and a cell expressing only negative markers will
have precision = 1. Thus, cells equivalent to the reference cluster C should be in
the third quadrant of the (precisionn, recalln) space, close to (0, 0), while other


































































































































































































































































































































































































































































































































































































































































































































































































































































BC7 (Cone Bipolar cell 7)
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BC7 (Cone Bipolar cell 7)
Figure 2.6: Projection of mouse retinal cells in the precision-recall space for the BC7
downregulated (negative) gene signature (Shekhar et al., 2016). Each dot represents a
cell coloured based on its cell type label. BC7 cells are expected to be close to (0, 0)
since they should not express any negative markers.
To identify target cells transcriptionally equivalent to reference cluster C, we
have combined the precision and recall for positive and negative markers into the
differential precision (DP ) and differential recall (DR) metrics.
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DP = precisionp − precisionn =
npme−nnme
ne
DR = recallp − recalln = npmenpm −
nnme
nnm
In this new space target cells equivalent to cluster C will be close to (1, 1), cells
very different from cluster C will be close to (−1,−1) and cells belonging to
clusters that are similar to cluster C and share markers will be around (0, 0)
(Figure 2.7). This will help separate cluster C from similar clusters that could
be grouped together when using only the positive markers. Additionally, this will
exclude doublets that consist of a cell equivalent to cluster C and a cell of another
cell type, as both positive and negative markers will be expressed.
To select putative positive and negative training populations from the DP-DR
space, we cluster the cells using different finite Gaussian mixture models (Scrucca
et al. (2016)) and select the model with the lowest Bayesian Information Criterion
(BIC). The cluster with highest DP and DR is selected as putative positive cluster
c and the remaining cells are used as putative negative cluster c−. In very rare
cases where the highest DP and the highest DR refer to different clusters the
cluster highest DP is selected as putative positive cluster c and the cells of the
cluster with highest DR are discarded from the training set. DP is expected to
have higher discriminatory power than DR as it ensures that the selected set
of cells has low false positives, thus providing a set of correct cells to represent
cluster c. High DR on the other hand, ensures that all true cells belonging to c are
selected but does not provide any information of how contaminated the selected
set of cells is with cells belonging to c−.
At this point we should note that recall can be close to one for a cell that matches
the gene signature in an ideal case scenario where dropout rate in the dataset
is very low. Precision on the hand cannot reach 1 since a cell is expressing
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Figure 2.7: Projection of mouse retinal cells in the differential precision- differential
recall space for the BC7 gene signature (Shekhar et al., 2016). Each dot represents a cell
coloured based on its cell type label. BC7 lie in the first quadrant of the precision-recall
space with recall close to 1 and precision much lower than 1 but still higher than other
cell types.
classification. However, target cells that are transcriptionally equivalent to the
respective reference cell type are expected to be more enriched for the signature
genes and hence have higher precision than other cells. Thus clustering can be
used to identify putative transcriptionally equivalent target cells.
Analogous to computing the weights from the reference data, weights can also be
computed from the target dataset using the training sets of cells (c and c−).










where µci , σ
c
i represent the mean and standard deviation, respectively, of




i represent the mean and standard
deviation, respectively, of gene i in all other clusters (c−). Each term of the weight





































where lc is the number of cells in cluster c.
Thus, we compute the weights from the target data, after identifying a subset of









where µc̃i , σ
c̃2
i represent the mean and variance, respectively, of expression of gene




i represent the mean and variance of gene
i in the rest of the target cells c̃−.
Then, to identify target cells transcriptionally equivalent to reference cluster c, we
fit different finite mixtures of Gaussians on the scores sC (Equation 2.1), select
the best model as indicated by the Bayesian Information Criterion (Schwarz,
1978) and assign cells that belong to the population with highest average score
to reference cluster C.
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When the reference data consist of highly similar clusters, the features of one
cluster can be correlated with the features of another cluster. This is expected
to lead to scID assigning multiple reference clusters to a target cell. To resolve
this, the scores of target cells sCj are first z-score normalised and the ambiguous
cells are assigned to the reference cluster with the highest normalised score. A
limitation of this approach is in cases of scores of a cell for two different signatures
are very close. One solution could be to explore information from the reference
and define a minimum relative ratio between two close scores required for a cell
to be unambiguously classified. However, this has not been implemented in the
version of scID presented in this Chapter due to time limitations.
2.2.2 Identification of cluster-specific features
scID uses differentially expressed genes extracted from each reference cluster as
cluster-specific features using the MAST method (Finak et al., 2015). MAST
implements a hurdle model to identify differentially expressed genes between two
groups of cells, assuming a bimodal distribution of gene expression that arises
from both the stochastic nature of single cell RNA-seq data, i.e. dropout events,
but also from the underlying biology of datasets that consist of transcriptionally
different cell populations. Hurdle models (Cragg, 1971) are two-part models used
for data with excess numbers of zero values and overdispersion and specify one
process for the zero and one for the non-zero values.
In MAST, the expression level of a gene is modelled using a Bayesian logistic
regression:
logit(P (Zig = 1)) = Xiβ
D
g (2.6)
where Zig is a binary variable indicating whether gene g is expressed in cell i
above zero or a selected background level.
Next a Gaussian is used to model the positive gene expression, i.e. given Zig = 1
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as
P (Yig = y|Zig = 1) = N(XiβDg , σ2g) (2.7)
where Yig is the log2(TPM + 1)-normalised expression of gene g in cell i.
Information from the two parts of the model (Eq. 2.6 and Eq. 2.7) are combined
to infer cluster-specific changes in gene expression.
MAST also uses the proportion of genes detected in each cell, referred to as
cellular detection rate (CDR), as a covariate in each part of the model to account
for variability between cells and decrease background correlation between genes.





2.2.3 Gene expression normalisation
When datasets were available as UMI counts, Counts Per Million mapped reads
(CPM) library-depth normalisation was performed prior to the analysis with scID.
CPM is a between-sample normalisation method that scales the read counts of
each gene by the total number of reads captured per sample (cell) (Law et al.,
2014). Thus, the CPM-normalised expression level of a gene i in a cell with N





This normalisation enables comparison of a gene across multiple cells but not
comparison of expression levels of different genes within the same cell.
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2.2.4 scID implementation
scID is available as an R library on GitHub (https://batadalab.github.io/
scID). scID uses MAST as implemented in the Seurat package for feature
extraction. Selection of training populations from the target data in the
differential precision - differential recall space is implemented using the Mclust
function of the mclust package and the final identification of equivalent cells
based on the scID scores is implemented using the densityMclust function from
the same package.
scID has the following user-specified options:
• logFC: Threshold of loge fold change between the mean expression of a gene
in the cluster of interest C and the mean expression of that gene in all other
cells C−1 for extracting cluster-specific genesets from the reference data.
• estimate_weights_from_target: Option to estimate the gene signature
weights using the target data by selecting training sets using the precision-
recall-like approach (default).
• only_pos: Use only positive marker genes from each reference cluster.
When set to FALSE both positive and negative markers are used.
2.2.5 Biomarker-based classification of cells
To assign labels to target cells using the biomarker-based approach we
implemented a computational method equivalent to FACS. To overcome missing
cells due to dropouts we used two markers for each cell-type instead of one
(referred to as biomarkers). Using more than two markers increases the chance of
observing one of the biomarkers in a cell of a different cell-type, hence increasing
the number of ambiguous cells, as explained below. The two genes with highest log
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fold expression change from differential expression analysis are used per reference
cluster.
Such biomarkers are expected to be highly expressed and not just present in the
respective cell type. Thus we need to select a gene-specific threshold of expression
over which we accept that the biomarker is highly expressed. Since expression
level is relative to each dataset, depending on the sequencing depth and other
technical characteristics, we infer this threshold from the expression of the gene
in the target dataset. To be unbiased, we select thresholds based on different
fractions of the gene’s expression across all target cells (0.10, 0.25, 0.50 and 0.75).
For thresholds below 0.1 all cells were classified as ambiguous and for thresholds
over 0.75 all cells were classified as orphans. Using one of these thresholds of gene
expression, we binarize the gene expression data, and count which biomarkers are
present (value of 1) in each cell.
We require at least one of the biomarkers of a cell type to be expressed in the cell
for labelling. Cells that express biomarkers of a single cell type are assigned to
the respective cell type. Cells that express biomarkers of multiple cell types are
labelled as ambiguous and cells that do not express any biomarker are labelled
as orphans. For assessing the performance of alignment and mapping methods
when “ground truth” labels are not available, we use the uniquely classified cells
from this approach.
2.2.6 Evaluation of classification accuracy
To evaluate the classification accuracy of each method we used the following
evaluation metrics.
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True Positive and False Positive Rate
In binary classification, the True Positive Rate (TPR), also referred to as
sensitivity or recall, is used to measure the proportion of the true instances that





where TP is the number of true instances that have been correctly identified and
FN is the number of true instances that have been incorrectly rejected.
The False Positive Rate (FPR), is used to measure the proportion of the true





where FP is the number of instances that have been incorrectly identified as
positive and TN is the number instances that have been correctly rejected.
Adjusted Rand Index (ARI)
Rand index (RI) (Rand, 1971) is a metric of similarity between two multi-class
partitions by measuring the number of agreements and disagreements. In cell
clustering, Rand Index will be the ratio between the number of pairs of cells
that have been grouped together in both classifications and the total number
of possible cell pairs. The Adjusted Rand Index (ARI) (Hubert and Arabie,
1985), that is widely used in comparing classification algorithms, is a corrected-
for-chance modification of the Rand Index.
Given a set of cells C = c1, ..., cm and two different partitions of the cells









































False instances✗True instances✓ Selected instances
Figure 2.8: Illustration of the four different categories of instances of binary
classification. True instances are indicated by green circles and false instances are
indicated by red circles. All selected instances lie in the grey circle. True instances
that lie in the grey circle are true positives (TP), true instances that lie outside the
grey circle are false negatives (FN), false instances that lie in the grey circle are false
positives (FP) and false instances that lie outside the grey circle are true negatives
(TN).



























































where nij is the number of pairs of cells that belong in clusters i = 1, ..., k and
j = 1, ..., l of the U and V partitions respectively, m is the total number of cells in
C and ai and bj are the total number of cells in clusters i = 1, ..., k and j = 1, ..., l
of the U and V partitions respectively. All values can be obtained from the
contingency Table 2.1.
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Table 2.1: Contingency table for calculating the adjusted rand index (ARI) between
two partitions.
V1 V2 ... Vl Sums
U1 n11 n12 ... n1l a1
U2 n21 n22 ... n2l a2
... ... ... ... ... ...
Uk nk1 nk2 ... nkl ak
Sums b1 b2 ... bl
The RI values range between 0 and 1, with 0 indicating complete disagreement of
the two partitions for all pairs of cells and 1 indicating identical partitions. ARI,
on the other hand, taking into account agreement by chance, ranges between -1
and 1. Random partitions will have ARI close to 0 and good partitions ARI
close to 1. Negative ARI means that the two partitions have more than random
disagreements; however, this is rarely the case.
Variation of Information (VI)
Another metric that is widely used for evaluation of multi-class classification
methods is the Variation of Information (VI) (Meil, 2007). VI is an information-
based distance metric, similar to mutual-information. Given a set of cells C =
c1, ..., cm and two different partitions of the cells U = u1, ..., uk and V = v1, ..., vl,
consisting of k and l clusters respectively, VI is defined as:
V I = −
∑
ij
rij[log(rij/pi) + log(rij/qj)] (2.13)
where pi = |Ui|/m, i = 1, ..., k, qj = |Vj|/m, j = 1, ..., l and m is the total number
of cells in C.
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VI is non-negative and is equal to 0 when the two partitions are identical. Thus
the closer to 0 the VI the better the agreement between the two partitions. The
upper bound of VI depends on the number of clusters.
2.2.7 Quantification of batch effect between pairs of
scRNA-seq data
To measure the extent of batch effect between the reference-target pairs of data
used for the evaluation of scID and other methods throughout this chapter, I used
kBET (Büttner et al., 2019) (version 0.99.5), that utilizes a k-nearest neighbour
test. First, a k-nearest-neighbour matrix is created using all cells from both
batches. Then, repeated χ2 tests are performed by selecting a random local
neighbourhood and comparing its label distribution to the label distribution in
the full dataset. If the distributions are not similar then the null hypothesis that
the batches are well mixed is rejected. A binary result, i.e. 0 for “not rejected”
and 1 for “rejected”, is returned from all tests and the final kBET result is the
average rejection rate. The higher the average rejection rate the greater the batch
effect between the two scRNA-seq datasets.
2.2.8 Materials
Data source
Human Metastatic Melanoma immune cells from Tirosh et al. (2016): This Smart-
seq2 data consists of a total of 4,645 malignant, immune and stromal cells from
metastatic melanoma tumours from 19 patients. We have used the 3,254 immune
(CD45+) cells for our analysis, which on average had 3,925 genes expressed per
cell. Data was downloaded from the Broad Institute Single Cell Portal.
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Mouse Retinal Bipolar Neurons from Shekhar et al. (2016): This study performed
Drop-seq and Smart-seq2 experiments on Vsx2-GPF mouse retinal cells. The
Drop-seq data had 27,499 cells with an average of 880 genes per cell. The Smart-
seq2 data had 288 cells with an average of 4,556 genes expressed per cell. Gene
expression data was downloaded from the Broad Institute Single Cell Portal.
Brain cells from E18 mouse: This Chromium 10X data consists of brain cells
from the cortex, hippocampus and subverticular zone of an mouse at embryonic
day 18 (E18). The scRNA-seq dataset had 9,128 cells with an average of
2,500 genes expressed per cell and the single nuclei RNA-seq data have 954
cells with an average of 2,832 genes expressed per cell. Both of these datasets
were downloaded from 10X Genomics (https://support.10xgenomics.com/
single-cell-gene-expression/datasets).
Murine tracheal epithelium cells from Montoro et al. (2018): This combination
of plate-based (Smart-seq2) and droplet-based (Chromium 10X) scRNA-seq data
of murine airway epithelial cells consists of 7,193 cells with an average of 1,712
genes expressed per cell. The cells were partitioned into seven clusters annotated
post hoc using a biomarker approach by the authors. Data was downloaded from
the Broad Institute Single Cell Portal.
Mouse brain cells from Hu et al. (2017): This Drop-seq single nuclei RNA-seq
data from cortical tissues of adult mice consists of 18,194 cells with 1,649 genes
expressed per cell on average that were partitioned into 40 annotated clusters.
Data was downloaded from the Broad Institute Single Cell Portal.
Unstimulated and stimulated PBMCs from Kang et al. (2018): This Chromium
10X data consists of 14039 human PBMCs from eight patients, split into two
groups; one control and one stimulated with interferon-beta (IFN-β). Seurat
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CCA (Butler et al. (2018)) was used to align and cluster the data in order to
obtain “gold standard” cell identities.
Human pancreatic islet cells from Segerstolpe et al. (2016): This Smart-seq2
data consists of pancreatic tissue and islets from six healthy individuals and four
type 2 diabetes patients. Reads Per Kilobase of transcript per Million mapped
reads (RPKM)-normalised gene expression data and cell labels were downloaded
from ArrayExpress (E-MTAB-5061).
Human pancreatic islet cells from Grün et al. (2016): This CEL-seq data
consists of pancreatic cells from deceased organ donors with and without type
2 diabetes. Gene expression data and cell labels were downloaded from NCBI
GEO (GSE81076).
Human pancreatic islet cells from Muraro et al. (2016): This CEL-seq2 data
consists of islets from cadaveric pancreas. Gene expression data and cell labels
were downloaded from NCBI GEO (GSE85241).
Human lung adenocarcinoma cell lines from CellBench (Tian et al., 2019): Three
cell lines HCC827, H1975 and H2228, were cultured separately and single cells
from each line were mixed together in equal proportions. Three single cell RNA-
sequencing data were generated using three different protocols, CEL-Seq2, Drop-
seq and Chromium 10X.
Table 2.2 summarizes the data used, providing information about the number
of cells, library depth and number of cell types where available from the original
publication.
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Table 2.2: Summary table of published datasets used for validation of scID throughout
this chapter.











Smart-Seq2 2394 6214 12
Grün et al. (2016) Human pancreatic
islet cells





CEL-Seq2 2285 5275 12



















Smart-Seq2 288 4,556 18




Smart-Seq2 3,254 3,925 7








Tian et al. (2019) Human lung
adenocarcinoma
cell lines
CEL-Seq2 274 7135 3
Tian et al. (2019) Human lung
adenocarcinoma
cell lines
Drop-seq 225 5737 3
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2.3 Results
2.3.1 Selection of training cells from target data
To evaluate the accuracy of precision/recall-like approach for identification of
training cell populations from the target data, we measured the true positive
and false positive rate of selected cells of different cell types in several published
datasets. We observed that although the precision/recall-like approach was able to
recover between 10-100% of true cells, the false positive rate was between 0 and 5%
(Figure 2.9 A). This shows that although the precision/recall-like approach can
be stringent thereby missing higher than desired levels of true cells, its role in the
overall mapping is to recover true cells with a very low false positive rate. Having
selected true matching and non-matching populations the weight estimation can
be accurate even if not using all the cells of the dataset.
I have further demonstrated that the weights estimated from the precision/recall-
like approach are accurate. I did so by calculating the Spearman rank correlation
between weights calculated in Step 2 of scID and weights calculated using the
cluster-based labels for the same data and for several gene signatures (Figure
2.9 B). For most of the gene signatures the correlation of weights is over 0.75
which indicates correct selection of training populations in Step 2 of scID. Lower
correlations for some gene signatures could be explained by Step 2 selecting only
a subset of the truly matching and non-matching cells and these are usually the
cells with higher quality, i.e. lower dropout rate. This might lead to slightly
different estimates of the variance of the gene expression in the two populations
that can lead to an overestimation of the weight of the genes in the signature.
However, this does not appear to affect the accuracy of mapping as will be seen
later in Figure 2.13.
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Figure 2.9: Quantification of accuracy of DPR classification (Step 2 of scID). (A)
Boxplot shows interquartile range for TPR for all the cell types in each published
dataset listed in the x- axis. (B) Boxplot shows interquartile range for FPR for all the
cell types in each published dataset listed in the x- axis.
2.3.2 Step 3 improves putative classification of Step 2
Since Step 2 of scID might miss some cells that match the given gene signature,
Step 3 aims to rescue them and correct misclassifications. Figure 2.10 shows the
TPR and FPR of scID Steps 2 and 3 for each of the 18 cell-types of the mouse
retinal bipolar dataset dataset from Shekhar et al. (2016). The TPR increases
significantly in Step 3 over Step 2 while FPR remains low and with no significant
increase, as indicated by a Kruskal-Wallis test between Step 2 and Step 3 rates.
2.3.3 Including negative markers improves separation
between similar cell subtypes
Using positive markers, i.e. genes that are significantly upregulated in the cell type
of interest compared to other cell types, is an intuitive way to label the cells, as it
follows the same idea as FAC sorting. However, with single-cell RNA-sequencing
being able to detect and group cells into many subpopulations with more subtle
differences, sometimes similar subpopulations cannot be clearly separated using

























Figure 2.10: Quantification of TPR and FPR of Step 2 (black) and Step 3 (white)
of scID. Significance was computed using a two-sided paired Kruskal-Wallis test for
difference in TPR or FPR between Step 2 and Step 3.
only positive markers, especially given the sparsity of the data that has been
discussed before. Figure 2.11 shows the scID scores for selected cell type gene
signatures in a dataset of mouse retinal bipolar cells (Shekhar et al. (2016)). It is
clear that transcriptionally distinct cell types, such as Rod Bipolar cells (RBC)
and Müller Glia (MG), are easy to separate from the other cells in the dataset
(Figure 2.11 A, B), even when using only positive markers.
However, when similar cell populations are present in the data, positive markers
may not be sufficient. For example BC1B cells are transcriptionally similar to
other BC subtypes, such as BC1A as indicated by the clusters’ closeness in a
UMAP (Figure 2.16 A). Using only positive markers, i.e. genes that need to
be upregulated in BC1B compared to other cell types, we are unable to clearly
separate this population (Figure 2.11 C). This is due to some genes of the
signature also being expressed in these other similar cell types. However, when
we include negative markers, i.e. genes that should be absent or lowly expressed in
BC1B but are expressed in other cell types, we are able to increase the difference
of scID scores between the true population and these near neighbours (Figure
2.11 D). Using negative markers the scID score can get negative values for cells
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Figure 2.11: scID scores of mouse retinal bipolar cells (Shekhar et al. (2016)) for
different gene sets using positive and negative markers. (A) scID scores for the RBC
(Rod Bipolar Cell) gene signature including only positive markers. Since this population
is abundant and transcriptionally distinct from the other cell types in the data, positive
markers are sufficient to distinguish them. (B) scID scores for the MG (Müller Glia)
gene signature including only positive markers. (C) scID scores for the BC1B gene
signature including only positive markers. (D) scID scores for the BC1B gene signature
including positive and negative markers.
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2.3.4 Evaluation of scID’s accuracy for datasets with
ground-truth labels
As a first evaluation of scID, we tested its performance for datasets with available
ground-truth labels. We obtained three datasets of human lung adenocarcinoma
cell lines HCC827, H1975 and H2228 from Tian et al. (2019). These cell lines
were cultured separately, then mixed in equal proportions and processed with
10X Chromium, Drop-seq and CEL-seq2 protocols, resulting in three different
datasets with high batch effect (Figure 2.12 A). We used the 10X dataset as
reference to extract cell line-specific genes (Figure 2.12 B,C) and mapped the
Drop-seq and CEL-seq2 cells using scID. scID was able to map all CEL-Seq2 cells
into the reference cell identities with high accuracy (ARI=0.98). 16 (7%) cells of
the Drop-seq data were unassigned by scID, but the remaining 93% of the Drop-
Seq cells were assigned to their true identities (ARI=1) as shown in Figure 2.12
D. Of the unassigned cells, 10 cells (62.5%) were doublets and only 6 cells were
singlets.
2.3.5 Evaluation of scID’s accuracy via self-mapping
The above datasets demonstrate scID’s accuracy despite the high batch effect
between the pairs of data. However, this is a simple example of having only
three cell populations that are very different from each other as indicated by their
distance in the t-SNE projection (Figure 2.12 B) and the specificity of their
marker genes (Figure 2.12 C).
To further evaluate scID in cases of more complex datasets, we tested its
performance via self-mapping for several published datasets with defined cell
types. Gene signatures were extracted from published single cell RNA-seq


























































































































































































































































































































































































































































































































































































































































































































Figure 2.12: (A) Extent of batch effect between the reference (10X) and each of the
target datasets (Drop-seq and CEL-seq2) as measured by kBET (Büttner et al. (2019))
is shown on the y-axis. (B) t-SNE projection of the cells belonging to each of the
three cell lines of the 10X dataset that was used as reference. (C) Expression of top 20
genes (rows) specifically expressed in each cell line (columns) in the 10X data. Yellow
represents enrichment and purple represents depletion of the gene’s expression. (D)
Adjusted Rand Index of scID for mapping across datasets, compared to the true labels.
the clusters using these signatures. Figure 2.13 shows the performance of scID
compared to the published labels using the Adjusted Rand Index (ARI) metric.
Similarity between the scID and the true labels is very high for most of the
datasets. For the datasets of Hu et al., 2017 (Hu et al., 2017), lower ARI could
be explained by the high number of subtypes that exist in the dataset (Table
2.2), which indicates that there is higher transcriptional similarity between them
that might lead to contaminated features extracted with differential expression
analysis. This is a limitation of the differential expression analysis method
used in Step 2 of scID in presence of many transcriptionally close cell types.
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An improvement would be to refine the extracted features so that they are
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Figure 2.13: Assessment of accuracy of scID via self-mapping of published datasets.
The indicated published data (x-axis labels) were self-mapped, i.e. used as both
reference and target, by scID and the assigned labels were compared to the published
cell labels.
2.3.6 scID is as accurate as other methods for datasets
with low batch effect.
Next we compared the accuracy of scID to other alignment and mapping methods
for a pair of datasets with relatively low batch effect (Figure 2.14 A). We used
the two 10X datasets from Kang et al. (2018) for which all assessed methods
are expected to be accurate due to the low batch effect. Each dataset consists
of PBMC cells from the same 8 individuals before (control) and after treatment
with interferon alpha (stimulated). We first co-clustered both the datasets after
CCA alignment. We then applied scID and other methods, specifically MNN,
scmap and CaSTLe, that were published at the time of evaluation of scID, to
assign the target (stimulated) cells into cell types equivalent to the cell types of
the control data, as identified by CCA. We measured the accuracy of each method
by comparing the labelling from each method to the labelling in the post-CCA


































Figure 2.14: (A) Extent of batch effect between the reference and each of the target
datasets as measured by kBET (Büttner et al. (2019)) is shown on the y-axis. (B)
Adjusted Rand Index of scID and other methods for mapping across the two datasets,
compared to the labels from CCA alignment.
2.3.7 Weights are adjusted to each target dataset
separately
Estimation of weights from the target data enables scID to adjust to each target
dataset’s technical characteristics. In this example, we have three datasets of
human pancreatic islets (Segerstolpe et al. (2016); Grün et al. (2016); Muraro
et al. (2016)) that are expected to have similar cell-type composition. The
datasets have been processed separately using three different technologies, Smart-
Seq2, CEL-Seq and CEL-Seq2, that result in different cell qualities as indicated
by the number of expressed genes per cell shown in Table 2.2. The scRNA-seq
dataset from Segerstolpe et al. (2016) can be used as reference due to the higher
number of cells and greater sequencing depth. Labels are available for all three
datasets from their respective publications. I sought to classify the cells in the
other two datasets into clusters equivalent to the reference cell types, using scID
but also other mapping and alignment methods. We can see that both datasets
have a high batch effect compared to the reference dataset (Figure 2.15 A). scID
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and scmap are the two methods with highest performance based on the similarity
of the assigned to the published labels (Figure 2.15 B). CaSTLe, on the other
hand, has high ARI only for one of the two datasets, which indicates that the
accuracy of the classification model trained on the reference data depends on the
technical characteristic of the target.
The ability of scID to overcome such technical biases lies in the adjustment of
gene weights for each target dataset separately. In Figure 2.15 C we can see
the gene weights estimated from each of the target datasets, from the Grün et al.
(2016) dataset on the x -axis and from the Muraro et al. (2016) dataset on the y-
axis, for each reference gene set. The Spearman rank correlation of the weights for
each gene set is shown in the title of each panel. We can see that the correlations
diverge from 1, meaning that the scID-estimated weights for the same cell type
and gene set but from different target datasets are not identical. However, scID’s
performance is equally high for both datasets.
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Acinar, r = 0.80
p-value = 2.88e-59



































































































































































































































































































































































































































Macrophage, r = 0.10
p-value = 1.25e-02
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Mast, r = 0.01
p-value = 0.72
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Epsilon, r = 0.30
p-value = 3.22e-08
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Figure 2.15: (A) Extent of batch effect between the reference and each of the target
datasets as measured by kBET (Büttner et al 2019, Nature Methods) is shown on the
y-axis. (B) Accuracy of final classification of scID and other methods for the two
target datasets, calculated using the Adjusted Rand Index. (C) Scatter plot of weights
estimated from pancreas scRNA-seq CEL-Seq data on the x -axis and weights estimated
from pancreas scRNA-seq CEL-Seq2 data on the y-axis using pancreatic scRNA-seq
SMart-Seq2 data (Segerstolpe et al., 2016) as reference. For each of the cell types in
the reference data (indicated in the title of each panel), gene weights were computed
using differential precision - differential recall (DPR) classification in the two target
cells. Spearman rank correlation (r) and p-value is shown in the title of each panel.
Divergence of the correlation from r =1 suggests that the weights are not identical for
the two target datasets for the same cell type and gene signature.
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2.3.8 Case Study I: Target dataset with low number of
high quality cells
It is known that the accuracy of unsupervised clustering increases with the number
of cells, regardless of their coverage (Kiselev et al., 2019) because even rare
populations can have a sufficient number of cells to drive a separate cluster. A
good example of this is the two datasets of mouse retinal bipolar cells from the
study of Shekhar et al. (2016). In this study the authors have generated Drop-
seq (Macosko et al., 2015) and Smart-seq2 data from the same tissue but with
very different numbers of cells and library coverage; the Drop-seq data consists
of 26,800 cells with around 800 genes per cell, while the Smart-seq2 data consist
of 288 cells with around 4500 genes per cell. Despite the high transcriptional
similarity of the cell types of the sample and the low coverage, unsupervised
clustering of the Drop-seq data was able to identify 18 distinct clusters that
could be annotated to known cell types (Figure 2.16 A). However, unsupervised
clustering of the Smart-seq data resulted in only 4 clusters (Figure 2.16 B). As
expected the batch effect between the two datasets is very strong (Figure 2.16
C).
One way to assess the similarity of reference and target clusters is through the
expression of cluster-specific gene sets. In Figure 2.17 A we can see that
there is a specifically enriched gene set per cluster in the Drop-Seq data. The
heatmap shows the average expression of each gene set indicated in the rows,
in each Drop-Seq cluster indicated in the columns, with red representing very
high and blue very low expression compared to the other clusters. Using the
expression of these genesets in the Smart-Seq2 clusters (Figure 2.17 B), we
can identify Rod Bipolar Cells (RBC) and Müller Glia (MG) in clusters T0 and
T3 respectively. These two cell types are both abundant and very distinct from












































Figure 2.16: (A) t-SNE plot showing clusters in Drop-seq (reference) data of mouse
retinal bipolar cells from Shekhar et al. (Shekhar et al., 2016). Cluster membership of
the cells was taken from the publication. (B) t-SNE plot showing clusters in Smart-
Seq2 (target) data of mouse retinal bipolar cells from Shekhar et al. (Shekhar et al.,
2016). Data were clustered using Seurat and cluster names assigned arbitrarily. (C)
Extent of batch effect between the reference (Drop-seq) and the target (Smart-Seq2)
datasets as measured by kBET (Büttner et al., 2019) is shown on the y-axis.
can detect them despite their low number. The other two Smart-Seq2 clusters,
however, express multiple reference gene signatures, indicating that they consist
of many different cell types that due to their low number and high transcriptional
similarity, unsupervised clustering did not manage to separate.
Based on the library depth of the target data, we would expect that the näıve
biomarker-based approach would allow us to annotate the target cells into the
reference cell types according to which markers they express. For this approach,
we used the top two differentially enriched genes per reference cluster and labelled
the target cells based on the expression of these two markers above a certain
threshold. I used different thresholds of gene expression as explained in the
Methods and counted how many different labels were assigned to each target
cell. Figure 2.18 summarises the results. It shows that only a small proportion
of cells could be unambiguously classified with the biomarker-based approach.















































































































Figure 2.17: Heatmap showing row-scaled average expression of gene signatures (rows)
in the reference Drop-seq (A) and the target Smart-seq2 (B) clusters (columns). Red
(khakhi) indicates enrichment and blue (turquoise) indicates depletion of the gene
signature levels relative to average expression of that gene signature across all clusters
of reference (target) data.
Next I tried the combined analysis of reference and target cells after batch effect
correction with CCA and MNN expecting the increased number of cells per cluster
would increase the power of identification through unsupervised clustering, despite
their high transcriptional similarity and low prevalence. Figure 2.19 A shows
the heatmap of average expression of each reference gene signature in clusters
after batch effect correction with CCA (left) and MNN (right). In order to be
able to directly compare the result with the reference heatmap of Figure 2.17 A,
we have retained only the reference cells in each cluster. We can see that although
the Drop-Seq cells have been grouped into clusters with similar gene expression
pattern as the reference data (Figure 2.17), there are clusters that consist of
only target cells, indicating that alignment did not succeed in removing the batch
effect from the two data so that equivalent cells can be grouped together. These
are clusters CCA-16, CCA-18 and MNN-20 that are shown in grey as they do not
contain any Drop-Seq cells. Additionally, some reference clusters have been split
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Figure 2.18: Identification of target (Smart-seq2) cells equivalent to reference (Drop-
seq) clusters using a biomarker-based approach. Bars represent percentage of classified
and unassigned cells using various thresholds for normalised gene expression (see
Methods) of the marker genes as indicated on the x-axis. Gray represents the percentage
of cells that express markers of multiple clusters (ambiguous); yellow represents the
percentage of cells that can be unambiguously classified to a single cluster; and blue
represents the percentage of cells that do not express markers of any of the clusters
(orphans).
and CCA-12) after CCA and four clusters (MNN-1, MNN-2, MNN-16 and MNN-
18) after MNN. Additionally, we have counted how many different signatures are
enriched in each post-CCA, post-MNN and reference cluster shown in Figure
2.19 B. Although all reference clusters have a single gene-set enriched, many
post-CCA post-MNN clusters are contaminated, expressing 2 different signatures
or are not enriched for any of them, indicating random grouping of cells of different
cell types.
Since alignment does not seem able to overcome the bias of batch effect due
to cell number imbalances between the reference and the target data, I next
tried to identify transcriptionally equivalent cell populations in the Smart-Seq2
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Figure 2.19: Batch correction by CCA and MNN alters the grouping of reference cells.
(A) Heatmap showing row-scaled average expression of gene signatures (rows) in the
reference Drop-seq clusters (columns) after batch correction of reference and target data
with CCA (left) or MNN (right). Red indicates enrichment and blue indicates depletion
of the gene signature levels relative to average expression of that gene signature across all
clusters. (B) Assessment of the extent of cluster merging in post-CCA and post-MNN
reference clusters compared to the uncorrected reference. Each segment represents
the percentage of clusters with the indicated number of significantly expressed gene
signatures.
data using mapping. scID and CaSTLe assigned 100% (n = 288) of the Smart-
seq2 cells into 15 and 16 Drop-seq clusters respectively, while scmap assigned
only 63.2% (n=182) of the Smart-seq2 cells into 10 clusters (Figure 2.20 A)
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missing cells of rare clusters. Although CaSTLe seems to group the target cells
in clusters equivalent to the reference data, there is very low similarity in gene
expression pattern between them (Figure 2.20 A; right and Figure 2.17
A). Quantification of the number of significantly enriched gene signatures in
each cluster (Figure 2.20 B) suggests that scmap and CasTLe have a higher
proportion of merged and oversplit clusters than scID clusters. scID and scmap
have the highest similarity to the biomarker-based labels for the target cells that
could be successfully labelled (“Classified” category in Figure 2.18), while all
other clusters had very low performance as indicated by the low ARI and high VI
scores (Figure 2.20 C,D).
Thus, we can conclude that scID is outperforming other alignment and mapping
approaches in datasets with imbalanced numbers of cells and cell quality by
being able to more accurately identify rare populations and label cells with lower
coverage.
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Figure 2.20: (A) Heatmap showing row-scaled average expression of gene signatures
(rows) in the target (Smart-seq2) retinal bipolar data grouped by scmap (left), scID
(middle) and CaSTLe (right). Khaki represents enrichment and turquoise represents
depletion. (B) Assessment of the extent of cluster merging in scmap- and scID-mapped
equivalent target cells. (C, D) Assessment of CaSTLe, CCA, MNN, scID and scmap.
Target cells that can be unambiguously labelled using the biomarker-based approach
were used as ground truth.
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2.3.9 Case Study II: Ultra-sparse target dataset with large
number of samples
In many clinical settings where only post-mortem tissues are available, single
nuclei-RNA seq (snRNA-seq) (Habib et al. (2017), Lake et al. (2016)) may be
possible. However, the transcript abundance in the nuclei is significantly lower
than in the cytoplasm and as a consequence the complexity of scRNA-seq libraries
from nuclei-scRNA-seq from the same tissue is significantly lower than in whole
cell scRNA-seq (Habib et al. (2017)). These strong imbalances indicate presence
of batch effect between the datasets (Figure 2.21 B), making it challenging
to cluster even when there is a sufficiently large number of cells. Thus, we
compared scID’s performance to alternative approaches for a pair of publicly
available Chromium 10X (Zheng et al. (2017)) based scRNA-seq data on mouse
brain cells and snRNA-seq on mouse brain nuclei.
The brain whole cells scRNA-seq data had 9K cells and the brain nuclei
snRNA-seq data had 1K cells. Unsupervised clustering of the data separately
identified different number of clusters which did not have an obvious one-to-one
correspondence (Figure 2.21 A,C). The higher number of cells in the whole cell
scRNA-seq data is expected to lead to more accurate clustering and identification
of rare clusters, thus explaining why it was used as reference for our analysis.
Efforts to identify cluster membership of nuclei-seq data based on top markers
in each of the clusters from the whole cell scRNA-seq data allowed unambiguous
classification of only a small number of cells possibly due to shallow coverage
which leads to low dynamic range in gene expression. Not surprisingly, there
was a substantial number of ambiguous and orphan cells (i.e. those in which
transcripts of cell markers were not captured) (Figure 2.21 D).
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Figure 2.21: (A) t-SNE plot showing clusters in mouse brain cells (reference)
and nuclei (target) data. (B) Extent of batch effect between the reference and the
target datasets as measured by kBET (Büttner et al. (2019)) is shown on the y-
axis. (C) Heatmap showing row-scaled average expression of gene signatures (rows)
in the reference (left) and the target (right) clusters (columns). Red (khakhi) indicates
enrichment and blue (turquoise) indicates depletion of the gene signature levels relative
to average expression of that gene signature across all clusters of reference (target) data.
(D) Identification of target samples equivalent to reference clusters using a biomarker-
based approach obtained from the reference data.
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Attempts to identify equivalent cells via joint clustering after aligning the data
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Figure 2.22: Batch correction by CCA and MNN alters the grouping of reference
cells. (A) Heatmap showing row-scaled average expression of gene signatures (rows)
in the reference clusters (columns) after batch correction of reference and target data
with CCA (left) or MNN (right). (B) Assessment of the extent of cluster merging in
post-CCA and post-MNN reference clusters compared to the uncorrected reference.
scID assigned 99.5% (n = 949) of the snRNA-seq cells into 14 scRNA-seq clusters
while scmap assigned 60.2% (n = 574) of the snRNA-seq cells into 11 clusters
and CaSTLe assigned 100% (n = 954) of the snRNA-seq cells into 15 clusters.
Enrichment of reference cluster-specific gene sets in the grouped cells from all
three mapping methods is similar to that in the reference data, but based on the
number of enriched gene sets per group of cells for each method, scmap has higher
number of merged and oversplit reference clusters (Figure 2.23 B). Both scmap
and CaSTLe have very low similarity to the biomarker-based classification, for the
cells that could be successfully annotated, while scID had the highest performance
amongst all alignment and mapping methods (Figure 2.23 C,D).





















scID scmapCaSTLe CCA MNN




















































































































































































































































































0 1 2 3-1-2-3 0 1 2 3-1-2-30 1 2 3-1-2-3
Figure 2.23: (A) Heatmap showing row-scaled average expression of gene signatures
(rows) in the target data grouped by scmap (left), scID (middle) and CaSTLe (right).
(B) Assessment of the extent of cluster merging in scmap- and scID-mapped equivalent
target cells. (C, D) Assessment of CaSTLe, CCA, MNN, scID and scmap. Target cells




Comparison of multiple scRNA-seq datasets across different tissues, individuals
and perturbations is necessary in order to reveal potential biological mechanisms
underlying phenotypic diversity. However, comparison of scRNA-seq datasets is
challenging because even scRNA-seq data from the same tissue but with different
technology or donor can have a significant batch effect that confounds technical
with biological variability. scRNA-seq datasets generated from different scRNA-
seq methods and quality (i.e. similar number of cells and library depth per cell) are
in general much easier to correct than data generated from different methods and
quality. Particularly, in cases of strong asymmetry in quality between datasets to
be compared, mapping target cells across data at the individual cell level rather
than performing batch correction can be a more appropriate route for identifying
known transcriptionally related cells (Figure 2.20 C,D; Figure 2.23 C,D).
scID uses the framework of Fisher’s linear discriminant analysis to map cells
from a target data to a reference dataset (Figure 2.2). Other similar linear
regression methods, such as support vector machine (SVM) and logistic regression
were also investigated. These two methods could accurately classify high quality
datasets with very distinct cell types but performed poorly when dropout rate and
transcriptional similarity between cell types in the data increased. Additionally,
such methods rely heavily on the similarity of gene expression distribution
between the training and the testing data and are thus not expected to perform
accurately for unbalanced pairs of data with significant differences in technical
characteristics, such as those presented in this chapter. On the other hand, the
weights estimated by scID using the LDA framework represent the “signal-to-
noise” ratio of a gene and are independent of the dynamic range (scale) of gene
expression.
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scID adapts to characteristics of the target data in order to learn the
discriminative power of cluster-specific genes extracted from the reference in the
target data. scID down-weights the genes within the signature that are not
discriminatory in the target data. These genes could be either falsely selected
as cluster-specific or not discriminative in the target dataset due to different data
quality (e.g. they have high dropout rates) or different cell composition (i.e.
presence of transcriptionally similar cell populations).
Through extensive characterisation of fourteen published scRNA-seq datasets,
I assessed scID’s accuracy relative to alternative alignment and mapping
approaches in situations where the reference and target datasets have strong
asymmetry in quality and show that scID outperforms existing methods for
recovering transcriptionally related cell populations from the target data which
do not cluster concordantly with the reference.
scID can either estimate gene signature weights from the reference or the target
data. When the reference and the target data have a strong batch effect,
estimation of weights from the target appears to be accurate, adjusting the
importance of the genes to both the technical (e.g. dropout rate, dynamic range
of gene expression) and the biological (e.g. tissue composition) characteristics of
each input dataset. However, in cases where there are very similar rare cell types
in the datasets to be compared, estimation of weights from the reference may be
more suitable.
For a data set to serve as a reference, we expect well defined clusters by cell type
such that cluster specific gene signatures exist and they are mutually exclusive as
can be seen in Figure 2.17 A and Figure 2.21 C. As unsupervised clustering
methods work better for datasets with high numbers of cells per cell type (Kiselev
et al., 2019), such datasets can serve as reliable references.
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However, due to a reliance on gene signatures to discriminate between clusters,
a limitation of scID is that it only works for reference clusters that have distinct
gene signatures. When there are very similar subpopulations in the target data
with a very limited number of markers, scID may assign multiple labels to a
cell and this for now has been solved by comparing the scaled scores of different
matching signatures to a cell and assigning the label with the highest score.
One way to avoid multiple labels is by improving the feature extraction step.
Current differential expression analysis methods compare the cluster of interest
to all other cells of the dataset, forming a pooled “background”. However, the
signals of relatively small neighbouring clusters will be masked by the majority
of the cells in the background falsely calling genes as differentially expressed. A
solution to this is to identify cluster-specific genes by comparing the cluster of
interest to its nearest neighbours instead of all cell population in the mixture.
An alternative method to select discriminative gene sets and their weights that
maximally separate a cluster of interest from its closest neighbours and thus from
all other clusters in the dataset will be discussed in the following chapter.
Another limitation of scID is that if the target data contains a cell type that is
only weakly related to but not identical to the cell type in the reference, scID
is susceptible to falsely classifying such cells. This is due to the fact that the
extracted genes are differentially expressed between the cell type of interest and
only all other cell types present in the reference dataset, thus relative to the cell
composition of this data. One solution to this could be to infer some minimum
matching score required for a cell to be labelled from the reference data. This,
however, needs to take into account the technical quality differences between the
two datasets that may lead to different scales of scores. Another solution could
be the improvement of extracted features by combining more than one annotated
datasets from the same tissue as reference. This will enable the expansion of the
cell composition of the reference data that can lead to extracted features that
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discriminate the cell population of interest from all possible cell populations in
that tissue. The main challenge of this is the presence of a batch effect between
datasets that have been processed separately. A recently published method,
SuperCT (Xie et al., 2019), uses a neural network implementation of a supervised
classifier to incorporate data from the Human (Regev et al., 2017) or Mouse Cell
Atlas (Han et al., 2018) for training. Such an approach could help create a big
reference dataset where all known cell types are represented leading to extraction
of better cell type-specific features.
2.4.1 Conclusion
As the scale of single cell RNA-seq data increases and the numbers of clusters
obtained become so large that manual annotation is cumbersome, scID can
enable automatic propagation of annotations and metadata across clusters in
these datasets. Each reference dataset needs to be processed only once and then
multiple target datasets can be mapped simultaneously, unlike other alignment
and mapping methods that need to process the reference dataset every time a
new target dataset becomes available.
scID can take advantage of the vast amount of high quality single-cell RNA-seq
datasets available in public repositories such as the Human Cell Atlas (Regev
et al., 2017) and the Mouse Cell Atlas (Han et al., 2018) to use as reference data
for cell type annotation of new target data sets. However, unlike other methods
that require reference gene expression data, scID can also be used with user-
specified gene lists obtained from curation or bulk RNA-seq data. In addition,
scID can be used for ordering cells based on an arbitrary user specified gene list
(such as those defining a pathway) without the need for providing information on
gene expression levels thus aiding in the interpretation of a subset of cells across
cell types.
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Future directions on enhancing scID could be to include a database of pre-
extracted cell type signatures from high quality reference datasets. In this way,
scID can be part of a standardised single-cell RNA-seq data analysis pipeline for
cell type annotation at the cell or the cluster level. Such a database can ensure
the specificity and sensitivity of cell type signatures used for the classification of
a new dataset and enable the use of scID without the need for literature research
to identify suitable reference datasets.
Chapter 3
Identification of sub-populations
in circulating and breast tumour
infiltrating γδ−T cells
3.1 Introduction
3.1.1 γδ-T cells in human peripheral blood
T lymphocytes can be divided into two distinct subsets, αβ-T and γδ-T cells,
based on the type of chains that compose their T Cell Receptor (TCR). αβ-
T cells use a CD3-associated alpha/beta (αβ) TCR for recognition of processed
peptide antigens presented on Major Histocompatibility Complex (MHC). On
the other hand, γδ-T cells express a gamma/delta (γδ) TCR, which can recognize
both peptide and non-peptide antigens directly (Sebestyen et al., 2019).
γδ-T cells exist in both circulation and tissues (Sebestyen et al., 2019) and multiple
γδ-T cell subgroups have been characterised based on their TCR composition and
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cellular functions. In human four TCR δ chains (Vδ1, Vδ2, Vδ3 and Vδ5) and
seven γ chains (Vγ2, Vγ3, Vγ4, Vγ5, Vγ8, Vγ9 and Vγ11) exist. Some Vδ chains
preferentially pair with Vγ chains. For instance, the Vγ9-Vδ2 γδ-T subtype,
which make up the majority of γδ-T cells in the peripheral blood (Dimova et al.,
2015), execute surveillance of endogenous mutant cells and the eradication of
exogenous invasive pathogens.
Two broad subgroups defined based on cellular function include effector γδ-T
cell, which can kill cells such as tumour cells directly (Kabelitz et al., 2007), and
regulatory γδ-T cell, that promote immunity through secreting cytokines (Zhao
et al., 2018). Classically, γδ-T subtypes are also defined based on whether they
produce IL17A or interferon gamma (IFNγ) (Ribot et al., 2009). Additionally,
γδ-T cell subtypes are also divided along the innate-like and adaptive-like axis,
depending on whether their cytotoxic function is induced by NKG2D receptor
or through TCR (Davey et al., 2018). A subset of γδ-T cells, particularly
the δ1 subtypes, express NKG2D receptor which can recognize stress-induced
antigens such as MICA/B and members of the ULBP family (Groh et al., 1999).
In humans, binding of stress induced ligands to NKG2D leads to activation
of immune function through phosphorylation of the adaptor protein DAP10
(Billadeau et al., 2003).
Using a candidate gene approach, Ryan et al (Ryan et al., 2016) have identified
CD16 and CD28 as markers of two distinct PBMC δ2 subtypes. However,
subtypes and markers of δ1 have not been studied. Single-cell RNA-sequencing
provides an opportunity to uncover γδ-T subtypes, their markers and putative
functions in an unbiased way (Regev et al., 2017). Pizzolato et al (Pizzolato
et al., 2019) carried out scRNA-seq of δ1 and δ2 sorted subsets of human γδ-T
cells from PBMC. Although their data allowed identification of genes differentially
expressed between sorted δ1 and δ2 subsets of γδ-T, the relatively low number
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of cells, approx. 1200 γδ-T cells combined from multiple datasets, that were
sequenced did not allow identification of subclusters within them.
3.1.2 The role of γδ-T cells in the tumour microenvironment
While the human γδ-T cells have been characterised largely in the peripheral
blood and in the context of bacterial and viral infection, computational study of
The Cancer Genome Atlas (TCGA) cancer data has shown that elevated levels of
γδ-T cells in a variety of solid tumours are associated with favourable prognosis
(Gentles et al. (2015), Ma et al. (2012), Wu et al. (2019)). γδ-T cells can recognize
transformed cells through their engagement of their TCR and/or natural killer cell
receptors (NKRs), such as NKG2D (Simões et al. (2018), Bauer et al. (1999)) and
directly kill them through expression of TRAIL, FASL or secretion of perforin and
granzyme, in a similar way as conventional cytotoxic T cells (Silva-Santos et al.,
2019). Additionally, γδ-T cells can play an indirect role in antitumour immunity
through the activation of αβ-T (Brandes et al. (2005), Altvater et al. (2012), (Mao
et al., 2014), Himoudi et al. (2012), Muto et al. (2015)) and NK (Maniar et al.,
2010) cells or the induction of class switching of B cells (Wen et al. (1996), Huang
et al. (2015), Rezende et al. (2018)). Using ex vivo grid culture expansion of
γδ-T cells isolated from breast tumours, Wu et al (Wu et al., 2019) identified an
IFNγ positive innate-like δ1 subtype in breast tumour that was associated with
favourable overall survival in triple negative breast cancer patients. However,
markers unique to this subtype and the gene expression programs that potentially
underlie their clinical association have not been defined.
γδ-T cells are also known to have pro-tumour functions. For example,
increase of expression of IL17A has been observed in γδ-T cells in the tumour
microenvironment and has been associated with tumour growth (Wakita et al.
(2010), Carmi et al. (2011), Benevides et al. (2015), Kimura et al. (2016), Kulig
et al. (2016), Ma et al. (2014), Rei et al. (2014), Patin et al. (2018)). IL17A
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has several pro-tumour functions, such as angiogenesis and stimulation of tumour
cell proliferation, which is also induced by expression of IL22 (Silva-Santos et al.,
2019). Additionally, γδ-T cells can inhibit DC maturation and suppress T cell
responses.
3.1.3 Aims of this Chapter
The above diverse functions of γδ-T cells make them an interesting subpopulation
for targeted cancer immunotherapy. However, we need to understand whether
specific subtypes are associated with either pro- or anti-tumour functions and
what are the markers that define them in order for them to be used as
immunotherapy targets. Despite the above efforts to identify subtypes of γδ-
T cells and understand their functions in normal and diseased tissues, their
heterogeneity is not fully resolved. This is partly due to their low abundance
in mammals, which makes them difficult to detect and study, but also due to the
high evolutionary divergence of the TCR genes between human and mice that are
often used as model organisms.
Single cell RNA-sequencing methods can enable the identification of
subpopulations of γδ-T cells in an unbiased way by revealing the heterogeneity
within this cell type that was masked in previous bulk RNA-seq experiments.
Better characterisation of the heterogeneity of γδ-T cells can help uncover markers
for their specific isolation and experimental functional characterisation.
In this chapter, I will be using four newly generated single cell RNA-seq datasets
of γδ-T cells from peripheral blood of three healthy donors and breast tissue
of two breast cancer patients. I will be using both alignment and mapping
methods to integrated them and identify equivalent populations across the
two conditions as well as other further downstream analysis of the resulting
subpopulations to identify markers that characterise them and computationally
CHAPTER 3. Identification of sub-populations in circulating and breast
tumour infiltrating γδ−T cells 83
annotate their putative functions. In addition, the methods presented here
can serve as an example of a standard pipeline of analysis of single-cell RNA-
sequencing data, starting from alignment of sequence reads and including quality
control and filtering of cells, batch effect correction through alignment and
mapping, clustering, identification of differentially expressed genes and functional
annotation.
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3.2 Materials and Methods
3.2.1 Experimental Methods
Sample acquisition, processing and sorting
Breast cancer patient samples (here on referred to with prefix “BC”) and blood
from healthy donors (here on referred to with prefix “HD”) were obtained with
informed consent (NHS Lothian, Tissue Request No. 2017/SR865). Acquired
samples were processed by Dr Victor González-Huici. Within approximately
30 minutes of obtaining each donor’s blood, PBMCs were isolated via the
Ficol density gradient centrifugation following the manufacturer’s protocol and
cryopreserved in 10% DMSO. Cryopreserved PBMCs were thawed rapidly and
then incubated for 30 minutes at 4 degrees with appropriate antibodies (Table
3.1). Fresh breast tumour biopsies were obtained and processed within 1 hour of
surgical resection. Tumour tissue was first manually dissected and then chemically
dissociated with a cocktail of Liberase DL/TL (Roche) for 30 minutes and then
immunostained with anti-CD45 (Table 3.1) antibody. Dissociated cells were
sorted for live singlet cells with appropriate gating strategy on BD FACSAria II
(Figure 3.1).
Single cell sequencing
Single cell sequencing was performed by Dr Victor González-Huici. Sorted cells
were counted on Countess and the gated population and the number of cells per
sample that were loaded on Chromium 10X (version 2) were as follows: 1) HD4/5
(CD45 +CD3 +pan-γδ+; 10K cells from HD4 + 10K cells from HD5) and loaded
on one lane; 2) HD6 (CD45 +CD3 +pan-γδ+; 20K cells were loaded on one lane);
3) BC1 (CD45 +; 18K cells were loaded on one lane); 4) BC2 (CD45 +; 12K cells
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Table 3.1: Antibodies used in isolation of pan-gamma delta T cells from blood and
validation.
Antibodies Clone Cat# Biolegend Fluorophore Laser/filter Dilution
anti-CD8 SK1 344713 APC-Cy7 640-780/60 1:200
anti-GPR56 4C3 391905 APC 640-670/30 1:100
anti-Vdelta2 B6 331423 PerCp-Cy5.5 488-695/40 1:200
anti-CD16 3G8 302053 PE-Dazzle 594 561-610/20 1:200
anti-CXCR6 K041E5 356013 BV421 405-450/50 1:10
anti-CD3 OKT3 317339 AF700 640-730/45 1:200
anti-CD45 HI30 304024 AF700 619-710/50 1:10






































































































































































































































































































Figure 3.1: FACS gating strategy shown for the three PBMC donor samples, HD4,
HD5 and HD6, that were subjected to 10X based single cell RNA-sequencing.
were loaded on one lane). scRNA library generation was carried out according
to the manufacturers guidelines. Libraries from HD4/5 and HD6 were sequenced
on NovaSeq S1 with 26bp + 90bp reads and an average of 42k reads per cell
for HD4/5 and 74k reads per cell for HD6. Libraries from BC1 and BC2 were
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sequenced on HiSeq2500 with 75bp + 75bp reads and an average of 53k reads per
cell for BC1 and 47k reads per cell for BC2.
The number of cells loaded on Chromium 10X and the sequencing depth were
decided after consultation with 10X Genomics representatives. Sequencing
saturation ranged between 88.3% and 91.2% in the four different data sets. Since
the multiplet rate increases with increased number of cells loaded, a QC step
with stringent filtering thresholds, as described in the next section, was required
to eliminate the number of multiplets included in downstream analyses.
Raw FASTQ format sequence reads were processed using the Cell Ranger (Zheng
et al., 2017) pipeline for human genome hg19 assembly.
Flow cytometry based validation of clusters
Top differentially expressed surface markers for which antibodies are commercially
available were selected and validated by Marcus Lindberg. Whole blood samples
were collected with EDTA from 3 healthy donors. PBMCs were purified from
whole blood using Ficoll-Paque PLUS. PBMCs were washed with 1x Dulbeccos
PBS and cryopreserved in 10% DMSO at -80°C.
Fluorophores were optimised for the panel using the BioLegend Fluorescence
Spectra Analyzer (BioLegend, 2019. http://www.biolegend.com/spectraanalyzer)
to minimise spectral overlap. Antibodies were titrated on healthy donor PBMCs.
PBMCs were thawed and rested for 30 minutes in fresh DMEM supplemented
with 10% FBS. Cells were filtered with a 40µm cell strainer and incubated with
Human TruStain FcX (BioLegend) for 20 minutes prior to staining. Cells were
incubated with antibody (Table 3.1) for 30 minutes at 4°C and washed twice with
FACS buffer (1X PBS, 1% BSA, 1 mM EDTA) prior to a final resuspension in
FACS buffer. Compensation was performed using UltraComp eBeads (Invitrogen)
compensation beads incubated with 1µL of antibody using the same protocol as
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was used with the PBMCs. Samples were analysed on a BD LSRFortessa cell
analyser. Flow cytometry files (.fcs) were analysed using FlowJo (version 10.0).
Data availability
Raw sequence data in FASTQ format and gene counts in matrix market format
produced by the Cell Ranger pipeline (for hg19 assembly) have been deposited in
GEO with study accession number GSE141665. 1) HD45 (GSM4210786) 2) HD6
(GSM4210787), 3) BC1 (GSM4210788) and 4) BC2 (GSM4210789).
3.2.2 Computational Analysis
Quality control (QC)
Counts data from the Cell Ranger pipeline were further filtered based on the
number of genes and housekeeping genes as well as the percentage of mitochondrial
genes. The list of human housekeeping genes was obtained from Tirosh et al.
(2016). The list of mitochondrial genes was obtained from each dataset by
selecting all genes whose names start with “MT”. Different thresholds were
selected for each dataset to account for the individual technical characteristics,
based on manual inspection of the distributions of the number of genes and
housekeeping genes and the proporion of mitochondrial genes per cell. Figure
3.2 shows the thresholds selected for each dataset. Dots indicate cells and the
retained cells are those inside the red box.
From the analysis of the remaining cells, I did not observe any clusters expressing a
mixture of signatures of other clusters, which would indicate presence of doublets.
I thus did not deem necessary to apply any other method for doublet detection.






































































































































































































Figure 3.2: Quality control of all datasets used in this chapter. Cells were filtered
based on the number of genes, the number of housekeeping genes and the percentage
of mitochondrial genes. Different thresholds were selected for each dataset, indicated
by the grey dotted lines. 3533 cells from HD4/5, 6147 cells from HD6, 4608 cells from
BC1 and 1257 cells from BC2 that fall in the red boxes are those that were retained for
further analysis.
Annotation of cells positive for the various TCR gamma and delta gene
segments
To determine the identity of the TRD and TRG gene segments present in each
cell, FASTQ reads from each cell were aligned to the VDJ gene sequences (refdata-
cellranger-vdj-GRCh38-alts-ensembl-2.0.0 from Cell Ranger) using BWA. Based on
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the CD45 + clusters in the BC1 data, only the TRDV1, TRDV2, TRGV4 and
TRGV9 gene sequences were specifically enriched in the TRDC + clusters. Thus
only reads uniquely mapping (mapping quality> 30) to TRDV1, TRDV2, TRGV4
and TRGV9 gene sequences were retained for further analysis in all four datasets.
Alignment and clustering of scRNA-seq datasets
The two PBMC γδ-T cell scRNA-seq datasets (HD4/5 and HD6) were obtained
from the same lab and with the same experimental protocol. Additionally, the
cell composition is expected to be similar and the numbers of cells are relatively
balanced. Thus, I chose to use alignment to remove the batch effect between the
two datasets, which will help distinguish small and transcriptionally similar cell
types due to the increased number of cells.
I used the Canonical Correlation Analysis (CCA, Butler et al. (2018)) from the
Seurat package (version 3.1.0) to align and cluster the two datasets combined.
Default parameters and 20 principal components were used. TRDC positive
clusters from the merged dataset were retained. The final PBMC γδ-T cell data
used here consisted of 6116 cells.
Similarly, the two breast tumour scRNA-seq datasets (BC1 and BC2), with a total
of 6677 cells, were integrated and clustered using CCA from the Seurat package
using the first 20 principal components that were significantly contributing to the
explained variance of the data (Jackstraw plot method of Seurat).
Identification and functional annotation of cluster-specific gene sets
The MAST function implemented in the Seurat package (version 3.1.0) was used
to identify genes differentially upregulated between δ1 and δ2 subtypes. For
the breast tumour data, depending on the required analysis, γδ-T cell clusters
were either compared to each other in order to obtain gene sets that can
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distinguish between γδ-T cell subtypes (conditional to the pan-gamma-delta
markers) or to all immune cells in the datasets. More specifically, due to the
high transcriptional similarity between γδ-T cell clusters and their relatively low
abundance compared to other immune cell populations in the breast tumour
data, I identified differentially expressed genes only between these three γδ-T cell
clusters to identify potential markers for isolation and subtype-specific functions.
On the other hand, for survival analysis, I used gene sets that distinguish each
γδ-T cell cluster from all other immune cell populations in our data, to avoid
detecting signals of other populations in TCGA samples (Ciriello et al., 2015) as
will be explained in the Survival Analysis section of the Methods.
DAVID (Huang et al., 2009) was used to obtain enriched Gene Ontology (GO)
Biological Process (GO-BP) and KEGG pathway terms for each extracted geneset.
Given the list of genes differentially upregulated in a cluster as target and the list
of all genes observed in the respective dataset as background, a list of GO-BP
terms (GOTERM BP FAT) and KEGG pathway terms that were significantly
enriched in the target list were downloaded as a functional annotation chart.
Only terms with Benjamini adjusted p-values ≤ 0.05 were retained.
Enrichment of selected functional gene sets in the γδ-T cell subtypes
scID was used to calculate an enrichment score per cell for IFNγ production,
IL17A production, cytotoxic, adaptive and innate gene sets. Since there is no
prioritisation of the contribution of each gene in the pathway, equal weights (equal
to 1) were used for all the genes of each set. The genes used in each gene set are
shown in Table 3.2.
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Table 3.2: List of genes selected for each functional gene set.
Geneset Genes
IFNγ production TBX21, EOMES, STAT1, STAT4, IL12RB, IFNG
IL17A production RORC, IL23R, CCR6, IL1R1, RORA, BLK, IL17A
cytotoxicity GZMA, GZMB, GZMK, GZMM, GZMH, PRF1, TRAIL, FAS, IL12
antigen presentation HLA-DQPB1, HLA-DRA, HLA-DPA1
innate KLRK1, HCST (DAP10 )
Enrichment of published CD28+ and CD16+ δ2 subtype gene sets in
the PBMC γδ-T cell subtypes
scID was used to calculate an enrichment score per cell for the CD28+ and CD16+
δ2 subtype gene sets from the study of Ryan et al (Ryan et al., 2016). Positive
markers for the two subtypes shown in Table 3.3 were used as input to scID
without a reference single-cell RNA-sequencing data set. Weights were inferred
from the target (PBMC) dataset.
Table 3.3: List of published CD28+ and CD16+ δ2 subtype gene sets from Ryan et
al (Ryan et al., 2016).
Gene set Genes
CD28+ GZMK, CD27, LTB, CCR7, MYC, CCR6, CD160, CD7, IL12RB2, CD28,
CXCR6, RORC, SIPA1, IL7R, IL23R, IRF1, IL18R1, CCR2
CD28+ CX3CR1, GZMB, KIR3DL1, KIR2DL4, GNLY, KIR2DL3, KIR2DL1,
KIR3DL2, GZMH, KIR2DS5, LAIR2, KIR3DL3, ITGB1, PRF1, SMAD7,
BCL9L, LY6E, IL18RB, FCAR, KIR2DL5A, ITGAM, CCL4L2
Survival analysis
Survival analysis was performed to test if presence or absence of any
breast tumour γδ-T cell subtype was associated with survival rates of
patients with breast cancer. RNA-seq and clinical data for TCGA breast
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Figure 3.3: Histogram of tumour purity (x -axis) of TCGA breast tumour samples
(Ciriello et al., 2015). A total of 191 samples with purity between 0.6 and 0.7, indicated
by the red lines, were retained for further analysis.
cancer study (Ciriello et al., 2015) were obtained from NCI GDC Data
Portal (https://portal.gdc.cancer.gov/projects/TCGA-Breast Cancer (BRCA)).
Samples were filtered based on purity with the following criteria. Samples with
low purity were removed as they are unlikely to reflect immune cells altered by
presence of tumour. Additionally, samples with very high purity were removed
as they are expected to contain only a small proportion of immune cells that is
unlikely to consist of γδ-T cells given their very low abundance. This filtering
resulted in 191 samples with purity between 0.6 and 0.7 (Figure 3.3).
I next calculated an enrichment score for each of the retained samples and each of
the three γδ-T subtype gene signatures, as the weighted average of the expression
of these gene signatures in each TCGA sample, with weights being the loge fold
change values obtained from differential expression analysis of the scRNA-seq
data. Then, for each signature, I selected the bottom and top 1/3 of the samples
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to represent the samples with low and high expression of the gene signature
respectively and performed survival analysis between the two groups using the
survfit function of the survival R library (Version 2.44.1.1).
Mapping across datasets with scID
To identify BC-equivalent γδ-T subpopulations in the PBMC I used scID and
calculated a score of each PBMC cell for each of the BC γδ-T subcluster
signature. Each signature consists of genes that are upregulated and genes that
are downregulated in the reference BC cluster, thus positive scID scores indicate
cells that express more upregulated than downregulated genes, and negative scores
indicate cells that express more downregulated than upregulated genes.
Prediction of signalling between γδ-T cells and other immune cells
CellPhoneDB (Efremova et al., 2019) was used to calculate the likelihood of cell
type specificity of receptor-ligand interactions between γδ-T and other tumour
infiltrating immune cell types. Gene expression data and cell type labels for the
BC1 and BC2 cells were used as input to CellPhoneDB statistical_analysis
method. Only interactions with p-values ≤ 0.01 were retained.
94 3.3 Results
3.3 Results
3.3.1 Identification of subtypes of γδ-T cells in peripheral
blood via unsupervised clustering of scRNA-seq
data
Peripheral blood γδ-T cells from 3 healthy donors were sorted using a pan-gamma-
delta antibody (Table 3.1) and subjected to droplet-based scRNA-seq using 10X
Chromium (Zheng et al., 2017) single cell 3’ gene expression library generation
and subsequently sequenced on the Illumina Nova-Seq S1 platform. Cells from
donors HD4 and HD5 were pooled before performing scRNA-seq and labelled as
HD4/5. Raw sequence reads were processed using the Cell Ranger pipeline (see
Methods). The resulting gene expression counts for each dataset were merged
and clustered using Seurat CCA (Butler et al. (2018), Stuart et al. (2019)). Only
clusters that were TRDC positive and present in all datasets were retained for
subsequent analysis. This final analysis-ready dataset comprised of 6,116 cells
with an average of 1,084 genes expressed per cell representing 12,943 different
genes in total.
Two-dimensional projection of the merged scRNA-seq data using UMAP (Becht
et al., 2019) revealed two macroclusters (Figure 3.4 A) containing 5 clusters
in total. Cells from each of the 2 datasets (HD4/5 and HD6) were relatively
evenly distributed among the clusters and thus biologically reproducible (Figure
3.4 B). All clusters had relatively uniform distribution of TCR delta constant
gene segment (TRDC ) and therefore are bonafide γδ-T cells. A macrocluster
positive for TCR δ2 variable gene segment (TRDV2 ) and a small macrocluster
positive for TCR δ1 variable gene segment (TRDV1 ) could be identified (Figure
3.4 C). Cells expressing genes that encode the other delta chains could not be
unambiguously identified in this short read (90bp) sequencing data. Thus we
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observe three TRDV2 positive (here on referred to as δ2) clusters and two TRDV1
positive (here on referred to as δ1) clusters.
As the sequencing coverage of individual cell transcriptomes are highly sparse and
the expression levels of the TRD and TRG genes may be different and thus have
different dropout rates, I determined their presence independently at the cluster
level. Only the TRGV4 and TRGV9 gene segments could be unambiguously
aligned with the 3’ UTR short read sequences that comprised this data (see
Methods). Computation of the proportion of cells in each cluster positive for
the various TRG gene segments (Figure 3.4 D), revealed that all of the three
δ2 clusters were preferentially enriched in TRGV9 positive cells consistent with
the reports in literature that the majority of PBMC γδ-T cells are TRDV2 -
TRGV9 positive (Dimova et al., 2015). In contrast, the δ1 clusters were enriched
for TRGV4 also consistent with the reported preferential pairing of Vδ1 and
Vγ4 chains (Jiang et al., 2012). The differential enrichment of the TRGV gene
segments between the δ1 and the δ2 was statistically significant (Chi-square
test for independence, χ2=17.836, P=0.000134, dof=2). Thus, we observe three
Vδ2Vγ9 and two Vδ1Vγ4 clusters in PBMC.
Differential gene expression analysis uncovered several cluster specific enriched
genes (Figure 3.5 A), which could be potentially used as markers for isolation of
these subsets for further functional validation. The complete list of differentially
expressed genes between the PBMC γδ-T cell subtypes can be found in Table
A.1. Functional annotation of these gene sets suggests that these five γδ-T cell
subtypes have different functions (Figure 3.5 B, Table A.6).
While the δ2.1 cluster has a distinct gene expression pattern that could be either
due to its abundance or due to being transcriptionally very different from the
other clusters, there is high transcriptional similarity between δ1.1 and δ1.2 and















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.4: Unsupervised analysis of scRNA-seq data on γδ-T cells from peripheral
blood of healthy adult donors identifies multiple δ1 and δ2 subtypes. (A) UMAP of
the merged single cell gene expression data of PBMC derived γδ-T cells from 3 healthy
donors. Different clusters are named according to TCR delta chain identity. TRDV1
(gene that encodes δ1 chain) positive clusters were labelled with prefix δ1 and TRDV2
(gene that encodes δ2 chain) positive clusters were labelled with prefix δ2. (B) Overlay
of data source on UMAP of scRNA-seq data. Cells from donor HD4 and HD5 were
pooled before performing scRNA-seq and are labelled as HD4/5. The number of cells
from each dataset is shown above the projection. (C) Identification of cells positive
for TCR delta genes. Overlay of cells that have genes mapping to the TRDC (left)
and TRDV1/2 (right) gene segments. Grey indicates absence and colour indicates
presence of reads mapping to TRDC (black), TRDV1 (red) and TRDV1/2 (blue) gene
segments. (D) Quantification of enrichment of genes expressing TCR gamma (γ) chain
in each cluster. Only the TCR gamma genes that could be unambiguously mapped (see
Methods) were considered. Y -axis shows the percentage of cells within each cluster
(x -axis) of the merged data that is positive for TRGV4 (white) or TRGV9 (black)
gene segments.
CHAPTER 3. Identification of sub-populations in circulating and breast
tumour infiltrating γδ−T cells 97
A B
SRP-dependent cotranslational protein targ...
protein targeting to ER
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T cell mediated cytotoxicity
cotranslational protein targeting to membrane
establishment of protein localization to ER
positive regulation of cell-cell adhesion
SRP-dependent cotranslational protein targ ...

























Figure 3.5: (A) Heatmap showing genes (rows) enriched in each of the clusters
(columns). Yellow represents enrichment and purple represents depletion. Top 4 genes
per cluster are labelled. (B) Functional annotation, as defined in GO and KEGG
databases, of cluster specific differentially expressed genes. The top 5 significantly
enriched functional terms are shown.
(Figure 3.5 A). In order to find markers and functions that better distinguish
between these similar subtypes, I also obtained differentially expressed genes for
these pairs of clusters separately and performed functional annotation of these
gene sets. Figure 3.6 shows the differentially expressed genes and annotated
functions between δ1.1 and δ1.2 (see also Table A.2 and Table A.7) and Figure
3.7 shows the differentially expressed genes and annotated functions between δ2.2







ribosomal large subunit assembly
ribosomal small subunit assembly
maturation of LSU-rRNA
liver regeneration
maturation of SSU-rRNA from tricistronic rNRA ...
intracellular signal transduction involved in G1 ...
DNA damage response, signal transduction by p53 ...




































Figure 3.6: Comparison of δ1.1 and δ1.2 clusters. (A) Heatmap showing top 15
genes (rows) differentially expressed between the two subtypes (columns). Yellow
represents enrichment and purple represents depletion. (B) Functional annotation of
genes differentially expressed between the two subtypes. The lengths of the bars (x -axis)
are proportional to the log fold enrichment. The negative values indicate enrichment
in δ1.2 (khaki) and the positive values indicate enrichment in δ1.1 (red) cluster. Terms
are as defined by the Gene Ontology and KEGG databases.
CHAPTER 3. Identification of sub-populations in circulating and breast





Antigen processing and presentation
regulation of leukocyte mediated immunity
positive regulation of immune effector process
αβ-T cell differentiation involved in immune response
ribosomal large subunit assembly
regulation of T cell mediated cytotoxicity




































Figure 3.7: Comparison of δ2.2 and δ2.3 clusters. (A) Heatmap showing top 15
genes (rows) differentially expressed between the two subtypes (columns). Yellow
represents enrichment and purple represents depletion. (B) Functional annotation of
genes differentially expressed between the two subtypes. The lengths of the bars (x -axis)
are proportional to the log fold enrichment. The negative values indicate enrichment in
δ2.3 (purple) and the positive values indicate enrichment in δ2.2 (blue) cluster. Terms
are as defined by the Gene Ontology and KEGG databases.
100 3.3 Results
Finally, I used curated gene sets for IFNγ production, IL17A production,
cytotoxicity, antigen presentation and innate pathways to annotate the clusters
based on the enrichment of these gene sets in the cells within each cluster (Figure
3.8).
























































































































































































































































































Figure 3.8: Distribution of gene signature scores (y-axis) for Cytotoxicity, IL17A
production, IFNγ production, Antigen presentation on MHC class 1 and Innate gene
sets (Table 3.2) in each of the PBMC γδ-T cell cluster (x -axis). scID but with equal
weights was used to calculate an enrichment score per cell for each of the gene signatures
(see Methods)
.
All the above results suggest the following annotation: i) the δ1.1 cluster appears
to be naive or immature, indicated by expression of LEF1 and CCR7, ii) the
δ1.2 cluster could be recent thymus emigrant (expression of CD7 ) , iii) the δ2.1
cluster appears to carry out canonical δ2 function, namely anti-bacterial and
antigen presentation function, and interferon gamma (IFNγ) production, and is
the most cytotoxic of all the other PBMC γδ-T cell clusters, iv) the δ2.2 cluster
appears to be involved in antigen presentation and, v) the δ2.3 cluster is a clear
IL17A producer. This IL17A producing subtype is also differentially enriched in
CCR6 and consistent with a previous report (Haas et al., 2009).
CHAPTER 3. Identification of sub-populations in circulating and breast
tumour infiltrating γδ−T cells 101
The above clustering was validated using FACS by selecting surface proteins from
the list of differentially expressed genes for which antibodies are commercially
available. More specifically antibodies against CXCR6 (present in both δ2.2 and
δ2.3) and GPR56 (present in δ2.1) were selected (Figure 3.9 A). PBMCs from
three donors (including two additional healthy donors, HD9 and HD10) were
stained with anti-CD3, anti-TCRγδ-δ2, anti-GPR56, and anti-CXCR6 (Figure
3.9 B). The L-shaped scatter plot of GPR56 and CXCR6 suggests mutual
exclusion and corroborates that they mark different δ2 sub-populations within
the human blood γδ-T population.
I additionally used literature to further validate the clusters identified in this
scRNA-seq data. The IL17A producing cluster (δ2.3) differentially expressed
CCR6 as reported previously (Haas et al., 2009). Ryan et al (Ryan et al., 2016)
identified two different δ2 subtypes in PBMC γδ-T cells that are marked by
mutually exclusive expression of CD28 and CD16, which were also observed in
the data presented in this chapter (Figure 3.9 C). While CD16 was specifically
enriched in only one δ2 subtype (i.e. δ2.1), CD28 was more diffused and also
present in the δ1 subtypes. To corroborate this with a larger gene set, I scored
all the subclusters for the published gene signatures of the γδ-T-cell partitioning
defined by CD16 and CD28 (Ryan et al., 2016). While the CD16 gene signature
was exclusive to one subtype of γδ-T cells, the CD28 gene signature was enriched
in all the other subtypes, including the two δ1 subtypes (Figure 3.9 D), hence
CXCR6 is better than CD28 as a marker for isolating CD16 negative δ2 cells,






Ryan CD28+ gene set Ryan CD16+ gene set





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.9: Validation of the PBMC γδ-T subtypes. (A) Feature plot showing
expression of GPR56 and CXCR6, markers that appear to be mutually exclusive in
PBMC δ2 subtypes. (B) Flow cytometry based validation of novel markers, GPR56
(y-axis) and CXCR6 (x -axis), of peripheral blood γδ-T δ2 subtypes. Healthy donor
identities are indicated in the title. Numbers in each quadrant indicate percentage of δ2
cells. This work was performed by Marcus Lindberg. (C) Feature plot showing CD16
and CD28, which are published markers of the δ2 subtype of PBMC γδ-T cells (Ryan
et al., 2016)). (D) Scores for published gene signatures of CD16 (white) and CD28
(black) δ2 subtypes in the clusters found in our PBMC γδ-T scRNA-seq data (x -axis).
P-values were computed using the Wilcoxon signed-rank test.
CHAPTER 3. Identification of sub-populations in circulating and breast
tumour infiltrating γδ−T cells 103
In summary, I have provided evidence that the classification suggested in this
chapter is consistent with what has been reported in the literature regarding
human PBMC γδ-T cells. Additionally, the genes differentially expressed in the
two CD28 positive δ2 subtypes of PBMC γδ-T cells further suggest that they are
two functionally different populations as one subtype was IFNγ+ while the other
was an IL17A producer, observations that were missed from previous studies.
104 3.3 Results
3.3.2 Identification of γδ-T cell subtypes within breast
tumour microenvironment
To uncover γδ-T cell subtypes and their gene expression programs in the tumour
microenvironment, we dissociated fresh Triple Negative Breast Cancer (TNBC)
and Her2+ breast tumour biopsies into single cells and performed scRNA-seq on
all immune cells (CD45+) (see Methods). Three clusters that were double positive
for CD3 and TRDC were present in both the samples and were designated as
γδ-T cells (Figure 3.10 A,B,C). While I was able to detect reads mapping
uniquely to TRDV2, I did not identify TRDV1 transcripts despite being able to
detect these in the PBMC γδ-T cells. There are two possible explanations for
this; either the shorter reads (75bp compared to 90bp in PBMC) do not include
this region, or the variable region in TRDV1 gene in breast tumour γδ-T cells
is much further away from the 3’ UTR than it is in the PBMC γδ-T cells. As
seen in PBMC γδ-T cells, the TRDV2 + cluster (i.e. γδ-T.3) is also TRGV9 +,
while the other two clusters (γδ-T.1 and γδ-T.2) are TRGV4 + (Figure 3.10
D). The preferential pairing of TCR δ2 and γ9 chains and of TCR δ1 and δ4
chains seen in PBMC γδ-T cells (Figure 3.4 D) suggests that γδ-T.1 and γδ-T.2
are possibly TRDV1 +. Additionally, presence of reads mapping to TCR δ and
γ chains further supports the evidence that these three clusters consist of γδ-T
cells.
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Figure 3.10: Unsupervised clustering of breast tumour infiltrating immune cells
uncovers three subtypes of γδ-T cells. (A) UMAP of the merged single cell gene
expression data of breast tumour infiltrating immune cell data sets from two patients.
Three clusters were double positive for CD3 and TRDC and were classified as γδ-T
cells. Abbreviations: Mph, Macrophage, T-reg, regulatory T cells; B, B cells; CD8-T,
CD8+ αβ-T cells; CD4-T, CD4+ αβ-T cells. (B) Overlay of donor identity on UMAP
of scRNA-seq data. The number of cells from each donor is shown above the projection.
BC1 is a triple negative subtype and BC2 is a Her2+ subtype of breast cancer (BC).
(C) Identification of cells positive for genes encoding TCR δchain. Overlay of cells
that have genes mapping to the TRDC (left) and TRDV2 (right) gene segments. No
TRDV1 positive cells were identifiable. (D) Quantification of enrichment of genes
encoding TCR γ chain in the BC γδ-T clusters. Y -axis shows the percentage of cells
positive for the indicated TRGV4 and TRGV9 gene segment within each BC γδ-T
cluster (x -axis).
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Cluster specific differentially expressed genes (Table A.4) suggested that these
clusters had different functional roles (Figure 3.11 A,B). The complete list of
functional annotations significantly enriched in these gene sets can be found in
Table A.9. γδ-T.1 had the highest levels of cytotoxicity. γδ-T.2 was the only
innate-like subtype and had the highest levels of IFNγ production and antigen
presentation. γδ-T.3 produced the highest level of IL17A relative to the other
clusters (Figure 3.11 C).
Using mathematical deconvolution to infer the proportion of various immune cell
types from bulk RNA-seq data, elevated levels of γδ-T cells were found to be
associated with better survival in breast cancer (Ma et al., 2012) and across all
cancers (Gentles et al., 2015); however, recent work observed an improved overall
survival in triple-negative breast cancer for a δ1 innate-like subtype of γδ-T cells
but not for the overall levels of γδ-T cells (Wu et al., 2019). I sought to repeat
this analysis using the BC γδ-T subtype specific gene signatures identified in this
chapter (Table A.5).
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Figure 3.11: Identification of genes differentially expressed between the three breast
tumour infiltrating γδ-T subtypes and functional annotation. (A) Heatmap showing
top differentially expressed genes (row labels) between the three BC γδ-T cell subtypes.
Yellow represents high expression and purple represents low expression. (B) Functional
annotation of genes differentially expressed between the three BC γδ-T cell clusters
using data from GO and KEGG databases. The lengths of the bars (x -axis) are
proportional to the log fold enrichment. (C) Distribution of gene signature scores
(y-axis) for IFNγ production, IL17A production, Cytotoxicity, Antigen presentation on
MHC class 1 and Innate gene sets in each of the BC γδ-T cell cluster (x -axis).
108 3.3 Results
Based on the enrichment score for each of the retained samples and each of the
three BC γδ-T subtype gene signatures (see Methods) I selected the bottom and
top 1/3 of the samples to represent the samples with low and high expression of
the gene signature respectively (Figure 3.12) and performed survival analysis















































































Figure 3.12: Enrichment scores of the retained TCGA breast cancer samples for each
of the three breast tumour γδ-T subtype gene signatures. Wilcoxon rank test was used
to compute statistical significance of the scores between the grouped samples.
Survival analysis of the breast cancer data from the Cancer Genome Atlas
(TCGA) (Ciriello et al., 2015), indicated that only the enrichment of BC γδ-T.2
gene signature, but not the signature of either of the other two BC γδ-T clusters,
was associated with improved survival (Figure 3.13 A). The group of patients
with high expression of BC γδ-T.2 gene signature did not have higher overall
levels of T-cells (Figure 3.13 B) or a higher mutation load (Figure 3.13 C) or
higher expression of NKG2D ligands (Figure 3.13 D) than the group of patients
with lower expression of BC γδ-T.2 gene signature, suggesting that the difference
in survival rates observed is possibly not due to a secondary consequence of these
previously well known factors associated with survival. These findings are also
consistent with the findings reported in Wu et al (Wu et al., 2019).
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Figure 3.13: Characterisation of breast tumour infiltrating γδ-T cells uncovers a
subtype of γδ-T cluster that is associated with favourable outcome. (A) Kaplan-Meir
survival curve of the TCGA breast cancer data (Ciriello et al., 2015). Patients were
partitioned into high and low group based on scores for gene signatures of each of the
indicated BC γδ-T cluster. Y -axis shows overall survival. (B) Boxplot of expression
(y-axis) of CD3D, CD4 and CD8A genes in TCGA breast cancer data samples with
high (red) and low (blue) expression of the BC γδ-T.2 subtype gene signature (x -axis).
(C) Boxplot of scID scores (y-axis) of the NKG2D ligands gene set in TCGA breast
cancer data samples with high and low expression of the BC γδ-T.2 subtype gene
signature (x -axis). Wilcoxon rank test was used to compute statistical significance of
different scores within each cluster. (D) Boxplot of mutation load (y-axis) of TCGA
breast cancer data samples with high and low expression of the BC γδ-T.2 subtype gene
signature (x -axis). Wilcoxon rank test was used to compute statistical significance of
different scores within each cluster.
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Sequencing unsorted breast tumour-infiltrating immune cells provided an
additional opportunity to explore preferential ligand-receptor interactions
between γδ-T and other immune cells using CellPhoneDB (Efremova et al., 2019).
Figure 3.14 shows the significant interactions (p − value ≤ 0.01) between each
γδ-T subtype and other immune cell subtypes in BC1 (left) and BC2 (right). Only
ligand-receptor pairs that are unique to a specific γδ-T subtype are shown. Colour
indicates the average expression of the ligand and the receptor in the interacting
cell types and white represents non-significant interactions (p−value > 0.01). γδ-
T.1 cells interact with various types of immune cells mainly through aMb2 (αMβ2)
and aXb2 (αXβ2) complexes and the tumour necrosis factor receptor superfamily
(TNF). aMb2 and aXb2 complexes are integrins expressed on the cell surface of
various leukocytes, including macrophages and NK cells, playing a pivotal role in
innate immunity, with the αM and αX subunits mediating adhesion and spreading
of cells and the b2 subunit mediating cell migration (Solovjov et al. (2005), Hynes
(2002)). γδ-T.2 cells interact mostly with macrophages and γδ-T.3 cells interact
mostly through the DPP4 receptor. However, there is very low confidence in the
above observations as most of the interactions are restricted to only one of the
BC samples.
CHAPTER 3. Identification of sub-populations in circulating and breast

































































































































Figure 3.14: Identification of preferential ligand-receptor interactions between γδ-
T and other immune cells using CellPhoneDB (Efremova et al., 2019). Heatmap
showing average expression of the ligand and the receptor in the interacting immune
cell types where the interaction is significant (blue scale). Only ligand-receptor pairs
that are unique to a specific γδ-T subtype are shown. White represents non-significant
interactions. Left panel shows interactions between immune cell types in BC1 and right
panel shows interactions between immune cell types in BC2.
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3.3.3 Comparison of PBMC and breast tumour γδ-T cells
Lastly, I sought to compare and contrast breast tissue infiltrating γδ-T cells with
their counterparts in the circulation, starting with selected genes relevant for anti-
tumour immune function. Overall, the BC γδ-T cells were more activated and had
higher abundance of transcripts of genes involved in cytotoxicity and exhaustion,
while the markers of memory and naive T cells were significantly lower in breast
tumour γδ-T cells compared to those in PBMC (Figure 3.15 A).
To identify equivalent clusters across the BC and PBMC γδ-T datasets, I used
scID to calculate matching scores of all PBMC cells from HD6 for the three BC γδ-
T subtype gene signatures (Figure 3.15 B). I decided to use the BC subtypes as
reference since the PBMC data represent a larger number of cells. Consequently,
an inability to detect an equivalent BC subpopulation in the PBMC indicates
absence. On the other hand, an inability to detect a PBMC subpopulation in the
BC data could be due to sampling, i.e. no cells representing this cell type were
selected due to low prevalence. Based on these scores, BC γδ-T.1 cluster seems
to be transcriptionally equivalent to the PBMC δ2.1 cluster. This is supported
by both clusters being marked by CD16 and being IFNγ producers (Figure
3.8, Figure 3.11 C). The BC γδ-T.3 cluster seems equivalent to the PBMC
δ2.3 cluster, consistent with both being marked by CCR6 and being positive for
IL17A (Figure 3.8, Figure 3.11 C). However, none of the PBMC clusters were
similar to BC γδ-T.2, which is defined by expression of NCAM1 (CD56 ).
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Figure 3.15: (A) Comparison of expression of genes (rows) involved in activation,
cytotoxicity, exhaustion and naive T-cell state between PBMC γδ-T cell and breast
tumour infiltrating γδ-T cell subtypes. Gray represents low average expression and
red represents high average expression of the genes in each subtype (columns). (B)
Assessment of similarity of the γδ-T cell subtypes in PBMC and breast tumour. Boxplot
of scID scores (y-axis) of the BC cluster specific gene signatures in the PBMC clusters
(x -axis). Scores above the dashed line indicates enrichment of the indicated gene
signature. A Mann-Whitney U test was used to compute statistical significance of
different scores within each cluster. “***” indicates P-value ≤ 0.001.
114 3.3 Results
All genes selected from this study that can help distinguish between subtypes of
γδ-T in PBMCs and breast tumours are summarised in the feature plots in Figure
3.16 A. These results suggest a refined classification of human γδ-T cells based
on the single-cell RNA-seq data presented in this chapter: SOX4 and NCAM1
can distinguish the three δ1 clusters, while the combination of CD16 and CCR6






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.16: Marker genes and refined classification of γδ-T cell subtypes suggested
from the data in this chapter. (A) Feature plots showing expression of suggested
cluster defining markers in the γδ-T subtypes in PBMCs (top row) and BC (bottom
row). Gray indicates low expression and purple indicates high expression. (B) Table
summarizing the proposed refinement of subtype classification of γδ-T cells supported
by the scRNA-seq data from this study.
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3.4 Discussion
γδ-T cells are a very heterogeneous and poorly understood subset of T cells with
untapped potential for exploitation for immunotherapy. Currently, subtypes of
γδ-T are defined by their TCR sequences and in particular, the two well-defined
ones from the circulation, namely TRDV1 and TRDV2 (Davey et al. (2018),
Hayday (2019)). The data and analysis presented in this chapter have revealed
that in the human peripheral blood, despite having the same TCR sequence, there
are various gene expression-based cell states which are specialised for different
functions.
Here I have used scRNA-seq to unbiasedly identify transcriptionally distinct
subtypes and markers of γδ-T cells from human blood and breast tumour samples.
This study is significant because 1) it identified new markers that will help sort
γδ-T cell subtypes so they can be further studied; 2) it identified previously
unappreciated heterogeneity in both the δ1 and δ2 subtypes; and 3) it identified
a δ1-like subtype in breast cancer that is associated with better survival.
The results are consistent with the previously described CD16 - CD28 axis in the
δ2 clusters (Ryan et al., 2016); however, the new data presented here suggests that
CD28 is also present in δ1 subtypes and therefore not a good marker. GPR56
was identified and validated as an alternative marker to CD16 and CXCR6 as a
more specific marker of the two non-CD16 δ2 subtypes (Figure 3.9).
In PBMC, the two δ1 subtypes have subtle differences but one is immature
while the other is recent thymus emigrant and has residual cytotoxic and antigen
potential. Of the three PBMC δ2 subtypes, one is marked by CCR6 and is
an IL17A producer whilst the other two (CD16 + and CCR7 -CD16 -) are IFNγ
producers. The CCR6 + and the CD16 + subtypes are detected in both PBMC
and BC. The one of the two IFNγ producer clusters that is marked by CD16 +
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has higher antigen presentation and lower cytotoxic potential than the one that
is CCR6 -CD16 -.
In BC, three subtypes were identified: an IL17A producer δ2 subtype (also marked
by CCR6 ), an IFNγ producer and highly cytotoxic subtype marked by CD16 (and
thus likely a δ2 subtype) and a δ1 subtype which was also an IFNγ producer with
high antigen presentation capacity (marked by NCAM1 ). Although previous work
showed that γδ-T cell abundance is correlated with better outcome for several
types of cancer (Gentles et al., 2015), here we see that, at least for the breast
cancer cases considered, it is only the presence of one specific subtype that is
associated with better outcome. Mapping of gene signatures suggests that this
subtype has no equivalent in PBMC.
The subtype of γδ-T cell defined in this chapter that associates with better
overall survival of breast cancer patients may be very similar or equivalent to
the one recently found by Wu et al (Wu et al., 2019) who also identify a δ1,
IL17A low/negative, IFNγ+ subtype that associates with better overall survival
of TNBC patients. While TRDV1 is absent from the BC data, clear enrichment
of TRGV4 suggests that this subpopulation is δ1. Although Wu et al (Wu et al.,
2019) performed a battery of functional assays on γδ-T cells in the in vitro setting,
the results presented in this chapter can help better understand this subtype by
defining differentially expressed genes that could be used as potential biomarkers
for isolation or targeting of this cell subpopulation.
A limitation of this study is that it does not capture very rare γδ-T subtypes
and the full extent of TRD-TRG pairing. Moreover, due to the cost of single cell
RNA-sequencing and the difficulty of obtaining fresh tissue this study is based
on a limited number of patients. Although it would be interesting to compare
γδ-T cells between blood and breast cancer samples from the same individuals,
it was not possible to obtain PBMC samples from the two breast cancer patients
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(BC1 and BC2). Additionally, none of the two breast cancer samples included NK
cells. It would be important to obtain datasets that consist of both It would be
important to analyse datasets that include NK cells which were absent from both
breast cancer samples, as these are expected to be the most transcriptionally and
functionally similar cell type to δ-T and NK cells to describe the transcriptional
and functional differences between these two similar immune cell types.
Future directions should involve validating these findings in additional samples,
functionally characterizing the NCAM1 + subtype, and determining if presence
of the NCAM1 + subtype also correlates with better survival in other cancers.
Publicly available atlas-level data sets of breast cancer infiltrate immune cells,
such as the data from Azizi et al. (2018) could be analysed to detect γδ-T cells,
validate the presence of the subtypes defined here, look into the interactions of
these subtypes with other cell types in the tumour microenvironment and evaluate
the clinical relevance of the NCAM1 + subtype. scID, presented in Chapter 2,
can be a useful tool for querying these data sets.
The clinical relevance of the NCAM1 + γδ-T subtype should be extended to a
larger cohort. AutoGeneS (Hananeh and Theis, 2020) has been recently developed
to use singe-cell extracted cell type signatures to perform deconvolution in bulk
RNA-seq data and could be used to analyse more datasets from breast cancer
studies in combination with the single-cell RNA-seq data presented in this chapter.
Further endeavours to perform single cell RNA-sequencing of γδ-T cells from other
tissues and tumour types are likely to be equally fruitful.
3.4.1 Conclusions
In summary, this chapter presents a large reference-level scRNA-seq dataset
on blood γδ-T cells generated from three healthy donors and from two breast
tumours. Analysis of this large dataset containing transcriptomes from a total of
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7,000 γδ-T cells identified multiple novel subsets and marker genes for both δ1
and δ2 subpopulations, including a δ1 breast tumour infiltrating γδ-T cell subtype
that is absent in PBMC and that is associated with favourable overall survival
of breast cancer patients. This data suggests a refined classification of γδ-T cells
shown in Figure 3.16.
Taken together, the data and results presented in this chapter have contributed
to a better understanding of the functional diversity of γδ-T and will serve as a
valuable resource for the community that can be mined to identify markers useful
for isolating novel subsets to be able to further interrogate their functions.
Chapter 4
Demultiplexing donor identities
in pooled single-cell RNA-seq
data
4.1 Introduction
In previous chapters, I discussed the importance of comparing equivalent cell
types across different conditions in order to understand their roles in various
diseases and their response to treatment. We also saw that the technical variation
introduced when samples are processed separately, also known as batch effect,
is much stronger than the biological variation and leads to cells being grouped
by these technical characteristics rather than biological similarity. Even when
alignment or mapping is used to identify equivalent cell types across datasets,
measured gene expression is still confounded by batch and does not allow further
comparison of the cells from the different datasets, such as differential gene
expression analysis or pseudotemporal ordering.
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In order to be able to disentangle biological from technical variation, pooled
experiments are performed, where cells from different samples are mixed and
processed together in a single RNA-seq experiment. An additional advantage
of clusters of pooled cells is the ability to show whether there are differences
in proportions of cells between individuals. This could explain differences in
disease progression and response to therapy observed between individuals with the
same disease. Finally, pooling samples prior to single-cell RNA-sequencing can
reduce the per-sample library cost, and thus allow for single-cell RNA-sequencing
experiments at a population scale.
While most droplet-based methods become cost effective only when a very large
number of cells is pooled and a very large number of cells will be required in
population-scale scRNA-seq experiments, increased numbers of cells loaded lead
to an increased proportion of multiplets obtained as discussed in Chapter 1.
Additionally, in order to be able to compare equivalent cell types across samples,
we need to be able to know the sample of origin of each cell after pooling for further
analysis. Both experimental and computational solutions have been developed to
tackle these problems.
4.1.1 Experimental demultiplexing of sample identity
Recent experimental protocols have been developed to enable tracking of sample
identity for each cell prior to pooling cells from multiple samples. SPLiT-Seq
(Rosenberg et al., 2018) achieves this with an extra barcoding step prior to cell
and DNA tagging as follows. Dissociated cells from each sample are placed into
a 96-well plate, one sample per well with a unique barcoded primer. This adds
an extra tag to each transcript that allows tracking of its sample of origin. Such
protocols, however, increase the complexity of the experiment that might add
extra stress to the cells as well as increase the cost of the experiment. Additionally,
the increased length of the barcode sequence, i.e a sample barcode, a cell barcode
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and a UMI, leads to a decreased length of the captured transcripts that can be
sequenced, resulting in even sparser single cell RNA-seq data.
Other methods, such as CITE-Seq (Stoeckius et al., 2018), assign sample labels
to the cells using oligo-tagged antibodies that target sample-specific cell surface
proteins. Besides the fact that obtaining proteomics data increases the cost of the
experiment, the most important limitation of such approaches is the requirement
for the existence of cell-surface proteins that are sample specific and highly
expressed in all cells of a sample regardless of their cell type.
4.1.2 Computational demultiplexing of sample identity
An alternative approach to the above experimental methods is computational
demultiplexing of sample identity using genetic information. Methods have been
developed to cluster the cells based on donor-specific genetic variants. These
variants can either be available as external information from genotypic profiling
of the donors, or be inferred from the single-cell RNA-sequencing data.
Demuxlet
One of the first such approaches was Demuxlet (Kang et al., 2018) that aimed
to combine genetic variation information from single cell RNA seq data and
genotype information from each donor to assign cells to donors and also identify
simultaneously doublets formed of cells from two different donors. Demuxlet is
using prior genotype information from each donor to calculate the probabilities of
a cell originating from each donor given the observed variants in the cell’s RNA
reads accounting for the dropout rate and the population allele frequency of the
alternative allele. A mixture model is also used to calculate the probability of a
cell being actually a doublet originating from two individuals, for each pairwise
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combination of individuals. All likelihoods are finally compared to annotate the
cell.
Cardelino
Similarly, Cardelino (McCarthy et al., 2018) uses bulk or single-cell DNA-
sequencing data from the different donors to infer a clonal tree from frequency
and co-occurrence of genetic variants and then assign pooled cells from single cell
RNA-seq data to the corresponding donors using a Bayesian mixture model.
Both Cardelino and Demuxlte are highly accurate, especially in presence of a high
number of pooled donors or when donors are genetically close. However, they are
restricted to samples that originate from previously genotyped individuals and
thus, are not applicable to already publicly available datasets. Additionally, the
cost of genotyping the samples of all pooled donors has to be added on top of the
single-cell sequencing cost of a study.
Vireo
Vireo (Huang et al., 2019) on the other hand, is able to demultiplex scRNA-
seq data without the need for prior genotype information. Given the observed
reference and alternative counts of known genetic variants (e.g. 1000 Genomes
Project) in each single cell, Vireo implements a variational Bayesian inference
model to estimate both the donor identity of each cell and the genotype of each
donor simultaneously.
In both Vireo and Cardelino, genomic variants are extracted from single-cell RNA-
sequencing data using cellSNP (Huang, 2019).
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scSplit
Another recently published method that does not require genotype information
or a list of common variants is scSplit (Xu et al., 2019). scSplit uses the counts
of reference and alternative alleles for each genomic position and each cell and
initializes the clusters’ centroids with k-means clustering. Each cluster’s centroid
is then represented as the alternative allele frequency. The cells are assigned to
clusters/donors based on their probability of being observed from each sample and
the centroids are updated iteratively until convergence, using the Expectation-
Maximisation algorithm.
4.1.3 Computational challenges of demultiplexing
In theory, a single variant is sufficient to distinguish between cells from two donors,
but this requires that this variant is captured in all cells of the donor. However,
Single Nucleotide Polymorphism (SNP) identification in single-cell RNA-seq data
poses several technical challenges. The main limitation is the low number of SNPs
we can detect for each cell. This is due to the fact that we can only detect exonic
SNPs and only in the expressed genes of a cell which is a small proportion of the
total number genes. Additionally, most methods only capture the 3’UTR ends of
the transcriptome, further reducing the probability of observing a SNP due to the
low number of nucleotides sequenced. Finally, on top of that is added the high
sparsity of the data due to dropouts, i.e. genes that are not captured although
they are expressed in the cell.
All these effects result in a much smaller number of SNPs being captured in each
cell compared to the actual SNPs we would observe from that donor from bulk
or even single-cell DNA-sequencing data. Despite the additional sparsity of the
SNP data compared to the gene expression data, the dimensionality of the data
remains very high. Dimension reduction is required due to the lack of sufficient
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number of samples even when thousands of cells can be sequenced. Finally, as
technology improves and cost decreases, we expect more and more cells to be able
to be processed simultaneously and more and more individuals to be multiplexed,
which requires a fast and scalable solution.
4.1.4 Aim and structure of this chapter
In this chapter I will be focusing on the application of Deep Learning methods to
identify the donor identity of cells in a pooled single-cell RNA-sequencing dataset
without prior genotype information from the donors. More specifically, I will be
showing a pipeline for extracting SNPs from the FASTQ files of the single-cell
RNA-seq data and clustering this data to group cells by donor identity. I will be
using non-negative matrix factorisation, in order to obtain a lower dimensional
representation of the original data that can additionally show the specific variants
used to classify the cells into donors. This information is very useful for validating
the results.




Deep learning is a class of machine learning methods inspired from the structure
and function of the brain, that aims to solve a problem by extracting higher level
features from raw input data using multiple layers of non-linear transformations
(Lecun et al., 2015). Similar to the structure of the nervous system with neurons
being connected to each other and passing information, deep learning models
consist of interconnected nodes that exchange information. These nodes are
however organised in layers with each layer accepting information only from the
previous layer and passing it on to the next layer. The first layer is the input and
the last layer is the output of the model and these are the only observable layers.
Any intermediate layer is called “hidden” (Figure 4.1)
Input layer Hidden layer 1 Hidden layer 2 Hidden layer n Output layer
Figure 4.1: General structure of a deep learning network. Each layer may have a
different number of nodes.
Deep learning has the ability to process natural data in their raw format. Unlike
conventional machine-learning methods that require a well-designed feature
extraction strategy, deep learning methods can automatically extract informative
features from the data and learn very complex functions to transform them to
higher representations by combining multiple non-linear transformations. Such
higher representations have the ability to enhance the effect of variables that
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are important for classification and suppress irrelevant variations. In high-
dimensional data, deep learning is able to discover complex structures. Another
advantage of Deep Learning compared to conventional machine learning methods
is the ability to improve their performance when the amount of data available
increases. Other machine learning methods, on the other hand, reach a plateau of
the performance after a specific amount of input data. This is a very important
advantage in the area of single cell data as new experimental protocols enable
the generation of a vast amount of publicly available single-cell RNA-sequencing
datasets.
Deep learning methods can be either supervised or unsupervised. Supervised
learning builds classifiers by training a deep network model with a vast amount
of labelled datasets and then the trained model is used to classify new unlabelled
datasets. However, supervised algorithms have several drawbacks. First, they
require a vast amount of labelled data for training that is not always possible
to obtain. Additionally, there is a risk of the model being bound by the biases
in the training data (overfitting). Unsupervised learning algorithms on the other
hand can extract informative features from the testing data itself that can be
used to group the data in an informative way. The idea of unsupervised learning
is similar to human and animal learning that involves observation of the objects
to understand their characteristics.
Deep learning methods have led to application breakthroughs in a wide range
of science and business fields, from image and natural language processing to
analysing particle accelerator data. In the field of genomics and medicine, deep
learning methods have been used to predict the effect of non-coding variants
(Zhou and Troyanskaya, 2015), the effect of mutations in gene expression and
cancer (Luo et al., 2019) or the effect of drugs (Kalinin et al., 2018).
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4.2.2 Non-negative matrix factorisation
Non-negative Matrix Factorisation (NMF) is widely used in applications aiming
to separate non-negative sources from complex mixtures. The basic model of
NMF is a factorisation of a non-negative input matrix X into two non-negative
matrices W and H, each of them being of lower rank than X, such that
X = WH (4.1)
Non-negative refers to all elements of the factor matrices W and H being equal
to or greater than zero.
The optimal functions are the solutions to the constrained optimisation problem
(Ŵ, Ĥ) = arg min
W,H≥0
f(W,H) = ‖X−WH‖2F (4.2)
where ‖·‖2F indicates the Frobenius norm and f is the squared Euclidean distance
function between the observed data X and the estimated WH.
NMF is conceptually similar to dimension reduction methods, such as PCA
and Independent Component Analysis (ICA), however, NMF produces a sparse
and parts representation of the high-dimensional data that leads to easier
interpretation of the factor matrices W and H as physical building blocks of
the input X (Montesdeoca et al., 2019).
Similar to PCA and ICA, NMF is a deterministic mapping between the input and
the latent space. However, for sparse data such as single-cell RNA-sequencing
data, a probabilistic approach is more suitable in order to represent the data by
approximating the underlying probability distribution.
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4.2.3 Probabilistic Non-negative Matrix Factorisation
with variational autoencoder
Several probabilistic extensions to non-negative matrix factorisation have been
proposed (Bayar et al. (2014), Heinz (2014), Mohammadiha et al. (2013), Cemgil
(2009), Schmidt et al. (2009)) that show advantages over deterministic NMF in
applications with noisy data, such as clustering of DNA microarray data (Bayar
et al., 2014). However, all above methods require the selection of appropriate
priors which require computationally intensive techniques such as Monte Carlo to
compute the full posterior.
Montesdeoca et al. (2019) on the other hand, suggest the use of Variational
Autoencoder (VAE) for PNMF (PAE NMF). VAEs are probabilistic models that
utilise the autoencoder (AE) framework for a neural network to find probabilistic
mappings from the input to the hidden (latent) layers and from the hidden layers
to the output. AEs consist of an encoder part that compresses the input into
a fewer dimensions layer and a decoder part that tries to reconstruct the input
from the compressed data. This forces the network to retain only informative
features of the data which works as denoising. AEs aim to only approximate the
input instead of perfectly reconstructing it, enabling the network to learn useful
properties of the data by ignoring signal noise, without the risk of overfitting.
In a simple autoencoder network shown in Figure 4.2, the coefficients matrix
H is the latent representation of the input X and the final weights should be
non-negative with an identity activation function such that the output X̂ = WH
and X̂ ≈ X.
The combination of the VAE framework and NMF sets a non-negative constraint
on the latent space of the autoencoder leading to interpretable results while
maintaining a higher degree of flexibility on the posterior distribution and
automatic regularisation. Here we have implemented the model suggested by








Figure 4.2: Simple autoencoder network for non-negative matrix factorisation. The
encoder part compresses the input into a fewer dimensions layer (here shown in two
dimensions) and the decoder part tries to reconstruct the input from the compressed
data.
Montesdeoca et al. (2019) to identify the sample identity of cells based on observed
single-nucleotide polymorphisms (SNPs) without genotypic information of the
individuals. More specifically, given a non-negative matrix X ∈ IRm×n, with m
being the number of observed SNPs and n being the total number of cells in the
dataset, we seek to deconvolve this to a factor matrix W ∈ IRm×l representing
the load of each SNP in each sample identity and a coefficients matrix H ∈ IRl×n
representing the sample identity of each cell, with l being the number of different






The first term of equation 4.3 represents the reconstruction error between the
input and the estimated output measured by the Frobenius norm and the second
term represents the KL-divergence between the prior (p(H)) and the posterior
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(qφ(H|X)) and acts as regularisation term forcing the posterior to remain close
to the prior.
As shown in Figure 4.3, the encoder is used to estimate the parameters k and λ
of the posterior distribution and the coefficients matrix H is obtained by sampling
from the posterior distribution. Sampling however from the posterior distribution




for each dimension i
required in the backpropagation step. Thus variational autoencoders use an extra
input node ε to introduce the stochasticity in the middle of the network without
needing to differentiate it through, making the H node deterministic. Finally, the
decoder part of the network is used to reconstruct the input from H such that














Figure 4.3: Schematic representation of the architecture of a variational autoencoder
for non-negative matrix factorisation. Adapted from Montesdeoca et al. (2019).
Standard VAEs use Gaussian distributions. However, with the restriction of non-
negativity we require a distribution that falls towards zero when x becomes large
and has a Probability Density Function (PDF) of zero below x = 0. Although
other distributions, such as NB, ZINB and gamma distribution have been used
for modelling genomic data (Eraslan et al., 2019) and for NMF (Squires et al.,
2017), for the reparametrisation trick and inverse transform sampling a Weibull
distribution is simpler. The PDF of a Weibull distribution is defined as:










)k), if x ≥ 0
0, if x < 0
Thus, for sampling from the Weibull distribution we need the inverse cumulative
function:
H = C−1(ε) = λ(−ln(ε))1/k (4.4)
where ε is a random variable sampled from a uniform distribution ε ∼ N(0, 1).
The KL-divergence between two Weibull distributions for the second term of the















+ 1)− 1 (4.5)
where k1 and λ1 are the parameters of the posterior distribution, k2 and λ2 are
the parameters of the prior distribution, Γ is the gamma function and γ ≈ 0.5572
is the Euler-Mascheroni constant.
Having all the components of the network we can summarise the structure for a
one-layer network as follows:
λ = f(WλX),k = g(WkX),H = C
−1
k,λ(ε), X̂ = WfH (4.6)
where f and g are element-wise non-linear functions defined by the neural network
and the inverse cumulative function C−1k,λ also works element-wise.
The PAE NMF model was implemented in python using the open source machine
learning library PyTorch (PyTorch, 2016).
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Extraction of donor-specific SNPs from W
As previously mentioned, W is an m× l matrix representing the load of m SNPs
in the identity of each of the l donors. For example, for a dataset with two donors
(i.e. l = 2), if wi1  wi2 for a SNP i ∈ 1, 2, ...,m then SNP i is present in sample
1 and absent in sample 2. For these two-donor cases, I calculate the difference
di = wi1−wi2 for all SNPs. SNPs with positive di are defining donor 1 and SNPs
with negative di are defining donor 2. To obtain SNPs with high contribution to
each donor’s identity, these SNPs are sorted by d and top positive and negative
SNPs are selected.
As expected, the majority of the SNPs will be noisy and will not be strongly
associated to any donor. To identify these SNPs we can fit a linear regression
in the relationship between wi1 and wi2 and filter out SNPs that are within one
standard deviation from the fitted line.
4.2.4 Extraction of single nucleotide polymorphisms from
single-cell RNA-seq data
For identifying single nucleotide variants in the single cell RNA sequencing data I
designed the following pipeline using a BAM file as input. The pipeline uses the
BAM fields and tags shown in Table 4.1. Detailed information on these fields
and tags can be found in the SAM format specification document (Li et al., 2009).
The MD tag is complementary to the CIGAR string as it can distinguish between
matches and mismatches that are both denoted as “M” in the CIGAR string, thus
why it used here. For example, MD = “10A25ˆ4” indicates that the first 10 bases
are identical between the reference and the query sequence, then the reference has
an A while the query sequence has whatever is reported in the SEQ field, the next
25 bases are identical and then there is a deletion in the query sequence indicated
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Table 4.1: Fields and tags obtained from BAM file for extraction of single nucleotide
polymorphisms from single-cell RNA-seq data.
Field/Tag Description
RNAME Reference chromosome.
POS Leftmost mapping position of the reference genome.
MAPQ Mapping quality. Maximum is 255 for alignment with STAR
FLAG Bitwise describing several features of the aligned sequence. Used
to infer whether the sequence was aligned to the forward or reverse
strand
CB/CR Cell barcode raw (CB) or error-corrected and confirmed against a
list of true barcodes (CR). CR is preferred if available.
UB/UR Unique Molecular Identifier (UMI) raw (UB) or error-corrected (UR).
UR is preferred if available.
NM Number of mismatches. Require exactly 1 mismatch to retain read.
MD String for mismatching positions complementary to the CIGAR
string.
by the “ˆ” symbol. Finally the last 4 bases are identical to the reference. To
obtain our variants matrix we only retain reads with a single mismatch, thus we
keep only reads with MD consisting of a single letter and numbers.
• Step 1: Only retain reads with mapping quality equal to 255 for STAR
alignment to ensure that observed variants are not due to sequencing errors.
• Step 2: Only retain reads in the forward strand as defined by
transcriptional orientation.
• Step 3: Retain reads of filtered cells based on their associated barcode for
Chromium 10X data.
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• Step 4: Only retain reads with exactly one mutation (tag NM = 1).
• Step 5: Of these reads remove those that have deletions (tag MD contains
“ˆ” symbol).
• Step 6: Filter out mutations that are outside of a gene coding region as
these are likely to be alignment errors.
A binary matrix showing whether a specific SNP (rows) is present (value of 1) or
absent (value of 0) in each cell (columns) will be used as input to the PAE NMF
model.
Preliminary comparison of the above binary matrix and the identified variants
using cellSNP as input to PAE NMF did not show significant differences in the
classification accuracy. This is due to PAE NMF not using allele frequencies that
are additionally calculated with cellSNP but not with the above pipeline. Since
the above method is marginally faster to run compared to cellSNP, it was selected
for all tests shown in the next section.
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4.3 Results
It is known that performance of variational autoencoders is highly dependent on
the choice of hyperparameters (Hu and Greene, 2019). The main hyperparameters
of this method are the number of layers, the number of hidden units (nodes) in
each layer, the number of epochs, the batch size and the learning rate. The
number of layers and hidden nodes depends on the size of the data. Too many
layers and nodes could lead to overfitting, while too few could lead to high bias.
For our high dimensional data, we do not have sufficient samples to estimate
internal weights of very deep wide networks. I have chosen to use two layers and
test the accuracy of the classification for different numbers of hidden nodes. Thus
the architecture of the network will be M - d1 - d2 - k - d2 - d1 - M, where M
is the dimension of the input data, i.e. the number of SNPs, d1 and d2 and the
number of nodes in layers 1 and 2, respectively, and k is the size of the bottleneck
of the network that should be equal to the total number of donors in the data.
The number of epochs is the number of times the training data is shown to the
model. High number of epochs might lead to overfitting and low number might
lead to poor training of the model. Different values will be tested to study the
effect of the number of epochs on the classification accuracy for each dataset. In
every epoch, the model is trained with different batches (sets) of samples (cells).
The batch size indicates the number of samples used in each batch. Small batches
can lead to unstable learning as feature patterns will be less repeating between
batches. Large batches, on the other hand, can lead to very slow learning as there
will be small variation between batches. Finally, the learning rate is automatically
adjusted during each iteration using the Adam optimizer (Kingma and Ba, 2015)
in order to avoid getting stuck in local optima or not converging to the minima.
Besides the hyperparameters of the variational autoencoder, I will be testing the
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effect of SNP filtering on the classification accuracy. SNPs will be filtered based
on their prevalence in the data. SNPs that are present in very few cells are not
expected to be useful for the classification of the cells and removing them can
help slightly reduce the dimensionality of the data.
Finally, I will be comparing the classification accuracy of the PAE NMF model
to that of the previously mentioned methods.
4.3.1 Test Case: 50%:50% Jurkat:293T cell mixture
A simple example to test the PAE NMF method and compare it to existing
methods is a mix of 293T and Jurkat cells provided from 10X Genomics. These
are two distinct cell lines originating from different tissues with little or no intra-
sample heterogeneity of gene expression. The 293T cell line originates from human
embryonic kidney cells (Graham et al., 1977), while the Jurkat cell line consists
of T cells from peripheral blood of a 14-year old boy with acute lymphoblastic
leukaemia (Schneider et al., 1977). Thus, it should be easy to detect genetic
variants that discriminate the two samples. “Ground truth” labels have been
obtained from the output of demuxlet (demuxlet, 2017). According to these
labels, of the 500 cells, 240 (48%) cells are 293T cells, 218 (43.6%) cells are
Jurkat cells and 42 (8.4%) cells are doublets.
Using the previously described method for extraction of variants from the BAM
file, a total of 11,317 variants were identified. Of these variants, 4288 (37.9%) are
only observed in a single cell and a cell has on average 378 SNPs. Figure 4.4 A
shows the distribution of number of SNPs per cell and Figure 4.4 B shows the
distribution of the SNPs’ prevalence.
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Figure 4.4: Distribution of identified SNPs. (A) Histogram showing number of
identified SNPs per cell. (B) Histogram showing frequency of each identified SNP.
x -axis shows number of cells a SNP is present and y-axis shows the number of SNPs in
log10 scale. SNP, single nucleotide polymorphism
Effect of SNP filtering in classification accuracy
To reduce the dimensions of the variants matrix and remove noisy SNPs, I
filtered SNPs that are present in very few cells. Based on the distribution of
SNPs’ frequency (Figure 4.4 B), there is no obvious threshold to select (e.g.
the distribution being bimodal). Thus, I tried different thresholds of minimum
number of cells per SNP from the set of {1, 2, 3, 4, 5, 10, 15, 20, 25}. Figure
4.5 shows the effect of SNP filtering in the classification accuracy for different
combinations of hyperparameters. The classification accuracy as measured by the
ARI (see Section 2.2.6) between the “ground truth” and the PAE NFM predicted
labels is shown on the y-axis. Each boxplot shows the ARI for a specific threshold
of SNPs’ prevalence (shown on the x -axis) and for different values of the previously
mentioned hyperparameters. The distribution of ARI within each group is very
wide, ranging from very poor to very accurate classification. However, there

































































































































































































































































































































































































































































































Figure 4.5: Effect of the SNP filtering threshold on the classification accuracy of
PAE NMF. Boxplot showing the ARI (y-axis) for different filtering thresholds of SNPs
based on their prevalence (x -axis). Each dot represents the ARI for the threshold
indicated on the x -axis and a different set of hyperparameters. ARI, Adjusted Rand
Index
Effect of depth of network
I next sought to test the effect of the number of nodes of each hidden layer in the
classification accuracy. Using too few nodes is expected to result in the model
not capturing well the true sources of variance in the data, known as underfitting.
On the other hand, too many nodes can result in overfitting and inability of the
model to remove noise from the data. However, there is no theoretically proven
rule for selecting an appropriate number of nodes. Thus, I experimented with
different numbers of nodes ranging between 10 and 150 while also changing the
other hyperparameters of the model.
Figure 4.6 shows the ARI of the classification of these models for different
numbers of nodes in layer 1 (grey) and layer 2 (yellow). Each dot represents
the average ARI of multiple models with the same number of nodes (indicated
on the x -axis) and different values of the other hyperparameters and the error
bars indicate the 95% confidence interval. Although there is a trend of increasing
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ARI with decreasing number of nodes in layer 1 and with increasing number of
nodes in layer 2, there is no significant difference between the different options
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Figure 4.6: Effect of the number of nodes in each hidden layer on the classification
accuracy of PAE NMF for the Jurkat dataset. Scatter plot showing the ARI (y-axis)
for different number of nodes (x -axis) of layer 1 (grey) and layer 2 (yellow). Dots show
average ARI of multiple models with the same number of nodes and different values of
the other hyperparameters (number of epochs and batch size) and error bars indicate
95% confidence interval. ARI, Adjusted Rand Index.
Effect of number of epochs in the classification accuracy
As expected using an increased number of epochs leads to increased classification
accuracy. Figure 4.7 shows the classification accuracy of the network with
different hyperparameters. A low number of epochs often resulted in poor
classifications. The ARI on average is constantly improving with an increased
number of epochs. However, there are still models with very poor performance
after many iterations. Thus, there is no guarantee that any model will result in




























































































































































































































































































































































Figure 4.7: Effect of the number of epochs on the classification accuracy of PAE NMF
for the Jurkat dataset. Boxplot showing the ARI (y-axis) for different numbers of epochs
(x -axis). Each dot represents the ARI for the number of epochs indicated on the x -axis
and a different set of hyperparameters. ARI, Adjusted Rand Index
Effect of batch size in the classification accuracy
Methods that use stochastic gradient descent operate in a small-batch regime,
since use of larger batches has shown poor ability to generalize (Keskar et al.,
2019). Small batch sizes, on the other hand offer a regularizing effect (Wilson
and Martinez, 2003). This could be due to noise induction that in non-convex
optimisation problems helps the model escape saddle points during training and
bad local minima (Ge et al., 2015). Here I tested the accuracy of classification
for batch sizes ranging between 4 and 128 (Figure 4.8). As expected, increased
batch size leads to more models failing to accurately classify the cells, since there
are no changes in the data presented to the model in each epoch that can help
the model converge.
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Figure 4.8: Effect of the batch size on the classification accuracy of PAE NMF.
Boxplot showing loss calculated after the last epoch for different batch sizes. Each
dot represents the loss (y-axis) of a model with batch size indicated on the x -axis and
a different set of hyperparameters (number of epochs, numbers of nodes, SNP filtering
threshold). SNP, single nucleotide polymorphism
Loss correlates with classification accuracy
The loss represents the difference between the observed variants matrix X and
the estimated X̂ = WH. It is expected that the lower the loss the better is
the classification accuracy of the model. This is confirmed by the classification






































Figure 4.9: Relationship between loss and classification accuracy for batch size of 16.
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However, the loss is highly dependent on the batch size (Figure 4.10). Although
higher batch size leads to lower loss, it does not lead to better classification
accuracy (Figure 4.8). Thus we can only compare the loss across models with









































Figure 4.10: Boxplot showing loss calculated after the last epoch for different batch
sizes. Each dot represents the loss (y-axis) of a model with batch size indicated on the
x -axis and a different set of hyperparameters (number of epochs, numbers of nodes,
SNP filtering threshold).
Extraction of donor-specific variants for validation
Besides using the H matrix for obtaining the sample identities of the cells, non-
negative matrix factorisation provides the ability to explore the W to find the
genetic variants (SNPs) that are most important to the definition of each sample.
These variants can be used for visualisation of the results as well as to guide
further experimental validation.
Figure 4.11 A shows the top 10 variants per sample sorted by weight. The
length of the bars represents the weight with positive values indicating enrichment
in sample 1 and negative values indicating enrichment in sample 2. Variants are
encoded as “chromosome position”. Figure 4.11 B heatmap shows the presence
of these selected variants in all cells, grouped by sample identity according to the
PAE NMF method. Rows show the top 10 variants for sample 1 and sample 2
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and columns show cells of sample 1 and sample 2. Red represents presence and
blue represents absence of a variant in a cell. Given the dissimilarity of the two
cell lines, all extracted variants are uniquely present in one of the samples with
very low noise.
A B
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Figure 4.11: Extraction of sample-specific variants. (A) Barplot showing top 10
variants per donor sorted by weight. The length of the bars represents the weight
with positive values indicating enrichment in donor 1 and negative values indicating
enrichment in donor 2. Variants are encoded as “chromosome position”. (B) Heatmap
showing the presence (red) or absence (blue) of the top 10 variants per donor (rows)
in cells (columns) grouped by hierarchical clustering using Euclidean distance. Three
main clusters are identified; cells corresponding to donor 1, cells corresponding to donor
2 and doublets enriched in SNPs from both donors.
Doublet detection
Methods such as Demuxlet, Cardelino and Vireo use mixture models to calculate
the probability of each cell originating from two individuals based on the presence
of variants from different genotypes. scSplit includes an additional cluster to
capture the doublets, based on the hypothesis that all doublets, regardless of
the samples they originate from, will fall in the same cluster, separate from the
singlets. One disadvantage of the method presented in this chapter is that it is
not able to identify doublets as they are not an independent group of cells with
unique variants.
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To overcome this issue, we can use the extracted variants to detect cells that
express variants from more than one sample. A simple solution is to use
hierarchical clustering with Euclidean distance to group the cells into three
clusters; one for each sample and one for the doublets. This results in a refined
classification shown in Figure 4.12, where 243 cells are assigned to sample 1,
252 cells are assigned to sample 2 and 5 cells are identified as doublets. However,
doublets consisting of two cells from the same sample cannot be identified with











































Figure 4.12: Doublet detection with hierarchical clustering. Heatmap showing the
presence (red) or absence (blue) of the top 10 variants per sample (rows) in cells
(columns) grouped by hierarchical clustering using Euclidean distance. Three main
clusters are identified; cells corresponding to sample 1, cells corresponding to sample 2
and doublets enriched in SNPs from both samples.
Comparison with existing methods
Next, I compared the accuracy of the classification of PAE NMF with and without
identification of doublets with that of vireo and scSplit. Demuxlet labels were used
as “ground truth”. Figure 4.13 A shows the ARI between the predicted labels
from each method indicated on the x -axis and the labels obtained from demuxlet.
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For PAE NMF, six different results have been used, the ones with the lowest loss
between all tests with equal batch size. The bar shows the average ARI from
these tests and the error bar shows the 95% confidence interval.
The result of PAE NMF with and without refinement is very similar to that of
demuxlet and vireo. scSplit seems to have the best performance, however, almost
40% of the cells have been classified as doublets (Figure 4.13 B), which is much
higher than the expectation and demuxlet’s and vireo’s prediction. The cells
that have been identified as doublets with hierarchical clustering highly overlap
with those selected as doublets by vireo and are a subset of those from demuxlet
(Figure 4.13 C). The 27 doublet cells unique in demuxlet could be doublets













































Figure 4.13: Comparison of PAE NMF to vireo and demuxlet, using demuxlet labels
as “ground truth”. (A) Barplot showing Adjusted Rand Index (y-axis) between
the predicted labels from each method indicated on the x -axis and demuxlet labels.
Doublets have been removed from this comparison. For PAE NMF, six different results
have been used, the ones with the lowest loss between all tests with equal batch size.
Bar shows the average ARI and the error bar shows the 95% confidence interval.
“PAE NMF refined” is the result from the combination of PAE NMF and hierarchical
clustering using the top 10 variants per sample. (B) Barplot showing the percentage
of identified doublets from each method. (C) Venn diagram showing overlap of the
identified doublets between the four methods.
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4.3.2 Application: Mix of γδ-T cells from donor 1 and
CD3+ T-cells from donor 2
To confirm the above conclusions regarding the tuning of hyperparameters of the
PAE NMF model as well as its accuracy compared to other methods, I used a more
complex dataset that consists of a mix of γδ-T cells from one donor and CD3+
T-cells from another donor. Although the number of donors is still low, there
is a higher number of cells and there is additional gene expression heterogeneity
within each donor’s cells due to different cell types.
Peripheral blood γδ-T cells from one donor and peripheral blood CD3+ T-cells
from a second donor were pooled before performing scRNA-seq. The obtained
dataset consists of 6690 cells with an average of 863 expressed genes per cell.
Unsupervised clustering of the gene expression data identified 10 clusters. Due
to the different types of cells selected from each donor, we expect each cluster to
consist of cells from a single donor, thus we are able to manually annotate the
donor identities of the cells based on expression of known CD3-T and γδ-T cell
markers. These labels will be used as “ground truth” to evaluate the classification
accuracy of each demultiplexing method. Although γδ-T cells are a subpopulation
of CD3+ T-cells, we do not expect to see a significant number of γδ-T cells from
donor 2 due to their very low prevalence.
Based on expression of known T cell markers, i.e. CD3D, CD4, CD8A and
FOXP3, and genes coding for the gamma and delta chains of the γδ-T cells,
i.e. TRDC, TRDV1, TRDV2, TRGV4 and TRGV9, that we saw in Chapter 3,
we can obtain a manual classification. From Figure 4.14 we have gene expression
evidence that clusters 1,3,4,6, and 7 originate from donor 2 due to expression of
non-γδ-T cell markers (CD4-T cells, CD8-T cells and T regulatory cells).
Additionally, the expression of pan-γδ-T markers can confirm the above






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A B C D
Figure 4.14: Expression levels of known αβ-T cell markers in the clusters of the pooled
dataset of CD3+ T and γδ-T cells. Purple indicates high expression and grey indicates
low expression. (A) Expression levels of CD3E confirms that all cells are T cells. (B)
Expression levels of CD4 indicates that clusters 1, 3 and 7 are possibly CD4-T cells,
thus originating from donor 2. (C) Expression levels of CD8A indicates that clusters
4 and 6 are possibly CD8-T cells, thus originating from donor 2. (D) Expression of
FOXP3 in combination with expression of CD4 in cluster 7 indicates that this cluster
is T regulatory cells, further corroborating that cluster 7 cells originate from donor 2.
conclusions and identify the γδ-T cell clusters. Based on the expression of TRDC
(Figure 4.15 A), TRDV2 (Figure 4.15 B) and TRGV9 (Figure 4.15 C), there
is strong evidence for clusters 0 and 2 being δ2 γδ-T cells and thus originating
from donor 1. Evidence of TRDV2 and TRGV9 expression in cluster 5 (Figure
4.15 B,C) additionally indicates these are also δ2 γδ-T cells, according to our
conclusions in Chapter 3. Thus, cluster 5 also originates from donor 1. Similarly,
there is some evidence that cluster 8 consists of δ1 γδ-T cells from donor 1, and
high sparsity could be due to higher dropout rates of these genes as observed in
Chapter 3.
Finally, cluster 9 cells do not have evidence of expression of any of the above
markers. Additionally, the distance from the other clusters on the UMAP could
indicate that it is contamination from one of the samples. Thus, these cells were
not considered in the comparison. The final dataset consists of 6674 cells, 3102
cells from donor 1 (clusters 0, 2, 5 and 8) and 3572 cells from donor 2 (clusters






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.15: Manual identification of γδ-T cells based on expression of known γδ-
T cell markers. (A) Projection of TRDC+ (black) and TRDC- (grey) cells on the
UMAP. (B) Projection of TRDV1+ (red) and TRDV2+ (blue) cells on the UMAP.
Grey represents cells that do not express any of these two markers. (C) Projection of
TRGV4+ (light blue) and TRGV9+ (yellow) cells on the UMAP. Grey represents cells
that do not express any of these two markers.
Using the sequence alignment file of this dataset, 127,742 SNPs were identified in
these cells. The matrix of SNPs by cells is even sparser than the gene expression
matrix with 40.52% of the SNPs being only present in a single cell and the median
number of SNPs per cell being 498 (Figure 4.16).
Effect of SNP filtering in classification accuracy
To reduce the dimensions of the variants matrix and remove noisy SNPs, I filtered
SNPs that are present in very few cells. Again, based on the distribution of
SNPs’ frequency (Figure 4.16 B), there is no obvious threshold to select. Thus,
I tried different thresholds of minimum number of cells per SNP from the set of
{1, 2, 3, 4, 5, 10, 15, 25, 30, 40, 50}. Figure 4.17 shows the effect of SNP filtering
in the classification accuracy for different combinations of hyperparameters. The
classification accuracy as measured by the Adjusted Rand Index (ARI) between
the “ground truth” and the predicted labels is shown on the y-axis. Each boxplot
shows the ARI for a specific threshold of SNPs’ prevalence (shown on x -axis) and


































Figure 4.16: Distribution of the identified SNPs in the pooled dataset of donors 1 and
2, (A) Histogram showing number of identified SNPs per cell. (B) Histogram showing
frequency of the identified SNPs. x -axis shows number of cells a SNP is present and
y-axis shows the number of SNPs in log10 scale. 40.52% of the SNPs are only present
in a single cell. SNPs, single nucleotide polymorphisms
for different values of the previously mentioned hyperparameters (dots). Although
the hyperparameters have a great effect on the classification accuracy, we can see
that the average ARI is improving after filtering SNPs that are present in fewer
than 10 cells.
I further tested whether there are any systematic differences in the ARI between
the different filtering thresholds using multiple Wilcoxon signed rank tests. The
results are summarised in Table 4.2, which shows the significance levels for each
pair of filtering thresholds, with “*” indicating p− value ≤ 0.01, “**” indicating
p−value ≤ 0.001 and “***” indicating p−value ≤ 0.001 and black cells indicating
non-significant differences. Only the upper triangle of the table is calculated
as the comparisons are symmetrical. Missing comparisons are shown in grey















































































































































































































































































































































































































































































































































































































































































































Figure 4.17: Boxplot showing classification accuracy as measured by the Adjusted
Rand Index (y-axis) for different filtering thresholds of SNPs based on their prevalence
(x -axis). Each dot represents the Adjusted Rand Index for the threshold indicated on
the x -axis and a different set of hyperparameters.
ARI compared to most of the other thresholds, and thus will be used for the rest
of the analysis.
Effect of depth of network
I next tested the accuracy of PAE NMF models with different numbers of nodes
ranging between 10 and 300. Figure 4.18 shows the ARI of the classification of
these models for different numbers of nodes in layer 1 (grey) and layer 2 (yellow).
Each dot represents the average ARI of multiple models with the same number of
nodes (indicated on the x -axis) and different values of the other hyperparameters
(number of epochs and batch size) and error bars indicate 95% confidence interval.
Wilcoxon signed rank test was used to test if there are significant differences in
classification accuracy between the various selected numbers of nodes. Although
there is a trend of decreasing ARI with increasing number of nodes in layer 1,
there is no constant significant difference between all pairs of values. For example,
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Table 4.2: Summary table of pairwise Wilcoxon signed rank tests between ARI of
different filtering thresholds (rows and columns). Only the upper triangle of the table
is calculated as the comparisons are symmetrical. Missing comparisons are shown in
grey colour. “*” indicates p − value ≤ 0.01, “**” indicates p − value ≤ 0.001 and
“***” indicates p − value ≤ 0.001 and black cells indicates non-significant differences
(p− value > 0.01).
1 2 3 4 5 10 15 25 30 40 50
1 * *** *** **
2 ** *** * *** *** ***
3 * ***
4 * ** *** *







although using 10 nodes is better than using 50 or 100 nodes, it is not better than
using 150 nodes. On the contrary, ARI is increasing with increasing number of
nodes in layer 2. However, again this difference is not significant between all
pairs of values, thus there is no confidence that this can be a generalised rule for
designing future models.
Based on these observations, we do not have the power to decide which option
is the most appropriate. To test the rest of the hyperparameters, I will be using


































Figure 4.18: Effect of number of nodes of the hidden layers in the classification
accuracy. Scatter plot showing classification accuracy as measured by the Adjusted
Rand Index (y-axis) for different number of nodes (x -axis) of layer 1 (grey) and layer
2 (yellow). Dots show average ARI of multiple models with the same number of nodes
and different values of the other hyperparameters (number of epochs and batch size)
and error bars indicate 95% confidence interval. Wilcoxon sign rank test was used to
compare the accuracy between pairs of selected numbers of nodes and only significant
values are shown. In all tests, the SNP filtering threshold is fixed at 40.
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Effect of number of epochs in the classification accuracy
As expected, an increased number of epochs leads to increased classification
accuracy. Figure 4.19 shows the classification accuracy of the network with
different hyperparameters and SNP filtering threshold fixed at 40. The ARI is
improving with increased number of epochs up to 30 epochs. However, after 30
epochs, any further increase does not lead to significantly better ARI. For the


































































































































































Figure 4.19: Effect of number of epochs on the classification accuracy. Boxplot
showing classification accuracy as measured by the Adjusted Rand Index (y-axis) for
different numbers of epochs (x -axis). Each dot represents the Adjusted Rand Index for
the number of epochs indicated on the x -axis and a different set of hyperparameters.
In all tests, the SNP filtering threshold is fixed at 40.
Effect of batch size in the classification accuracy
Here I tested the accuracy of classification for batch sizes ranging between 4 and
512 (Figure 4.20) due to the increased number of cells compared to the previous
example. A batch size of 16 seems to achieve the best accuracy for a set of tests
with different hyperparameters and with SNP filtering threshold of 40. Pairwise
Wilcoxon signed rank tests between results with batch size 16 and results with
154 4.3 Results
other batch sizes confirms that classification accuracy is significantly higher when

























































































































Figure 4.20: Effect of batch size in the classification accuracy. Boxplot showing
classification accuracy as measured by the Adjusted Rand Index (y-axis) for different
batch sizes (x -axis). Each dot represents the Adjusted Rand Index for the batch size
indicated on the x -axis and a different set of hyperparameters. P-values indicate
significance level of ARI with batch size 16 being higher than the ARI of any other
group using an one-sided Wilcoxon signed rank test. In all tests, the SNP filtering
threshold is fixed at 40 and epochs are between 30 and 100.
Effect of batch size in loss
As seen in the previous dataset, the loss is highly dependent on the batch size
(Figure 4.21) with higher batch size leading to lower loss. This however does not
correspond to better classification accuracy (Figure 4.20). For this reason, we
will only compare different PAE NMF models with the same batch size to select
the one with the lowest loss for the final classification.
Extraction of donor-specific variants for validation and doublet
detection
From the W matrix, I extracted the top 10 genetic variants that contribute most to
the identity of each donor. Figure 4.22 A shows the extracted variants sorted
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Batch size

















































Figure 4.21: Boxplot showing loss calculated after the last epoch for different batch
sizes. Each dot represents the loss (y-axis) of a model with batch size indicated on the
x -axis and a different set of hyperparameters (number of epochs, numbers of nodes,
SNP filtering threshold).
by their weight. The length of the bars represents the variants’ weight with
positive values indicating enrichment in donor 1 and negative values indicating
enrichment in donor 2. Variants are encoded as “chromosome position”. Figure
4.22 B heatmap shows the presence of these selected variants (rows) in all cells
(columns), grouped by donor identity according to the PAE NMF method. Red
represents presence and blue represents absence of a variant in a cell. Due to the
within-donor heterogeneity, there is higher variability within each donor and more
noise compared to the previous example. However, there are at least 3 variants
unique to one of the donors and captured in all donor’s cells.
Doublet detection
Using hierarchical clustering with Euclidean distance to group the cells into three
clusters, we obtain the refined classification shown in Figure 4.23. 2914 cells are
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Figure 4.22: Extraction of donor-specific variants. (A) Barplot showing top 10
variants per donor sorted by weight. The length of the bars represents the weight
with positive values indicating enrichment in donor 1 and negative values indicating
enrichment in donor 2. Variants are encoded as “chromosome position”. (B) Heatmap
showing the presence (red) or absence (blue) of the top 10 variants per donor (rows) in









































Donor 1 cells Donor 2 cells Doublets
Figure 4.23: Doublet detection with hierarchical clustering. Heatmap showing the
presence (red) or absence (blue) of the top 10 variants per donor (rows) in cells (columns)
grouped by hierarchical clustering using Euclidean distance. Each identified group of
cells is manually annotated.
Comparison with existing methods
Next, I compared the accuracy of the classification of PAE NMF with and without
identification of doublets with that of vireo and scSplit. Demuxlet and cardelino
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cannot be used with this data due to unavailable genotypic information of the
two donors.
Figure 4.24 A shows the ARI between the predicted labels from each method
and the “ground truth” labels. Since the “ground truth” labels do not include a
class for doublets, predicted doublets from each method have been removed from
the comparison. For PAE NMF, eight different results have been used, the ones
with the lowest loss between all models with equal batch size and the error bar
shows the 95% confidence interval. The initial result of PAE NFM has lower ARI
than the other methods. However, the refined labels after hierarchical clustering
with the top 10 variants per donor shows considerably improved accuracy, very
similar to that of vireo. scSplit has the highest ARI (equal to 1), however, almost
40% of the cells are identified as doublets indicating low sensitivity, as doublets
are not expected to exceed 10% of the cells. Indeed, the percentage of identified
doublets by vireo and PAE NMF with hierarchical clustering are below 5% which
is much closer to our expectation. Finally, 90% of the identified doublets with
PAE NMF (163 cells) have been also identified as doublets by one or both of the













































Figure 4.24: Comparison of PAE NMF to vireo and cardelino. (A) Barplot showing
Adjusted Rand Index (y-axis) between the predicted labels from each method indicated
on the x -axis and the “ground truth” labels. Doublets have been removed from the
comparison since the “ground truth” labels do not contain any doublet class. For
PAE NMF, eight different results have been used, the ones with the lowest loss between
all tests with equal batch size and the error bar shows the 95% confidence interval.
“PAE NMF refined” is the result from the combination of PAE NMF and hierarchical
clustering using the top 10 variants per donor. (B) Barplot showing percentage of
identified doublets from each method. (C) Venn diagram showing overlap of identified
doublets between the three methods.
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4.4 Discussion
In this chapter, I presented a deep learning approach for demultiplexing the donor
identities of cells in pooled single-cell RNA-seq experiments. An implementation
of non-negative matrix factorisation using variational autoencoders has two
main advantages for the analysis of noisy single-cell RNA-sequencing data.
Variational autoencoders aim to only approximate the input instead of perfectly
reconstructing it, enabling the network to learn useful properties of the data while
ignoring signal noise. Additionally, the use of non-negative matrix factorisation
enables tracking of the genetic variants that contribute to the definition of each
donor. These variants can then be used for validation of the clustering. Using two
different datasets, I explored the effect of the hyperparameters of the model in
the classification accuracy and compared it to other published methods, namely
demuxlet, vireo and scSplit.
The high dimensionality of the data is the main bottleneck of the data. As
previously discussed, besides sparsity and dropouts that also exist in the single-
cell gene expression datasets, there are systematic differences between cells of a
single donor based on cell type specific gene expression. Filtering very rare SNPs
can potentially improve the accuracy of the model by removing too noisy variables
without sufficient numbers of measurements. This can also have a positive effect
on the computational time of the model. While there is no obvious threshold
based on the distribution of the SNPs prevalence, I tried several thresholds and
showed that pre-filtering can improve the classification accuracy in the complex
dataset of pooled CD3+ T and γδ-T cells that consists of a very high number of
identified SNPs.
An alternative filtering approach could be to select only variants in the genomic
regions of housekeeping genes, in order to ensure there is equal probability of
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capturing a SNP in all donor’s cells. However, this runs the risk of reducing the
number of observed variants and might lead to increasing the number of cells
with no SNPs. Additionally, the set of housekeeping genes is relative to the cell
populations in the mixture and it is challenging to identify them within each
dataset separately with minimum user interaction and expertise.
Besides the filtering threshold, it is known that the performance of variation
autoencoders is strongly dependent on the tuning of the hyperparameters (Hu
and Greene (2019), Eraslan et al. (2019)). In the results presented here we
observe very high variation of the classification accuracy depending on the
hyperparameters used. As expected, increased number of epochs significantly
increase the classification accuracy. Regarding the depth of the network, i.e. the
number of nodes in each hidden layer, the results do not show a clear dependence
and a rule that can be generalised for the design of new models.
The final reconstruction loss is expected to correlate with the classification
accuracy, with low loss indicating better hyperparameter configuration and better
accuracy Eraslan et al. (2019). Thus, in a similar method for denoising and
imputation of single-cell RNA-sequencing data (DCA), Eraslan et al. (2019) are
implementing a hyperparameter search. The DCA is trained with 1,000 different
hyperparameter configurations, and the model with the lowest reconstruction
error is selected as the final result.
Here we have found that the loss is indicative of the classification accuracy when
comparing models with the same batch size. However, the loss is highly dependent
on the batch size selected which does not correlate with the classification accuracy.
The solution that worked for both datasets was to train multiple models with
equal batch size and different sets of the rest of the hyperparameters and select
the model with the lowest loss but not compare across models with different
batch sizes. This assumption needs to be confirmed for a higher number of
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datasets. Given the low computational time and the ability to train the different
models in parallel, this is a feasible solution without requirement of user-specified
hyperparameters.
Identification of doublets has not been implemented in the PAE NMF method.
One suggestion for improvement could be to increase the number of requested
clusters in order to account for extra clusters consisting of doublets. This was
not successful with the above datasets, possibly due to the fact that the doublets
do not have unique SNPs, but a combination of SNPs observed in two different
donors. To account for this, here I extended the method by adding a last step of
hierarchical clustering of the cells using the top 10 most important SNPs selected
from the W matrix. This was shown to improve the classification accuracy of
PAE NMF and there is high confidence that the cells detected as doublets are
correct based on the agreement with the other methods. It is however unclear
whether this can be generalised in datasets with a very high number of donors.
Here I have only used top 10 SNPs per donor to refine the clustering of the
PAE NMF model and detect doublets. Further exploration of the resulting W
matrix is required to develop a generalisable approach for identifying all SNPs
that significantly contribute to a donor’s identity and test whether this can further
improve the classification accuracy.
Overall, the classification accuracy of the selected models with minimum loss
was close to that of vireo and demuxlet after refinement of the cell labels with
hierarchical clustering. While scSplit seems to correctly label all cells identified
as non-doublets showing a very high specificity, the sensitivity is very low with a
very high number of cells labelled as doublets.
This study was restricted to testing the model with two datasets due to lack of
publicly available datasets with ground truth labels of the donor identities. While
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it was shown that PAE NMF can overcome the bias of intra-donor variability
due to celltype-specific gene expression, this was only demonstrated for a dataset
(PBMCs) comprising cells of two different donors. To further test the classification
accuracy of this method and it’s potential for contribution in population-scale
studies, more complex datasets are required that comprise of cells of a higher
number of donors and cells.
4.4.1 Conclusions
There has been an increased interest recently in using deep learning methods
for the analysis of single-cell RNA-sequencing data, with applications on
normalisation, clustering and identification of differentially expressed genes. The
method presented here is the first application of deep learning on demultiplexing
donor identities of cells in pooled experiments. Preliminary results show that
although the accuracy is highly dependent on the hyperparameters of the
model, it can achieve high classification accuracy with proper hyperparameters.
Although no generalised rules could be found to tune the hyperparameters, the
reconstruction loss could be used to find the most accurate result amongst models
with different settings but same batch size.
The interpretability of non-negative matrix factorisation allows not only the
clustering of cells by donor identity, but also the identification of donor-specific
genetic variants that distinguish between individuals. This information can be
leveraged in other applications. For example, the identified donor-specific variants
can be removed from the sequencing data prior to them becoming publicly
available in order to become anonymised. Finally, this approach can be used




With rapid improvement of sequencing protocols and decreasing sequencing costs,
single-cell RNA sequencing has become a routine method for studying cell biology.
scRNA-seq enables measurement of gene expression at the individual cell level
leading to an understanding of cell-to-cell heterogeneity at greater resolution
compared to bulk RNA-sequencing. This new information has helped uncover
previously unknown cell types and states.
However, new computational challenges have emerged. The low amounts of
mRNA available and amplification biases lead to uncertainty about measured
gene expression levels. Relative gene expressions between cells are unbalanced,
with no corresponding reads observed for a high number of genes (dropout events)
(Kharchenko et al., 2014). Additional systematic technical variability exists
between data that have been processed separately, known as a batch effect, that
confounds biological variation of gene expression.
This thesis contributes computational methods for the analysis of single-cell RNA-
seq data to overcome the bias of batch effects, as well as a better understanding of
163
164
the transcriptional and functional heterogeneity of γδ-T cells in human peripheral
blood and breast tumour.
Identification of transcriptionally equivalent cell types across datasets
with batch effect
Cross-sample comparison is essential in order to understand the role and altered
states of cell populations in development and disease. Batch effect, however, is
posing technical challenges for the integrated analysis of datasets that have been
processed separately. While batch effect correction methods exist (Haghverdi
et al. (2018), Hoffman et al. (2018)) that can identify and regress out technical
variability, these do not work as expected in pairs of data with strong imbalances
in numbers of cells and sequencing depth. Additionally, they run the risk of
over-correcting and removing true biological variability and finally, they require a
repeat of the analysis for any new dataset obtained. A more promising strategy
is mapping cells to reference datasets (Lähnemann et al., 2020).
In Chapter 2 of this thesis I presented a mapping method for the identification
of transcriptionally equivalent cell populations across datasets with batch effect.
scID uses the framework of Fisher’s LDA to score the cells of a dataset for a
given gene set and then partitions the cells based on this score as matching and
non-matching to that gene set. The gene set is expected to represent a cell type
or state and can be either extracted from a reference single-cell RNA-sequencing
dataset or given as a list from the user, as a result of curation or analysis of bulk
RNA-seq data.
Through extensive evaluation and comparison with other methods, I showed that
scID outperforms existing methods in cases of pairs of datasets (reference and
target) that have strong imbalances in numbers of cells and sequencing depths.
This is due to scID sorting genes based on their discriminative power in the
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target dataset which leads to filtering out genes that in the target dataset are
not discriminative due to higher dropout rate or different cell type composition.
Moreover, gene sets are only extracted once from the reference dataset and can
be used with any new target dataset acquired.
An important limitation of scID is that a cell might be selected by more than
one gene set if these represent transcriptionally similar cell types. The current
implementation resolves these multi-assignments by comparing the scores of a cell
for all tested gene sets and assigning the cell to the identity with the highest score.
However, this temporary solution needs to be replaced by a better approach.
Replacing the score with the probability of a cell being drawn from a population
described by the given gene set would allow better classification of the cells as
well as leave ambiguous cells unclassified to reduce false positives. Inference of
minimum probability or score from the reference data could also improve the
accuracy of scID but needs further exploration.
Uncovering previously unappreciated heterogeneity with the γδ-T cell
population
While γδ-T cells in PBMC have been previously characterised based on the
variable segment of the delta chain of the TCR (Pizzolato et al., 2019) or based
on production of IL17 or INFγ (Ribot et al., 2009), the underlying heterogeneity
of these subtypes was not understood. In Chapter 3 using scID and other
published scRNA-seq data analysis methods, I sought to unbiasedly identify
transcriptionally and functionally distinct subpopulations of γδ-T cells in human
peripheral blood (PBMC) and breast tumour samples.
Unsupervised clustering revealed five subpopulations of γδ-T cells in PBMC and
three subpopulations of γδ-T cells in breast tumour samples. Two of the γδ-T cell
subtypes in PBMC are possibly δ1 and three are δ2 which confirms what is known
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regarding the relative prevalence of δ1 and δ2 subsets in human peripheral blood.
There is evidence that one of the γδ-T cell subtypes in breast tumour samples
is δ2 while the TCR δ chain identity of the other two clusters is unclear. Based
on gene markers and comparison of gene expression signatures with the clusters
in PBMC, we inferred that one of the clusters is most like δ1 and the other δ2.
While in these experiments the 3’ UTR chemistry of Chromium 10X was used,
the 5’ UTR chemistry could capture the δ and γ variable region of each cell with
higher confidence and lower dropout rate. Thus, this preliminary characterisation
of the subpopulations needs further validation.
Regardless of the γ and δ chains, the identified subtypes showed different
gene expression patterns and annotated functions. Extended lists of cluster-
specific genes and annotated functions are provided for further study of
these subpopulations either through sorting with cell surface markers or
computationally using a longer set of genes. Interestingly, a breast tumour
subtype was associated with improved overall survival of breast cancer patients.
While some well-known factors associated with survival, such as the mutation
load, the overall levels of T-cells and the expression of NKG2D ligands, could
be eliminated, other factors could be confounding the result. For example, since
NK cells are absent from the two breast cancer datasets, it is possible that the
extracted gene set is also expressed in NK cells and thus the high scoring samples
from TCGA are selected due to higher proportion of NK cells instead of this
γδ-T cell subtype. Refinement of the selected gene set is required to eliminate
this factor. Additionally, it would be interesting to investigate whether enriched
samples from other cancer studies and types yield similar results.
It has been previously seen that there is variation in the relative proportion of
δ2 subtypes between different individuals (Ryan et al., 2016). The new data
presented in this thesis could be also used to observe such inter-donor variation
of the identified subtypes. To achieve this, we can use the PAE NMF method
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presented in Chapter 4 to demultiplex the donor identities of the cells of the
pooled HD4/5 dataset in order to quantify the relative proportion of all cell
subtypes in each of the three PBMC donors.
Demultiplexing donor identity of cells in pooled scRNA-seq
experiments
As ultra high throughput single-cell RNA-sequencing becomes efficient and cost
effective (Zhang et al., 2019a), another way to overcome batch effects is to pool
cells from multiple individuals in one experiment. In cases where donors represent
different conditions, e.g. different developmental stages or health conditions,
such datasets enable differential gene expression analysis between conditions with
existing methods. Additionally, it can scale single-cell RNA-seq data analysis to
the population level, due to a decrease of the per-individual library cost. Using
data from multiple donors in a study increases the confidence and reproducibility
of the results, while enabling the comparison of cell type composition between
individuals.
Such an approach requires tracking of cells’ donor identity. Experimental methods
that enable tracking of donor identity of each cell, such as SPLiT-Seq (Rosenberg
et al., 2018) and CITE-Seq (Stoeckius et al., 2018), require heavy manual
processing and are costly. Computationally, donor identities can be assigned to
cells based on donor-specific genetic variants. Technical factors, such as sparsity
and gene fragment capturing, as well as biological factors, such as cell-type-specific
gene expression, need to be addressed in such computational methods.
In Chapter 4 I presented a deep learning application for non-negative matrix
factorisation using Variational Autoencoders (VAEs) to identify the donor identity
of cells by clustering them using the observed genetic variants. NMF is a
factorisation of the input genetic variants matrix into two non-negative matrices,
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with one representing the load of each variant in each donor’s identity and
the other representing the probability of cell belonging to each donor. VAEs
add a probabilistic extension to NMF that works as denoising. The input is
approximated instead of perfectly reconstructed which leads to retention of only
informative features of the data without the risk of overfitting. This enables both
clustering the cells based on their donor identity, as well as extracting donor-
specific variants that can be used for validation.
Although the accuracy of this method is highly dependent on the selection
of hyperparameters of the model, the final reconstruction loss can be used to
compare models with different sets of hyperparameters. The model with the
lowest loss can be selected and is expected to have good performance. Since
this was not extensively evaluated, further testing is required to prove the
validity of this hypothesis. Finally, it would be of great interest to test the
method for datasets with more than two donors. All other methods have shown
good classification accuracy for datasets with up to 8 donors, while vireo shows
decreased performance for synthetic datasets with more than 12 donors (Huang
et al., 2019). PAE NMF needs to be tested with such complex datasets to
investigate its potential advantage over existing methods and ensure that it can
be used at population-scale scRNA-seq studies.
5.1 Open challenges in single-cell RNA-sequencing
data analysis
Even though many methods for the analysis of single cell RNA-seq data, such
as dimensionality reduction, clustering and visualisation, are becoming parts of
standardised pipelines, there are still many open computational challenges.
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Differential gene expression
For the improvement of scID, the most important open challenge is differential
gene expression analysis for the extraction of cluster-specific genes from reference
scRNA-seq datasets. Identification of cluster-specific gene sets needs to be
separated into two problems, depending on the scope of the study.
When extracted genes are expected to be used as biomarkers for sorting a cell
population, selected genes need to be either exclusively present or the distributions
of gene expressions in that population and in any other cell should not be highly
overlapping. Markers often need to be hierarchical to provide a set of biomarkers
that need to be combined in order to distinguish between similar subpopulations.
An example of a hierarchical approach for defining gene expression profiles of cell
types is CHETAH (de Kanter et al., 2019).
On the other hand, for any computational analysis, such as functional annotation
or mapping across datasets, longer lists of genes that in combination are cluster-
specific need to be identified. As discussed in Chapter 1, current methods for
differential gene expression analysis, such as MAST (Finak et al., 2015) used in
scID, identify differentially expressed genes in a cluster by testing for differences
in the gene expression or the distribution of the gene expression between that
cluster and a pool of cells from the other clusters in the dataset. This leads to
identifying genes as differentially expressed those that are also expressed in other
similar cell populations that do not contribute equally to the signal of the pool
of cells, given that they are a minor population.
A solution for this problem within scID could be to perform multiple pairwise
comparisons between clusters to find a set of genes for a reference cluster c
that can distinguish between cells of type c and cells of transcriptionally close
clusters. Using the minimax approach (Devroye and Lugosi, 2001), we can find a
170 5.1 Open challenges in single-cell RNA-sequencing data analysis
feature vector wc = [w1, ..., wM ]
T
c for each reference cluster c of M genes and their
corresponding weights that define a one-dimensional projection of the reference
cells so that cluster c is maximally separated from the transcriptionally closest
cluster, and thus from any cluster in the reference data. This can be achieved by





(wT (µc − µj))2
wT (Σc + Σj)w
(5.1)
where µ is a vector of the average expression of each of the M genes in cluster c
(µc) or any other cluster j (µj) and Σ is the covariance matrix between genes in
cluster c (Σc) and any other cluster j (Σj).
Unlike the currently implemented method of Step 2 of scID, in this approach
the cost is computed in the projected line instead of each gene individually.
Preliminary results showed better separation between clusters of various reference
datasets and did include known markers for each cell type. However, the need to
calculate the full covariance as well as perform all these pairwise comparisons
is computationally intensive and did not scale to greater than 3000 genes.
Restriction of the number of genes does not only require supervised gene filtering
prior to applying this method, but can also lead to decreased accuracy in cases
with many and transcriptionally similar clusters in the data, which requires
longer lists of features to distinguish them. Working towards the direction of
improving the computational time of the method might enable the implementation
of this method within scID but also as an alternative method for differential gene
expression analysis.
Finally, another limitation of the cluster-specific gene sets extracted from the
reference clusters in scID, is that these gene sets are relative to the other cell types
present in the reference dataset. This does not guarantee that a cell population in
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a target dataset that is closely related but not identical to the reference population
will not be selected as matching. There is thus the need to build better reference
gene sets that consist of genes differentially expressed between the cell population
of interest and any other population that can be possibly present in the same
type of tissue. Datasets from the Human Cell Atlas can serve as an important
reference resource. The main challenge of this is the presence of a batch effect
between datasets, thus differential gene expression analysis methods for integrated
data are required.
Data integration and scaling
As protocols improve and the cost of single-cell RNA-sequencing decreases, bigger
and more heterogeneous types of single-cell data can be generated for a single
study. This will need Big Data methods for the analysis that will involve both
the ability of methods to scale up to more cells as well as to combine different
types of measurements into the same analysis.
In addition to single-cell RNA-sequencing, methods exist for measuring DNA
methylation (Karemaker and Vermeulen, 2018), protein levels (Virant-Klun et al.,
2016) as well as chromatin accessibility (Cusanovich et al., 2015) at the single cell
level. Integration of genomic, proteomic and epigenomic information can lead to
better resolution of cell types and their distinct functions, however, at the cost
of further increasing the dimensionality of the data. The increase of both the
number of features as well as the number of cells per dataset will be challenging
for many in-memory processing methods and interest should be shifted to parallel
processing. Finally, an important challenge of such data integration is to model
the dependencies between the different measurements.
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Table A.1: List of differentially expressed genes between γδ-T cell subtypes from
PBMC.
gene HD45 avg logFC HD6 avg logFC max pval min pval cluster
RPL21 3.68e-01 4.32e-01 2.9e-40 2.82e-256 δ1.1
RPL32 3.14e-01 5.07e-01 2.98e-32 5.44e-236 δ1.1
RPL34 2.76e-01 4.46e-01 4.88e-28 1.49e-221 δ1.1
LEF1 9.76e-01 1.31e+00 8.43e-50 1.3e-214 δ1.1
RPS6 2.49e-01 4.61e-01 1.81e-22 7.65e-209 δ1.1
LDHB 7.9e-01 9.37e-01 2.56e-45 3.16e-205 δ1.1
LTB 6.09e-01 1.14e+00 2.27e-24 1.77e-193 δ1.1
CCR7 5.93e-01 1.33e+00 9.33e-14 1.5e-191 δ1.1
RPS13 3.24e-01 5.44e-01 2.39e-23 1.23e-189 δ1.1
EEF1A1 2.42e-01 3.69e-01 1.82e-20 1.06e-163 δ1.1
RPS3A 2.83e-01 3.77e-01 8.12e-26 1.53e-135 δ1.1
RPL11 2.65e-01 3.86e-01 9.67e-21 5.46e-132 δ1.1
PABPC1 3.52e-01 6.13e-01 8.89e-17 2.33e-122 δ1.1
NELL2 6.05e-01 7.63e-01 1.12e-26 2.25e-114 δ1.1
RTKN2 6.47e-01 8.88e-01 2.42e-18 4.34e-106 δ1.1
ACTN1 5.3e-01 7.53e-01 2.21e-22 1.28e-104 δ1.1
RPS28 2.19e-01 3.15e-01 4.94e-17 4.18e-101 δ1.1
RPS5 3.19e-01 4.38e-01 4.72e-16 6.67e-99 δ1.1
RPL18A 2.29e-01 3.28e-01 6.76e-17 3.48e-94 δ1.1
RPL22 2.87e-01 4.5e-01 1.42e-12 1.57e-86 δ1.1
RCAN3 4.46e-01 7.46e-01 1.7e-11 1.31e-85 δ1.1
RP4.594I10.3 5.23e-01 6.46e-01 5.3e-20 2.75e-83 δ1.1
RPL4 2.83e-01 4.16e-01 1.54e-12 1.85e-80 δ1.1
RPS25 2.03e-01 2.99e-01 6.81e-11 1.96e-75 δ1.1
RPLP2 2.41e-01 2.55e-01 2.75e-20 3.46e-74 δ1.1
ID3 5.13e-01 6.29e-01 2.3e-19 7.81e-73 δ1.1
RPS14 2.01e-01 2.38e-01 9.6e-17 5.22e-71 δ1.1
MAL 5.09e-01 5.77e-01 1.33e-21 5.55e-71 δ1.1
RPL19 2.31e-01 2.56e-01 1.97e-16 4.49e-67 δ1.1
CAMK4 3.79e-01 6.3e-01 5.15e-07 3.31e-66 δ1.1
TCF7 5.35e-01 7.14e-01 5.02e-12 4.86e-64 δ1.1
RPL30 2.65e-01 2.8e-01 1.39e-15 8.42e-63 δ1.1
PIK3IP1 5.81e-01 6.84e-01 1.57e-14 3.03e-61 δ1.1
LDLRAP1 5.34e-01 6.65e-01 3.19e-12 1.05e-60 δ1.1
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NGFRAP1 4.75e-01 5.5e-01 3.05e-17 5.3e-60 δ1.1
FYB 5.27e-01 6.67e-01 5.16e-12 4.36e-55 δ1.1
RPS16 2.22e-01 2.95e-01 7.17e-11 1.05e-54 δ1.1
RPL36 2.03e-01 2.81e-01 5.22e-11 1.2e-54 δ1.1
EEF1B2 2.72e-01 3.88e-01 5.69e-09 8.87e-52 δ1.1
EIF3E 2.84e-01 4.62e-01 3.82e-05 4.65e-50 δ1.1
NUCB2 6.82e-01 6.04e-01 1.05e-14 4.05e-48 δ1.1
RPL29 2.15e-01 2.98e-01 2.38e-08 2.7e-47 δ1.1
TRABD2A 3.15e-01 5.11e-01 1.89e-06 2.3e-46 δ1.1
RPS9 2.13e-01 2.54e-01 4.29e-11 2.4e-46 δ1.1
SPINT2 4.81e-01 4.63e-01 3.61e-14 1.34e-43 δ1.1
GCSAM 3.3e-01 3.82e-01 5.59e-09 1.74e-42 δ1.1
RPL8 2.05e-01 2.68e-01 1.44e-08 1.08e-41 δ1.1
SERINC5 2.8e-01 4.12e-01 3.81e-10 1.11e-41 δ1.1
CHMP7 4.25e-01 5.33e-01 9.81e-10 3.52e-39 δ1.1
HSPB1 5.54e-01 5.36e-01 1.59e-11 1.53e-38 δ1.1
MYC 3.19e-01 5.57e-01 7.32e-04 3.39e-38 δ1.1
CCDC109B 3.41e-01 5.09e-01 1.04e-06 1.99e-37 δ1.1
TXK 3.4e-01 4.99e-01 2.23e-08 1.23e-34 δ1.1
EEF2 2.69e-01 2.94e-01 2.26e-09 5.76e-34 δ1.1
RGCC 4.45e-01 4.94e-01 4.47e-10 1.06e-29 δ1.1
CD27 4.84e-01 4.19e-01 3.25e-12 1.73e-29 δ1.1
ARID5B 5.21e-01 4.98e-01 1.8e-09 1.27e-27 δ1.1
TMEM123 4.57e-01 3.7e-01 3.94e-11 7.89e-26 δ1.1
PRKCQ.AS1 2.71e-01 4.09e-01 2.27e-04 3.86e-25 δ1.1
BIRC3 3.67e-01 4.35e-01 1.04e-06 1.36e-24 δ1.1
EIF3H 2.05e-01 3.66e-01 9.78e-04 1.57e-24 δ1.1
DGKA 3.28e-01 3.94e-01 7.66e-06 6.52e-24 δ1.1
NBEAL1 2.44e-01 3.56e-01 1.15e-05 8.87e-24 δ1.1
SUSD3 3.47e-01 3.74e-01 5.62e-07 2.61e-23 δ1.1
MAP3K1 3.51e-01 3.17e-01 1.71e-10 5.08e-23 δ1.1
COTL1 4.87e-01 4.01e-01 3.21e-08 4.6e-22 δ1.1
TMEM66 2.21e-01 2.97e-01 2.62e-04 4.98e-22 δ1.1
FAM102A 2.29e-01 3.23e-01 3.18e-05 9.66e-22 δ1.1
FBLN5 2.78e-01 3.64e-01 1.91e-05 2.19e-21 δ1.1
SNHG8 3.38e-01 3.52e-01 4.7e-06 3.6e-20 δ1.1
ISG20 2.52e-01 3.31e-01 1.39e-04 3.85e-20 δ1.1
PFDN5 2.14e-01 2.44e-01 1.25e-06 5.04e-20 δ1.1
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COMMD6 2.1e-01 2.86e-01 3.23e-04 1.26e-19 δ1.1
BTG1 2.39e-01 2.16e-01 1.36e-04 1.65e-15 δ1.1
ANP32B 2.08e-01 3.27e-01 5.69e-03 3.41e-15 δ1.1
C1ORF162 2.36e-01 2.66e-01 9.72e-03 3.82e-15 δ1.1
PRKCA 2.7e-01 2.08e-01 2.62e-09 5.17e-15 δ1.1
SYPL1 2.25e-01 2.9e-01 3.22e-04 6.31e-15 δ1.1
ST13 2.89e-01 3.18e-01 4.64e-05 8.18e-15 δ1.1
PIM2 2.17e-01 3.51e-01 1.99e-03 8.44e-15 δ1.1
ARHGAP15 3.18e-01 2.99e-01 6.01e-06 1.05e-13 δ1.1
TESPA1 2.93e-01 2.83e-01 4.44e-04 1.53e-13 δ1.1
RIC3 2.49e-01 2.74e-01 5.84e-04 2.28e-13 δ1.1
RPS4Y1 2.2e-01 2.06e-01 7.43e-06 1.64e-12 δ1.1
EIF3L 2.41e-01 2.57e-01 3.05e-05 1.92e-12 δ1.1
CCNI 3.5e-01 2.65e-01 6.04e-08 3.37e-12 δ1.1
GYPC 3.04e-01 2.72e-01 8.56e-05 4.38e-12 δ1.1
AL592284.1 3.12e-01 2.64e-01 1.03e-06 4.82e-12 δ1.1
STMN3 3.83e-01 2.83e-01 1.98e-07 1.16e-11 δ1.1
FOXP1 2.15e-01 2.68e-01 6.43e-03 8.75e-11 δ1.1
FAIM3 2.88e-01 2.73e-01 2.16e-05 1.93e-10 δ1.1
FAM65B 2.63e-01 2.36e-01 2.59e-03 2.19e-09 δ1.1
ADSL 2.57e-01 2.27e-01 1.12e-04 5.65e-09 δ1.1
ZNF101 2.4e-01 2.44e-01 2.48e-03 1.02e-08 δ1.1
EIF4B 2.09e-01 2.14e-01 7.37e-03 1.56e-07 δ1.1
NCF1 2.51e-01 2.08e-01 3.71e-04 6.35e-07 δ1.1
SOX4 1.14e+00 1.55e+00 1.78e-30 2.38e-129 δ1.2
LEF1 1.29e+00 1.51e+00 1.78e-32 4.1e-111 δ1.2
LTB 1.01e+00 1.21e+00 8.32e-23 9.03e-71 δ1.2
CHST2 5.63e-01 8.09e-01 3.79e-12 1.7e-55 δ1.2
TCF7 7.35e-01 9.77e-01 7.95e-15 2.26e-52 δ1.2
TMSB10 4.13e-01 5.49e-01 1.22e-12 1.47e-51 δ1.2
CD7 7.76e-01 8.05e-01 6.32e-21 5.68e-49 δ1.2
SMC4 7.69e-01 1.15e+00 1.04e-10 5.74e-49 δ1.2
RTKN2 9.04e-01 1.02e+00 2.68e-13 1.51e-45 δ1.2
TMSB4X 2.72e-01 2.78e-01 2.47e-14 8.55e-41 δ1.2
ID3 9.03e-01 9.51e-01 4.11e-16 4.9e-38 δ1.2
SLC25A5 6.02e-01 7.58e-01 4.69e-08 1.02e-33 δ1.2
NUCB2 9.98e-01 7.96e-01 6.53e-20 6.73e-33 δ1.2
HSPB1 5.16e-01 7.63e-01 4.15e-06 6.56e-32 δ1.2
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CHMP7 2.78e-01 7.92e-01 5.5e-03 8.12e-31 δ1.2
IKZF2 4.96e-01 6.03e-01 1.79e-06 1.76e-28 δ1.2
ACTN1 7.26e-01 7.12e-01 1e-14 2.72e-28 δ1.2
SPINT2 4.51e-01 5.39e-01 3.3e-08 1.95e-27 δ1.2
SLFN5 4.21e-01 6.9e-01 8.78e-06 2.26e-27 δ1.2
FYB 5.07e-01 6.85e-01 2.34e-06 1.67e-26 δ1.2
AIF1 6.31e-01 6.99e-01 3.45e-15 2.6e-25 δ1.2
RHOH 7e-01 6.89e-01 1.69e-10 5.57e-25 δ1.2
PABPC1 4.39e-01 4.46e-01 5.05e-09 1.8e-24 δ1.2
ZNF683 1.34e+00 8.97e-01 4.01e-18 4.69e-24 δ1.2
CHI3L2 3.86e-01 7.13e-01 1.9e-05 6.79e-24 δ1.2
EVL 5.44e-01 5.09e-01 3.11e-10 1.49e-23 δ1.2
GCSAM 3.32e-01 5.55e-01 5.3e-05 2.31e-23 δ1.2
MARCKSL1 6.82e-01 6.95e-01 1.82e-09 1.44e-21 δ1.2
HIST1H2AC 4.87e-01 6.49e-01 1.33e-05 2.4e-21 δ1.2
YBX1 2.8e-01 4.18e-01 6e-05 3.4e-20 δ1.2
H3F3A 2.1e-01 4.17e-01 1.1e-02 4.29e-20 δ1.2
RBL2 4.38e-01 6.04e-01 1.87e-04 1.03e-19 δ1.2
ADSL 3.89e-01 5.91e-01 1.44e-06 4.96e-19 δ1.2
TOX 3.24e-01 4.69e-01 5.58e-05 7.79e-19 δ1.2
MYOM2 3.3e-01 4.06e-01 2.74e-01 1.43e-18 δ1.2
BAZ2B 4.15e-01 4.5e-01 1.04e-03 7.91e-18 δ1.2
STMN1 7.46e-01 5.48e-01 4.09e-09 4.52e-17 δ1.2
TMEM123 3.92e-01 5.43e-01 5.72e-04 6.82e-17 δ1.2
CD27 6.03e-01 5.46e-01 8.91e-09 1.91e-16 δ1.2
RPIA 5e-01 6.05e-01 1.06e-06 4.23e-16 δ1.2
RCAN3 2.24e-01 5.48e-01 1.94e-04 9.44e-16 δ1.2
EEF2 2.54e-01 3.27e-01 1.96e-03 4.77e-15 δ1.2
FAM65B 3.24e-01 5.07e-01 8.77e-03 7.88e-15 δ1.2
CAMK4 4.73e-01 5.25e-01 8.69e-09 1.19e-14 δ1.2
COX6C 2.86e-01 4.11e-01 9.82e-03 1.81e-14 δ1.2
C4ORF48 2.2e-01 5.31e-01 1.25e-01 1.87e-14 δ1.2
NGFRAP1 3.91e-01 4.84e-01 1.3e-04 2.27e-14 δ1.2
GYPC 4.65e-01 4.56e-01 4.31e-06 5.4e-14 δ1.2
TESPA1 3.84e-01 4.84e-01 9.75e-08 9.24e-14 δ1.2
ITGB2.AS1 4.87e-01 4.68e-01 7.58e-06 1.41e-13 δ1.2
CD79A 3.01e-01 3.88e-01 2.33e-08 1.46e-13 δ1.2
40057 3.26e-01 4.69e-01 9.41e-03 1.94e-13 δ1.2
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ITM2C 6.05e-01 4.26e-01 1.59e-07 5.57e-13 δ1.2
CRTAM 3.37e-01 4.75e-01 3.15e-03 5.63e-13 δ1.2
HMGA1 5.85e-01 4.68e-01 2.28e-06 9.72e-13 δ1.2
PPP2R5C 4.91e-01 4.34e-01 9.36e-06 1.31e-12 δ1.2
MAL 3.04e-01 4.2e-01 2.84e-03 1.45e-12 δ1.2
PIM2 3.93e-01 5.16e-01 1.06e-02 3.23e-12 δ1.2
LDHB 4.67e-01 3.77e-01 8.54e-08 4.15e-12 δ1.2
STMN3 2.19e-01 4.67e-01 4.92e-02 5.4e-12 δ1.2
STK17B 5.62e-01 4.78e-01 5.75e-08 6.62e-12 δ1.2
CCR7 3.75e-01 4.49e-01 6.75e-03 4.52e-11 δ1.2
HMGN1 4.71e-01 4.05e-01 1.17e-07 5.97e-11 δ1.2
MFGE8 4.01e-01 2.67e-01 1.13e-05 5.97e-11 δ1.2
HMGN2 2.78e-01 3.26e-01 6.29e-02 6.37e-11 δ1.2
COTL1 5.54e-01 4.92e-01 8.8e-07 7.72e-11 δ1.2
GNB2L1 2.78e-01 2.59e-01 3.88e-05 9.62e-11 δ1.2
IFITM1 4.69e-01 4.28e-01 1.27e-07 3.45e-10 δ1.2
FKBP1A 3.52e-01 4.02e-01 5.96e-05 8.22e-10 δ1.2
INF2 3.04e-01 2.67e-01 4.67e-06 9.93e-10 δ1.2
PRKCH 5.03e-01 4.18e-01 3.37e-07 9.95e-10 δ1.2
CCNI 3.63e-01 3.63e-01 4.64e-04 1.32e-09 δ1.2
EPHX2 3.06e-01 3.16e-01 3.26e-04 1.58e-09 δ1.2
ILF3.AS1 2.11e-01 4.55e-01 4.19e-02 2.77e-09 δ1.2
FAM173A 2.42e-01 4.46e-01 2.58e-03 3.02e-09 δ1.2
LIMD2 2.12e-01 3.4e-01 9.24e-02 3.78e-09 δ1.2
ARID5B 5.75e-01 4.83e-01 3.66e-08 4.74e-09 δ1.2
CLEC11A 3.11e-01 2.54e-01 2.85e-09 5.44e-09 δ1.2
PARP1 3.06e-01 4.13e-01 1.89e-03 8.04e-09 δ1.2
RASGRP2 2.73e-01 4.37e-01 3.92e-02 8.99e-09 δ1.2
FCGRT 4.03e-01 3.71e-01 1.87e-05 1.05e-08 δ1.2
FAM102A 2.73e-01 3.4e-01 2.19e-03 1.15e-08 δ1.2
LDLRAP1 5.7e-01 3.83e-01 6.77e-06 1.42e-08 δ1.2
NSMCE1 3.52e-01 3.44e-01 1.84e-03 1.52e-08 δ1.2
ACAP1 2.14e-01 3.49e-01 1.83e-01 2.11e-08 δ1.2
DGKA 3.47e-01 3.77e-01 5.08e-03 2.52e-08 δ1.2
IRF2BP2 2.22e-01 2.95e-01 3.35e-02 2.66e-08 δ1.2
TCF12 2.44e-01 3.24e-01 2.15e-03 2.82e-08 δ1.2
ELF1 3.92e-01 4.28e-01 1.28e-02 4.03e-08 δ1.2
RP11.347P5.1 5.23e-01 4.31e-01 9.1e-05 4.35e-08 δ1.2
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HIST1H2BK 3.06e-01 3.37e-01 5.17e-04 5.39e-08 δ1.2
TNRC6B 2.87e-01 3.7e-01 7.83e-02 7.24e-08 δ1.2
EIF5A 2.17e-01 3.11e-01 5.3e-02 9.05e-08 δ1.2
SERINC5 2.67e-01 2.22e-01 7.39e-03 1.02e-07 δ1.2
CCDC69 2.6e-01 3.31e-01 1.78e-02 1.06e-07 δ1.2
CD52 3.96e-01 2.01e-01 7.78e-06 1.11e-07 δ1.2
NOSIP 4.48e-01 3.87e-01 9.51e-06 2.25e-07 δ1.2
SUSD3 4.87e-01 2.84e-01 3.35e-05 4.49e-07 δ1.2
CLDND1 2.88e-01 3.53e-01 3.34e-02 6.54e-07 δ1.2
38961 3.76e-01 3.27e-01 2.91e-04 7.25e-07 δ1.2
MLLT11 3.5e-01 2.25e-01 9.17e-06 7.44e-07 δ1.2
EIF3L 4.09e-01 2.76e-01 2.53e-05 1e-06 δ1.2
CXXC5 4.69e-01 2.42e-01 7.78e-05 1.26e-06 δ1.2
LPGAT1 2.01e-01 2.34e-01 3.86e-02 1.36e-06 δ1.2
ATXN10 2.06e-01 2.08e-01 4.11e-03 1.38e-06 δ1.2
PRMT1 5.07e-01 3.15e-01 2.38e-05 1.39e-06 δ1.2
BIRC2 2.5e-01 3.25e-01 4.16e-02 1.8e-06 δ1.2
CCDC109B 3.24e-01 3.65e-01 4.83e-03 2.13e-06 δ1.2
TUBA1A 2.36e-01 3.46e-01 1.09e-01 2.17e-06 δ1.2
CTD.2020K17.1 4.5e-01 2.81e-01 2.71e-05 2.52e-06 δ1.2
FNBP1 2.06e-01 3.51e-01 8.14e-02 2.56e-06 δ1.2
ETFB 3.92e-01 3.61e-01 6.16e-05 2.64e-06 δ1.2
CCDC57 3.67e-01 3.46e-01 6.35e-05 2.65e-06 δ1.2
NIN 4.82e-01 3.46e-01 8.08e-06 2.91e-06 δ1.2
H2AFY 4.59e-01 3.62e-01 3.97e-05 3.14e-06 δ1.2
C16ORF54 3.33e-01 4.01e-01 3.41e-03 3.21e-06 δ1.2
37135 2.83e-01 2.75e-01 4.24e-02 6.61e-06 δ1.2
ALKBH7 2.2e-01 2.37e-01 1.46e-02 7.75e-06 δ1.2
BEX4 4.74e-01 2.49e-01 1.36e-04 9.86e-06 δ1.2
AP1S2 2.36e-01 3.02e-01 8.07e-02 1.16e-05 δ1.2
ZSCAN18 3.19e-01 2.04e-01 2.36e-04 1.16e-05 δ1.2
RTN4 2.39e-01 2.91e-01 1.76e-03 1.26e-05 δ1.2
CALM2 2.39e-01 2.53e-01 3.71e-03 1.38e-05 δ1.2
CCNG2 2.43e-01 2.84e-01 1.7e-02 1.53e-05 δ1.2
UBL7 2.02e-01 2.04e-01 1.01e-02 2.01e-05 δ1.2
MDM4 5.83e-01 3.25e-01 2.71e-05 2.2e-05 δ1.2
ADD3 2.73e-01 3.4e-01 3.59e-03 2.48e-05 δ1.2
CXCR3 4.69e-01 3.1e-01 6.69e-04 2.81e-05 δ1.2
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ETS1 2.41e-01 2.9e-01 6.91e-02 2.88e-05 δ1.2
CCDC167 2.18e-01 3.12e-01 4.63e-02 3.08e-05 δ1.2
N4BP2 3.26e-01 2.44e-01 1.23e-04 3.26e-05 δ1.2
RAB37 3.76e-01 3.25e-01 4.36e-03 5.25e-05 δ1.2
SDCCAG8 4.04e-01 2.35e-01 3.62e-04 5.37e-05 δ1.2
LAT 3.59e-01 2.74e-01 5.7e-04 6.08e-05 δ1.2
ATP5C1 3.01e-01 2.85e-01 4.18e-05 6.22e-05 δ1.2
ESYT1 2.91e-01 2.96e-01 1.27e-04 6.34e-05 δ1.2
C6ORF48 3.82e-01 2.6e-01 6.11e-04 6.63e-05 δ1.2
PRPSAP2 3.53e-01 2.39e-01 2.58e-03 7.03e-05 δ1.2
ZFX 2.45e-01 2.75e-01 7.32e-02 7.69e-05 δ1.2
ANP32A 3.02e-01 2.19e-01 4.67e-03 8.05e-05 δ1.2
CD84 3.71e-01 2.83e-01 1.54e-04 9.48e-05 δ1.2
SMARCA4 3.21e-01 2.46e-01 8.77e-04 1.04e-04 δ1.2
PGLS 2.21e-01 2.91e-01 1.08e-01 1.25e-04 δ1.2
NRROS 2.74e-01 2.56e-01 3.27e-04 1.32e-04 δ1.2
STT3B 3.61e-01 2.65e-01 7.16e-04 1.34e-04 δ1.2
IP6K2 3.82e-01 3.14e-01 1.28e-03 1.38e-04 δ1.2
QARS 3.63e-01 2.72e-01 4.96e-04 1.45e-04 δ1.2
ARGLU1 3.42e-01 2.34e-01 3.2e-03 1.49e-04 δ1.2
ARHGEF1 2.8e-01 2.72e-01 2.52e-03 1.71e-04 δ1.2
NAP1L4 3.17e-01 2.9e-01 3.26e-04 1.89e-04 δ1.2
TLE4 2.43e-01 3.08e-01 3.95e-03 1.99e-04 δ1.2
DCAF7 2.65e-01 2.13e-01 5.51e-02 2.01e-04 δ1.2
MLXIP 2.08e-01 2.39e-01 9.19e-03 2.01e-04 δ1.2
B3GNT2 3.57e-01 2.92e-01 8.53e-04 2.02e-04 δ1.2
PPP1CC 2.69e-01 2.38e-01 3.6e-02 2.14e-04 δ1.2
LSM2 2.34e-01 2.22e-01 3.27e-02 2.18e-04 δ1.2
PTEN 3.21e-01 2.58e-01 1.08e-02 2.43e-04 δ1.2
TRAF3IP3 3.38e-01 2.77e-01 3.98e-04 2.5e-04 δ1.2
ZNF428 2.43e-01 2.13e-01 8.28e-02 2.62e-04 δ1.2
CNN2 2.3e-01 3e-01 1.39e-01 2.94e-04 δ1.2
TIMM10 2.78e-01 2.04e-01 2.98e-02 3.01e-04 δ1.2
BIRC3 2.08e-01 2.76e-01 2.51e-02 3.44e-04 δ1.2
TXK 4.04e-01 2.52e-01 1.13e-03 3.49e-04 δ1.2
GTF3A 2.14e-01 2.21e-01 1.82e-02 3.58e-04 δ1.2
R3HDM4 2.21e-01 2.57e-01 8.16e-02 3.61e-04 δ1.2
CSK 2.96e-01 2.39e-01 5.08e-03 3.74e-04 δ1.2
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DCK 2.48e-01 2.79e-01 1.52e-03 5.54e-04 δ1.2
CCM2 4.28e-01 2.46e-01 3.84e-04 6.18e-04 δ1.2
UCP2 2.16e-01 2.62e-01 8.72e-02 7.17e-04 δ1.2
PPP4R2 3.78e-01 2.53e-01 7.97e-04 7.73e-04 δ1.2
HDAC2 2.7e-01 2.1e-01 5.92e-02 1.18e-03 δ1.2
HDAC7 2.95e-01 2.57e-01 5.63e-03 1.32e-03 δ1.2
CCT8 2.07e-01 2.12e-01 1.17e-01 1.44e-03 δ1.2
UBE2V2 3.61e-01 2.11e-01 1.82e-03 1.53e-03 δ1.2
EIF4G2 2.33e-01 2.03e-01 4.32e-02 1.63e-03 δ1.2
STK17A 3.79e-01 2.54e-01 2.94e-03 1.71e-03 δ1.2
EPB41 2.04e-01 2.4e-01 1.66e-01 1.99e-03 δ1.2
SETD5.AS1 2.7e-01 2.12e-01 6.07e-03 2.1e-03 δ1.2
TRAF5 2.88e-01 2.26e-01 3.48e-03 2.44e-03 δ1.2
CCSER2 2.35e-01 2e-01 2.55e-03 2.83e-03 δ1.2
IFNAR2 2.01e-01 2.01e-01 6.33e-03 5.37e-03 δ1.2
LUC7L3 3e-01 2.33e-01 3.86e-02 5.45e-03 δ1.2
USP11 2.01e-01 2.2e-01 7.75e-03 5.69e-03 δ1.2
TPR 2.79e-01 2.85e-01 1.13e-02 6.44e-03 δ1.2
AKIRIN1 2.81e-01 2.1e-01 3.44e-03 6.6e-03 δ1.2
FBXL3 2.12e-01 2.1e-01 1.33e-02 7.73e-03 δ1.2
PPM1M 2.62e-01 2.11e-01 3.11e-02 9.66e-03 δ1.2
SNORA76 2.13e-01 2.26e-01 2.96e-01 1.85e-02 δ1.2
GRK6 2.1e-01 2.27e-01 1.04e-01 1.93e-02 δ1.2
CHD4 2.06e-01 2.22e-01 1.69e-01 3.48e-02 δ1.2
GNLY 1.97e+00 1.44e+00 7.2e-233 0e+00 δ2.1
FGFBP2 2.04e+00 1.56e+00 1.19e-210 0e+00 δ2.1
GZMH 1.84e+00 1.36e+00 7.01e-197 0e+00 δ2.1
NKG7 9.68e-01 8.62e-01 2.64e-183 0e+00 δ2.1
B2M 2.35e-01 2.57e-01 2.6e-90 9.85e-299 δ2.1
GZMB 1.9e+00 1.24e+00 2.21e-209 1.98e-245 δ2.1
PRF1 9.49e-01 7.88e-01 2.13e-117 3.23e-200 δ2.1
CST7 6.27e-01 5.99e-01 1.24e-70 6.71e-190 δ2.1
KLRD1 6.04e-01 7.07e-01 3.87e-49 9.89e-165 δ2.1
CCL4 9.78e-01 7.3e-01 3.32e-81 3.62e-156 δ2.1
CCL5 3.42e-01 3.66e-01 1.04e-41 9.48e-153 δ2.1
CX3CR1 9.02e-01 8.06e-01 3.72e-77 4.3e-145 δ2.1
FCGR3A 1.39e+00 7.48e-01 4.11e-103 7.42e-133 δ2.1
HLA.C 2.83e-01 3.14e-01 1.28e-41 4.27e-126 δ2.1
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GPR56 9.16e-01 6.93e-01 4.11e-77 2.98e-112 δ2.1
S100A4 3.11e-01 3.94e-01 9.09e-31 2.61e-108 δ2.1
HLA.B 2.36e-01 2.23e-01 2.93e-44 9.91e-94 δ2.1
SH3BGRL3 4.34e-01 3.91e-01 3.35e-49 3.68e-89 δ2.1
TTC38 6.58e-01 5.55e-01 2.33e-47 4.64e-88 δ2.1
PRSS23 7.76e-01 5.49e-01 5.91e-70 1.3e-84 δ2.1
GZMA 2.94e-01 3.29e-01 9.73e-24 9.93e-83 δ2.1
SRGN 4.09e-01 4.07e-01 9.77e-33 6.75e-82 δ2.1
SPON2 7.73e-01 6.09e-01 5.99e-46 1.25e-78 δ2.1
S1PR5 6.75e-01 5.64e-01 2.47e-45 1.95e-75 δ2.1
TBX21 6.76e-01 5.62e-01 2.7e-41 3.55e-75 δ2.1
ZEB2 6.49e-01 5.09e-01 4.07e-48 1.08e-68 δ2.1
ITGB2 4.65e-01 3.87e-01 4.26e-34 3.1e-68 δ2.1
PLEK 6.63e-01 5.19e-01 1.48e-47 3.13e-66 δ2.1
CD247 4.47e-01 4.34e-01 1.93e-23 2.72e-63 δ2.1
HLA.DPB1 4.05e-01 4.72e-01 5.63e-22 1.09e-62 δ2.1
APOBEC3G 3.61e-01 4.87e-01 1.86e-14 1.44e-62 δ2.1
ARPC2 4.31e-01 3.21e-01 1.59e-36 3.64e-62 δ2.1
LGALS1 7.35e-01 6.62e-01 5.97e-28 3.59e-61 δ2.1
EFHD2 5.46e-01 5.05e-01 3.07e-29 3.69e-60 δ2.1
PLAC8 4.73e-01 4.17e-01 2.18e-27 6.65e-59 δ2.1
ITGB1 2.35e-01 5.3e-01 8.93e-10 1.24e-57 δ2.1
ASCL2 4.85e-01 4.16e-01 1.07e-24 1.51e-56 δ2.1
CYBA 3.74e-01 2.97e-01 2.41e-35 2.21e-56 δ2.1
HOPX 5.88e-01 4.32e-01 2.07e-31 1.56e-53 δ2.1
IFITM2 3.71e-01 3.49e-01 1.98e-21 1.22e-51 δ2.1
PYHIN1 2.72e-01 4.6e-01 3.05e-07 1.43e-51 δ2.1
ZNF683 2.59e-01 5.42e-01 2.71e-09 5.45e-51 δ2.1
FGR 5.35e-01 4.53e-01 7.48e-27 2.04e-50 δ2.1
LITAF 5.46e-01 3.42e-01 3.37e-40 5.59e-50 δ2.1
HLA.E 2.04e-01 2.41e-01 3.84e-15 1.02e-49 δ2.1
C1ORF21 4.94e-01 4.58e-01 3.15e-23 5.65e-49 δ2.1
CTSW 3.52e-01 3.1e-01 7.85e-27 1.29e-48 δ2.1
CD3D 2.95e-01 2.79e-01 1.12e-19 1.75e-48 δ2.1
MYO1F 3.55e-01 3.81e-01 3.47e-16 6.29e-48 δ2.1
PFN1 3.32e-01 2.3e-01 2.09e-36 2.39e-45 δ2.1
RAP1B 5.72e-01 3.18e-01 9.76e-42 3.46e-45 δ2.1
AKR1C3 4.15e-01 3.94e-01 1.92e-21 4.44e-44 δ2.1
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CD99 3.62e-01 3.04e-01 1.03e-21 2.04e-43 δ2.1
CTSC 4.48e-01 3.64e-01 7.7e-22 7.36e-40 δ2.1
CLIC1 2.54e-01 3.12e-01 1.2e-10 9.64e-40 δ2.1
ABI3 5.47e-01 3.99e-01 2.64e-25 1.4e-39 δ2.1
ADRB2 3.66e-01 4.11e-01 1.68e-14 3.6e-39 δ2.1
C12ORF75 5.75e-01 3.64e-01 1.22e-33 5.13e-37 δ2.1
FCRL6 5.62e-01 3.62e-01 1.35e-26 1.13e-36 δ2.1
APMAP 4e-01 3.52e-01 3.9e-18 4.29e-36 δ2.1
TYROBP 5.06e-01 5.08e-01 6.21e-12 6.55e-36 δ2.1
SPN 3.38e-01 3.54e-01 2.46e-10 2.57e-35 δ2.1
SAMD3 3.14e-01 3.3e-01 6.59e-12 3.58e-35 δ2.1
CHST12 3.41e-01 3.44e-01 1.11e-13 1.65e-34 δ2.1
THEMIS2 2.69e-01 3.39e-01 6.33e-09 2.8e-34 δ2.1
TNFRSF1B 4.33e-01 3.71e-01 3.64e-18 8.35e-34 δ2.1
ACTB 3.42e-01 2.5e-01 3.24e-26 3.33e-32 δ2.1
DOK2 3.67e-01 3.41e-01 4.89e-14 6.58e-32 δ2.1
BIN2 3.06e-01 2.57e-01 4.17e-14 1.68e-31 δ2.1
ACTG1 2.89e-01 2.82e-01 4.06e-11 3.25e-31 δ2.1
PATL2 4.46e-01 3.67e-01 3.73e-18 9.64e-30 δ2.1
CAP1 2.83e-01 2.52e-01 1.31e-10 2.97e-29 δ2.1
CCND3 3.05e-01 2.61e-01 2.08e-10 3.1e-29 δ2.1
PPP1CA 3.21e-01 2.44e-01 9.16e-14 5.69e-29 δ2.1
CLIC3 3.89e-01 3.68e-01 3.83e-14 8.4e-28 δ2.1
ID2 3.97e-01 3.13e-01 1.12e-15 2.54e-27 δ2.1
MATK 2.27e-01 2.95e-01 1.54e-05 5.22e-27 δ2.1
GZMM 2.93e-01 2.69e-01 3.16e-11 1.22e-26 δ2.1
LPCAT1 2.48e-01 2.96e-01 1.94e-07 1.97e-26 δ2.1
GNPTAB 3.09e-01 3.05e-01 3.7e-09 2.26e-26 δ2.1
GTF3C1 2.4e-01 3.11e-01 3.69e-07 1.21e-25 δ2.1
CD63 3.71e-01 2.89e-01 2e-13 3.68e-25 δ2.1
CD3G 3.61e-01 2.35e-01 1.87e-18 5.95e-25 δ2.1
DBI 2.84e-01 2.44e-01 2.7e-09 1.21e-24 δ2.1
EMP3 2.27e-01 2.26e-01 1.03e-09 1.61e-24 δ2.1
MIAT 2.43e-01 2.8e-01 4.3e-07 1.73e-24 δ2.1
CD300A 2.65e-01 3.18e-01 3.11e-06 2.28e-24 δ2.1
UBE2F 3.61e-01 2.86e-01 2.31e-16 3.05e-24 δ2.1
FLNA 2.5e-01 2.57e-01 2.99e-06 2.59e-23 δ2.1
MT2A 3.29e-01 2.98e-01 3.12e-10 7.45e-23 δ2.1
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TPST2 3.02e-01 2.87e-01 6.24e-09 9.91e-23 δ2.1
BSG 2.2e-01 2.03e-01 3.37e-06 1.08e-22 δ2.1
SH3BP5 2.21e-01 2.89e-01 2.69e-05 2.2e-22 δ2.1
DYNLL1 2.43e-01 2.69e-01 1.77e-06 3.55e-22 δ2.1
RHOC 3.57e-01 2.98e-01 3.02e-13 3.85e-22 δ2.1
FAM49B 2.45e-01 2.38e-01 3.45e-07 5.26e-22 δ2.1
CTSD 3.45e-01 2.2e-01 3.84e-12 6.39e-22 δ2.1
GNG2 3.61e-01 2.61e-01 2.06e-12 6.96e-22 δ2.1
CD97 3.3e-01 2.61e-01 3.7e-12 1.04e-21 δ2.1
ITGAM 3.21e-01 2.51e-01 4.38e-13 2.81e-21 δ2.1
MYO1G 4.03e-01 2.54e-01 1.4e-15 3.21e-21 δ2.1
PLEKHG3 2.48e-01 2.49e-01 6.01e-08 5.57e-21 δ2.1
LSP1 3.63e-01 2.16e-01 2.53e-20 5.97e-21 δ2.1
C5ORF56 2.88e-01 2.7e-01 3.65e-07 8.85e-21 δ2.1
ARL6IP5 2.91e-01 2.07e-01 4.41e-09 2.28e-20 δ2.1
GSTP1 2.54e-01 2.16e-01 2.3e-07 3.64e-20 δ2.1
ACTR3 2.36e-01 2.02e-01 2.61e-06 3.87e-20 δ2.1
TOB1 3.13e-01 2.88e-01 3.32e-08 3.92e-20 δ2.1
SLC9A3R1 3.85e-01 2.31e-01 2.41e-17 5.19e-20 δ2.1
PSAP 3.9e-01 2.09e-01 1.41e-15 1.33e-19 δ2.1
WDR1 2.44e-01 2.11e-01 4.44e-06 1.59e-19 δ2.1
PTGER2 3.59e-01 2.73e-01 2.38e-11 1.62e-19 δ2.1
CD320 3.99e-01 2.41e-01 5.23e-15 4.39e-19 δ2.1
PTGDR 2.35e-01 2.69e-01 3.74e-06 7.55e-19 δ2.1
PPP1R18 2.47e-01 2.05e-01 6.43e-07 7.15e-18 δ2.1
TMEM173 2.16e-01 2.34e-01 2.94e-05 1.16e-17 δ2.1
CRIP1 3.86e-01 2.57e-01 2e-15 2.78e-17 δ2.1
ITGAL 3.4e-01 2.13e-01 1.47e-11 5.02e-17 δ2.1
MAPK1 2.73e-01 2.04e-01 1.11e-06 8.9e-17 δ2.1
ABHD17A 3.69e-01 2.34e-01 2.97e-13 2.66e-16 δ2.1
AOAH 3.01e-01 2.33e-01 2.48e-10 3.11e-16 δ2.1
LAIR1 3.68e-01 2.24e-01 2.21e-13 3.36e-16 δ2.1
AC092580.4 2.33e-01 2.43e-01 8.52e-08 3.72e-16 δ2.1
APOBEC3C 3.8e-01 2.64e-01 5.56e-11 6.47e-16 δ2.1
PLEKHF1 2.62e-01 2.16e-01 2.89e-07 6.02e-14 δ2.1
TPM4 2.4e-01 2.02e-01 1.94e-05 2.6e-13 δ2.1
STARD3NL 2.18e-01 2.08e-01 1.9e-06 5.74e-13 δ2.1
GZMK 1.13e+00 1.48e+00 1.61e-182 0e+00 δ2.2
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CD74 4.65e-01 7.58e-01 8.14e-28 1.25e-152 δ2.2
KLRB1 4.78e-01 3.91e-01 8.69e-32 5.25e-92 δ2.2
XCL1 3.04e-01 5.28e-01 1.33e-09 3.58e-63 δ2.2
CXCR6 4.83e-01 4.7e-01 5.87e-24 1.13e-52 δ2.2
DUSP2 4.53e-01 3.94e-01 2.73e-20 6.91e-47 δ2.2
LYAR 3.25e-01 3.25e-01 5.39e-14 1.09e-39 δ2.2
CEBPD 3.17e-01 4.01e-01 3.69e-11 1.81e-37 δ2.2
CD160 2.55e-01 3.69e-01 1.06e-06 7.67e-34 δ2.2
DPP4 3.42e-01 2.77e-01 1.82e-14 2.05e-31 δ2.2
CCR5 3.11e-01 2.86e-01 5.87e-13 6.96e-29 δ2.2
KLRG1 2.39e-01 2.41e-01 1.13e-10 8.34e-29 δ2.2
HLA.DRB1 2.6e-01 3.8e-01 8.07e-06 1.65e-27 δ2.2
IL7R 4.08e-01 2.22e-01 1.96e-22 2.59e-22 δ2.2
HLA.DMA 2.2e-01 2.36e-01 5.27e-07 6.66e-22 δ2.2
IFNGR1 2.13e-01 2.69e-01 1.46e-05 5.93e-20 δ2.2
GPR171 2.43e-01 2.97e-01 1.8e-07 1.23e-19 δ2.2
TRAT1 2.84e-01 2.65e-01 6.42e-10 2.58e-17 δ2.2
GPR183 2.12e-01 2.68e-01 1.06e-04 4.16e-16 δ2.2
CD44 2.12e-01 2.21e-01 4.05e-07 3.49e-14 δ2.2
PDCD4 2.43e-01 2.05e-01 3.25e-08 1.96e-12 δ2.2
CCR6 5.42e-01 9.7e-01 2.25e-17 1.93e-73 δ2.3
SLC4A10 7.8e-01 8.52e-01 2.93e-34 1.12e-71 δ2.3
KLRB1 6.33e-01 7.79e-01 5.09e-17 1.46e-53 δ2.3
GZMK 2.34e-01 6.22e-01 1.31e-09 3.77e-50 δ2.3
AQP3 5.42e-01 8.06e-01 3.04e-10 1.07e-37 δ2.3
NCR3 5.09e-01 8.58e-01 1.48e-08 7.39e-36 δ2.3
RPL10 2.03e-01 2.54e-01 9.3e-16 2.69e-33 δ2.3
LTB 6.77e-01 7.17e-01 2.77e-20 3.05e-31 δ2.3
IL23R 5.09e-01 4.68e-01 8.59e-16 1.43e-28 δ2.3
LST1 5.19e-01 6.74e-01 4.72e-11 2.75e-28 δ2.3
RPL13 2.48e-01 2.41e-01 1.83e-18 3.3e-28 δ2.3
RPS2 2.45e-01 2.46e-01 2.78e-18 5.6e-28 δ2.3
RPS18 2.41e-01 2.54e-01 1.92e-17 1.27e-26 δ2.3
RORC 3.69e-01 4.17e-01 1.08e-12 4.63e-25 δ2.3
LTK 4.69e-01 3.43e-01 2.62e-20 6.08e-25 δ2.3
RPL34 2.46e-01 2.32e-01 2.3e-19 5.13e-24 δ2.3
LGALS3 4.72e-01 4.24e-01 3.26e-12 4.61e-23 δ2.3
RPL32 2.18e-01 2.37e-01 1.87e-12 3.16e-22 δ2.3
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S100A4 3.05e-01 3.9e-01 1.17e-11 4.34e-22 δ2.3
TMIGD2 2.5e-01 4.66e-01 6.36e-08 5.48e-22 δ2.3
EEF1A1 2.37e-01 2.12e-01 3.19e-17 1.41e-21 δ2.3
AMICA1 5.61e-01 5.9e-01 7.52e-11 4.42e-19 δ2.3
RPLP0 3.33e-01 3.37e-01 8.78e-14 3.32e-18 δ2.3
IL7R 4.36e-01 4.02e-01 1.85e-11 3.67e-17 δ2.3
RPLP1 2.99e-01 2.27e-01 1.97e-15 2.49e-15 δ2.3
DPP4 4.43e-01 4.55e-01 2.91e-10 2.29e-14 δ2.3
CTSH 2.16e-01 3.9e-01 1.14e-05 8.33e-14 δ2.3
RPS13 2.22e-01 2.2e-01 7.66e-10 8.42e-14 δ2.3
PHACTR2 3.66e-01 4.86e-01 2.92e-06 1.65e-13 δ2.3
ALOX5AP 3.32e-01 4.36e-01 3.59e-08 2.37e-13 δ2.3
RPL12 2.22e-01 2.29e-01 2.61e-09 8.35e-13 δ2.3
CTSA 2.65e-01 4.99e-01 1.95e-03 4.07e-12 δ2.3
GPR183 2.89e-01 4.77e-01 1.11e-03 1.04e-11 δ2.3
RPL10A 2.27e-01 2.02e-01 7.88e-11 7.05e-11 δ2.3
TNFRSF25 3.77e-01 4.56e-01 1.08e-06 9.4e-11 δ2.3
CEBPD 2.84e-01 4.71e-01 5.19e-03 5.07e-10 δ2.3
S100A6 3.06e-01 3.17e-01 5.37e-09 5.61e-10 δ2.3
GYG1 3.04e-01 4.04e-01 6.11e-04 1.94e-08 δ2.3
YWHAH 2.46e-01 3.98e-01 1.71e-03 3.34e-08 δ2.3
GPR65 2.88e-01 4.17e-01 4.52e-04 4.24e-08 δ2.3
GPR171 2.83e-01 3.92e-01 3.53e-04 5.64e-08 δ2.3
TNFAIP8 2.48e-01 3.56e-01 2.51e-03 2.1e-07 δ2.3
CD28 2.6e-01 3.48e-01 1.56e-03 3.61e-07 δ2.3
MKNK1 2.89e-01 2.07e-01 1.58e-04 1.13e-06 δ2.3
NBEAL1 2.4e-01 2.82e-01 2.03e-04 2.28e-06 δ2.3
MAF 3.17e-01 2.02e-01 9.26e-05 7.42e-06 δ2.3
CCR2 3.1e-01 2.42e-01 2.23e-05 1.43e-05 δ2.3
EDEM2 2.78e-01 2.17e-01 2.47e-03 2.01e-04 δ2.3
CCR5 2.27e-01 2.48e-01 2.42e-02 2.16e-03 δ2.3
SESN1 2.44e-01 2.02e-01 1.64e-02 3.2e-03 δ2.3
CMC1 3.15e-01 3.59e-01 5.31e-03 3.84e-03 δ2.3
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Table A.2: List of differentially expressed genes between δ1.1 and δ1.2 γδ-T cell
subtypes from PBMC.
gene HD45 avg logFC HD6 avg logFC max pval min pval cluster
RPL21 3.55e-01 4.49e-01 1.67e-17 7.86e-81 δ1.1
RPS14 3.8e-01 5.19e-01 5e-17 2.27e-78 δ1.1
RPS29 2.87e-01 4.23e-01 7.51e-15 4.79e-68 δ1.1
RPL32 2.75e-01 3.48e-01 5.23e-12 5.66e-50 δ1.1
RPL34 3.07e-01 3.29e-01 3.32e-14 1.87e-49 δ1.1
RPLP2 3.6e-01 3.52e-01 3e-17 1.03e-48 δ1.1
RPS6 2.21e-01 3.36e-01 1.86e-07 2.13e-47 δ1.1
RPS27 2.23e-01 2.59e-01 1.11e-11 2.82e-46 δ1.1
RPS25 2.83e-01 3.73e-01 1.31e-07 9.94e-43 δ1.1
RPS28 2.5e-01 3.31e-01 1.64e-08 1.17e-41 δ1.1
RPS12 2.23e-01 3.56e-01 2.35e-05 1.14e-40 δ1.1
RPS27A 1.78e-01 2.98e-01 4.99e-04 3.63e-40 δ1.1
RPL14 2.6e-01 4.73e-01 4.33e-06 2.16e-36 δ1.1
RPL31 1.97e-01 3.33e-01 2.17e-03 3.7e-35 δ1.1
RPL3 1.76e-01 2.67e-01 6.32e-05 6.27e-35 δ1.1
RPL27A 2.81e-01 3.34e-01 2.03e-08 2.72e-34 δ1.1
RPS3 2.2e-01 2.94e-01 1.18e-06 3.23e-31 δ1.1
RPL35A 2.11e-01 3.08e-01 3.89e-04 4.3e-31 δ1.1
RPL11 2e-01 2.78e-01 3.55e-05 4.18e-30 δ1.1
RPL30 2.87e-01 3.25e-01 1.58e-06 4.19e-30 δ1.1
RPL13 1.57e-01 2.39e-01 1.76e-04 2.65e-29 δ1.1
RPS3A 1.65e-01 2.53e-01 5.72e-05 2.54e-26 δ1.1
EEF1A1 1.51e-01 2e-01 4.7e-04 4e-24 δ1.1
RPL38 3.85e-01 3.7e-01 2.79e-09 3.53e-23 δ1.1
RPL39 2.26e-01 2.46e-01 4.61e-06 2.03e-22 δ1.1
RPL7 1.15e-01 2.26e-01 1.28e-02 3.81e-21 δ1.1
RPL13A 1.55e-01 1.89e-01 7.99e-05 5.14e-21 δ1.1
RPL9 2.28e-01 2.96e-01 1.04e-04 2.29e-20 δ1.1
RPL23A 1.08e-01 2.19e-01 1.38e-02 7.38e-20 δ1.1
RPS13 1.28e-01 2.36e-01 1.89e-02 1.46e-19 δ1.1
RPS15 1.68e-01 2.36e-01 3.04e-03 4.31e-19 δ1.1
RPS19 1.96e-01 2.19e-01 4.27e-05 1e-18 δ1.1
RPL19 2.21e-01 2.14e-01 9.06e-07 1.04e-18 δ1.1
RPL41 1.08e-01 1.59e-01 3.83e-03 1.6e-16 δ1.1
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RPS20 3.31e-01 2.63e-01 8.69e-07 2.31e-16 δ1.1
RPL36 2.8e-01 2.58e-01 7.61e-08 2.46e-16 δ1.1
RPS15A 1.79e-01 1.89e-01 7.78e-05 3.5e-16 δ1.1
NELL2 5.16e-01 6.23e-01 1.14e-04 1.65e-15 δ1.1
RPLP1 2.4e-01 2.68e-01 6.99e-04 7.74e-15 δ1.1
RPS18 2.42e-01 1.75e-01 2e-09 1.48e-14 δ1.1
LDHB 2.35e-01 4.05e-01 4.46e-02 9.08e-14 δ1.1
MT.ND3 1.22e-01 3.11e-01 6.78e-02 2.15e-13 δ1.1
RPS21 2.04e-01 2.72e-01 4.34e-03 3.19e-13 δ1.1
RPL35 3.52e-01 2.61e-01 8.65e-08 6.09e-13 δ1.1
EEF1B2 2.61e-01 3.23e-01 1.81e-03 1.4e-12 δ1.1
TPT1 2.28e-01 2.38e-01 8.31e-05 2.04e-12 δ1.1
CXCR4 4.37e-01 5.22e-01 2.32e-04 1.64e-11 δ1.1
CCR7 1.6e-01 6.09e-01 4.75e-01 1.91e-11 δ1.1
PIK3IP1 1.76e-01 5.54e-01 4.04e-02 4.95e-11 δ1.1
RPL5 1.29e-01 2.11e-01 1.6e-01 6.52e-10 δ1.1
RPS16 1.71e-01 1.92e-01 3.7e-03 8.86e-10 δ1.1
PFDN5 2.07e-01 3.08e-01 6.71e-03 6.39e-09 δ1.1
RPL10A 1.37e-01 1.63e-01 2.68e-02 1.65e-08 δ1.1
RPL4 1.68e-01 1.97e-01 1.74e-02 1.76e-08 δ1.1
RPL8 2.1e-01 1.89e-01 9.19e-04 2.67e-08 δ1.1
GLTSCR2 1.83e-01 3.03e-01 6.7e-02 3.06e-08 δ1.1
IL7R 4.99e-01 4.3e-01 3.44e-05 5.18e-08 δ1.1
RPL37 1.55e-01 1.73e-01 2.82e-02 8.6e-08 δ1.1
MT.CO3 1.42e-01 2.21e-01 6.07e-02 9.21e-08 δ1.1
RPL22 1.47e-01 1.97e-01 3.81e-02 3.02e-07 δ1.1
SELL 2.45e-01 3.06e-01 1.29e-02 4.21e-07 δ1.1
RPS4X 1.47e-01 1.28e-01 5.88e-04 6.07e-07 δ1.1
RPL36A 2.87e-01 2.58e-01 3.86e-04 6.69e-07 δ1.1
RPL12 1.98e-01 1.3e-01 1.01e-03 1.47e-06 δ1.1
MT2A 1.46e-01 4.48e-01 2.85e-01 3.66e-06 δ1.1
GIMAP4 1.51e-01 3.74e-01 1.33e-01 4.38e-06 δ1.1
SOX4 1.08e+00 1.44e+00 4.04e-11 9.52e-55 δ1.2
CD7 8.13e-01 8.54e-01 6.17e-14 2.29e-34 δ1.2
TMSB4X 2.38e-01 2.81e-01 6.59e-08 1.08e-30 δ1.2
ZNF683 1.22e+00 1.32e+00 7.07e-11 3.58e-28 δ1.2
PFN1 3.21e-01 4.65e-01 1.91e-05 3.05e-25 δ1.2
ACTB 2.99e-01 4.09e-01 5.13e-05 2.37e-23 δ1.2
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SMC4 7.01e-01 1.04e+00 9.89e-05 6.03e-21 δ1.2
CHI3L2 4.93e-01 7.71e-01 1.47e-05 5.18e-19 δ1.2
PTPRC 3.23e-01 4.94e-01 6.67e-04 1.54e-18 δ1.2
DOK2 5.06e-01 7.39e-01 1.46e-03 3.74e-18 δ1.2
PPP2R5C 6.36e-01 6.15e-01 2.65e-06 4.08e-18 δ1.2
H3F3A 2.65e-01 4.42e-01 6.66e-03 5.3e-18 δ1.2
MYL6 4.53e-01 4.54e-01 4.84e-07 7.07e-17 δ1.2
CHST2 3.74e-01 6.15e-01 2.24e-03 1.91e-15 δ1.2
CD3D 3.46e-01 4.35e-01 7.23e-04 4.2e-15 δ1.2
CFL1 2.9e-01 3.53e-01 1.29e-05 4.84e-15 δ1.2
RPS24 2.03e-01 3.52e-01 1.25e-03 6.09e-15 δ1.2
SLC25A5 4.73e-01 5.74e-01 1.09e-03 7.82e-15 δ1.2
HIST1H2AC 5.27e-01 6.64e-01 3.23e-04 1.29e-14 δ1.2
CLIC1 1.17e-01 5.87e-01 4.81e-01 5.85e-14 δ1.2
C16ORF54 2.74e-01 7.2e-01 6.17e-02 7.8e-14 δ1.2
ACTG1 2.88e-01 4.36e-01 2.46e-02 2.17e-13 δ1.2
CDC42 1.99e-01 4.66e-01 1.78e-01 2.65e-13 δ1.2
TOX 3.01e-01 4.78e-01 7.46e-03 3.04e-13 δ1.2
SLFN5 1.34e-01 5.3e-01 2.5e-01 6.16e-13 δ1.2
STMN1 9.28e-01 5.6e-01 2.21e-07 1.75e-12 δ1.2
SET 2.36e-01 5.59e-01 1.96e-01 1.97e-12 δ1.2
C4ORF48 2.16e-01 5.66e-01 2.04e-01 6.67e-12 δ1.2
ITGB2 1.89e-01 4.93e-01 2.45e-01 6.84e-12 δ1.2
LSP1 3.54e-01 4.69e-01 1.51e-04 7.01e-12 δ1.2
CD52 3.3e-01 3.49e-01 3.8e-04 1.81e-11 δ1.2
CTSW 4.7e-01 4.94e-01 6.97e-04 2.01e-11 δ1.2
RAC2 2.48e-01 4.51e-01 6.05e-02 5.84e-11 δ1.2
ARPC3 2.06e-01 3.96e-01 6.63e-02 6.32e-11 δ1.2
SH3BGRL3 2.43e-01 3.87e-01 2.35e-02 9.14e-11 δ1.2
ARPC2 2.19e-01 3.75e-01 1.17e-02 2e-10 δ1.2
BAZ2B 5.27e-01 4.39e-01 6.23e-04 5.75e-10 δ1.2
RRAS2 3.69e-01 4.07e-01 1.36e-03 7.09e-10 δ1.2
IL32 2.89e-01 5.15e-01 4.84e-04 9.73e-10 δ1.2
FAM173A 4.2e-01 5.27e-01 7.8e-04 2.04e-09 δ1.2
EVL 3.69e-01 3.45e-01 1.21e-03 4.07e-09 δ1.2
DBN1 2.38e-01 3.87e-01 3e-03 4.71e-09 δ1.2
CXXC5 5.62e-01 3.01e-01 2.94e-04 9.61e-09 δ1.2
MATK 3.85e-01 4.85e-01 6.02e-02 1.76e-08 δ1.2
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PRKCH 4.93e-01 4.39e-01 4.94e-05 2.23e-08 δ1.2
RHOH 5.36e-01 4.45e-01 1.74e-04 2.75e-08 δ1.2
PTPRCAP 1.54e-01 2.97e-01 8.02e-02 3.64e-08 δ1.2
IFITM2 3.11e-01 4.69e-01 1.84e-02 4.64e-08 δ1.2
EIF5A 2.84e-01 3.5e-01 1.47e-01 6.01e-08 δ1.2
HMGN1 3.94e-01 3.88e-01 2.37e-04 7.14e-08 δ1.2
EMP3 1.3e-01 4.1e-01 2.84e-01 7.7e-08 δ1.2
IP6K2 4.57e-01 4.66e-01 1.51e-03 8.49e-08 δ1.2
MBNL1 2.07e-01 4.48e-01 3.56e-01 9.88e-08 δ1.2
PLAC8 1.31e-01 4.54e-01 7.52e-01 1.05e-07 δ1.2
DDAH2 2.9e-01 4.07e-01 1.32e-02 1.16e-07 δ1.2
C12ORF75 2.79e-01 4.64e-01 3.42e-03 1.36e-07 δ1.2
PSME2 2.79e-01 4.18e-01 5.51e-02 1.76e-07 δ1.2
DYNLL1 3.26e-01 4.48e-01 6.6e-02 2.07e-07 δ1.2
CD3G 3.56e-01 3.65e-01 8.17e-03 2.18e-07 δ1.2
LEF1 3.57e-01 3.53e-01 5.46e-03 2.2e-07 δ1.2
HMGN2 3.31e-01 2.97e-01 3.18e-02 3.11e-07 δ1.2
UBB 4.06e-01 3.04e-01 5.64e-05 3.47e-07 δ1.2
YBX1 1.54e-01 2.6e-01 2.84e-02 4.47e-07 δ1.2
CCDC167 2.49e-01 4.44e-01 1.4e-01 5.29e-07 δ1.2
AOAH 2.93e-01 4.1e-01 5.74e-02 5.49e-07 δ1.2
IFITM1 3.4e-01 4.11e-01 2.25e-03 5.78e-07 δ1.2
MARCKSL1 4.83e-01 4.71e-01 3e-03 1.05e-06 δ1.2
HIST1H2BK 2.97e-01 3.83e-01 5.86e-03 1.45e-06 δ1.2
ANXA6 2.91e-01 3.84e-01 6.64e-02 1.65e-06 δ1.2
FCGRT 3.63e-01 3.82e-01 5.51e-03 1.73e-06 δ1.2
ATP5B 2.41e-01 3.7e-01 1.21e-01 1.93e-06 δ1.2
BIN2 3.79e-01 3.45e-01 1.73e-03 2.22e-06 δ1.2
CALM2 1.69e-01 3.03e-01 5.47e-02 2.54e-06 δ1.2
FNBP1 1.05e-01 4.04e-01 7.75e-01 2.6e-06 δ1.2
PSME1 2.63e-01 3.25e-01 3.22e-02 3.11e-06 δ1.2
TBC1D10C 1.06e-01 3.38e-01 6.96e-01 4.33e-06 δ1.2
COX6C 2.43e-01 2.76e-01 9.37e-02 6.07e-06 δ1.2
SSBP4 1.77e-01 3.73e-01 2.01e-01 8.39e-06 δ1.2
HMGB1 1.77e-01 2.59e-01 5.28e-02 8.6e-06 δ1.2
PTP4A2 3.26e-01 3.72e-01 3.09e-02 8.74e-06 δ1.2
PARP1 3.72e-01 3.85e-01 6.85e-03 8.83e-06 δ1.2
PRMT1 5.74e-01 3.61e-01 1.26e-04 9.07e-06 δ1.2
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MYOM2 5.39e-01 3.11e-01 7.66e-02 1.1e-05 δ1.2
TCF7 2.23e-01 3.16e-01 1.3e-02 1.13e-05 δ1.2
IKZF2 3.53e-01 3.64e-01 2.18e-02 1.22e-05 δ1.2
UCP2 2.3e-01 3.83e-01 2e-02 1.45e-05 δ1.2
RPIA 3.66e-01 4.3e-01 3.29e-03 1.48e-05 δ1.2
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Table A.3: List of differentially expressed genes between δ2.2 and δ2.3 γδ-T cell
subtypes from PBMC.
gene HD45 avg logFC HD6 avg logFC max pval min pval cluster
CCL5 5.79e-01 5.11e-01 2.46e-33 1.34e-41 δ2.2
KLRD1 6.25e-01 1.02e+00 3.51e-14 7.25e-34 δ2.2
XCL1 5.08e-01 9.31e-01 3.07e-07 8.75e-26 δ2.2
CST7 3.95e-01 5.53e-01 3.46e-09 4.17e-24 δ2.2
MALAT1 1.84e-01 1.61e-01 9.22e-11 1.43e-21 δ2.2
NKG7 1.94e-01 4.14e-01 3.14e-05 3.69e-19 δ2.2
KLRC1 8.99e-01 9.26e-01 3.65e-14 1.87e-18 δ2.2
GZMH 2.67e-01 8.73e-01 2.93e-02 1.85e-17 δ2.2
GZMB 3.7e-01 7.75e-01 3.03e-03 2.73e-14 δ2.2
CCL4 3.87e-01 5.75e-01 1.15e-03 2.4e-11 δ2.2
CD74 2.38e-01 4.83e-01 2.74e-03 4.56e-11 δ2.2
GNLY 4.79e-01 9.42e-01 1.6e-02 5.6e-11 δ2.2
SELL 2.61e-01 4.93e-01 9.12e-03 1.6e-09 δ2.2
HLA.DPA1 3.71e-01 5.04e-01 2.64e-04 1.27e-08 δ2.2
HLA.DPB1 4.54e-01 4.96e-01 2.09e-05 1.36e-08 δ2.2
TPST2 2.31e-01 4.86e-01 1.73e-02 1.83e-08 δ2.2
DUSP2 6.39e-01 4.21e-01 1.37e-07 2.35e-08 δ2.2
PTPRC 2.47e-01 2.54e-01 2.84e-05 6.43e-08 δ2.2
HLA.DRB1 6.01e-01 4.67e-01 9.61e-07 1.64e-07 δ2.2
CD300A 4.2e-01 4.54e-01 3.7e-05 1.67e-07 δ2.2
LITAF 4.03e-01 3.83e-01 6.76e-06 3.38e-07 δ2.2
GZMM 2.31e-01 3.54e-01 8.47e-03 1.07e-06 δ2.2
GZMK 2.44e-01 1.44e-01 2.39e-05 1.37e-06 δ2.2
C1ORF21 2.53e-01 3.83e-01 9.81e-03 1.45e-06 δ2.2
PYHIN1 2.45e-01 4.21e-01 1.1e-02 1.64e-06 δ2.2
HLA.DRB5 3.86e-01 3.31e-01 6.94e-06 3.37e-06 δ2.2
FTH1 1.37e-01 2.42e-01 1.04e-01 3.85e-06 δ2.2
CLIC3 2.34e-01 4.36e-01 4.42e-02 4.32e-06 δ2.2
HLA.DMA 3.16e-01 3.09e-01 2.53e-04 8.11e-06 δ2.2
FGR 3.75e-01 3.36e-01 5.83e-05 1.45e-05 δ2.2
SYTL3 3.09e-01 3.92e-01 1.76e-03 1.56e-05 δ2.2
SLC4A10 7.14e-01 8.22e-01 9.8e-23 8.1e-47 δ2.3
CCR6 4.65e-01 9.06e-01 2.71e-11 1.05e-44 δ2.3
RPL10 1.39e-01 2.13e-01 1.3e-08 3.49e-29 δ2.3
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TMIGD2 2.62e-01 5.12e-01 5.46e-08 3.63e-27 δ2.3
KLRB1 3.35e-01 4.85e-01 1.36e-05 4.85e-27 δ2.3
RPL34 1.76e-01 2.09e-01 3.62e-12 8.72e-25 δ2.3
NCR3 4.16e-01 7.28e-01 1.99e-05 2.93e-24 δ2.3
LTB 5.38e-01 6.84e-01 6.69e-12 3.34e-24 δ2.3
S100A4 3.45e-01 4e-01 1.78e-13 2.67e-23 δ2.3
AQP3 4.16e-01 6.98e-01 9.04e-06 9.82e-23 δ2.3
RPL32 1.55e-01 2.11e-01 5.89e-07 1.23e-22 δ2.3
LST1 4.87e-01 6.26e-01 1.31e-08 1.29e-19 δ2.3
IL23R 4.57e-01 4.45e-01 2.76e-10 2.49e-17 δ2.3
RPL13 1.47e-01 1.56e-01 4.99e-09 3.98e-17 δ2.3
EEF1A1 1.87e-01 1.6e-01 1.21e-12 2.4e-16 δ2.3
LTK 4.49e-01 3.38e-01 2.63e-14 2.66e-16 δ2.3
RORC 3.51e-01 3.93e-01 1.8e-09 5.9e-15 δ2.3
LGALS3 4.12e-01 4e-01 1.93e-07 1.14e-14 δ2.3
RPS13 1.82e-01 2.2e-01 7.22e-07 1.51e-14 δ2.3
RPL18A 1.22e-01 1.81e-01 7.25e-05 2.32e-14 δ2.3
RPS2 1.57e-01 1.52e-01 3.01e-09 4.82e-13 δ2.3
RPS18 1.27e-01 1.46e-01 1.78e-06 3.37e-12 δ2.3
AMICA1 4.55e-01 4.85e-01 2.11e-06 5.26e-12 δ2.3
CTSH 2.04e-01 3.78e-01 3.39e-05 1.5e-10 δ2.3
RPS19 1.21e-01 1.38e-01 2.79e-04 1.44e-09 δ2.3
CTSA 2.21e-01 4.51e-01 5.19e-03 1.08e-08 δ2.3
S100A6 3.21e-01 3.01e-01 8.06e-09 1.17e-08 δ2.3
RPL11 1.48e-01 1.48e-01 3.03e-07 1.44e-08 δ2.3
RPL8 1.14e-01 1.83e-01 8.58e-04 1.68e-08 δ2.3
RPL29 1.33e-01 2.03e-01 1.24e-02 7.92e-08 δ2.3
RPS5 1.24e-01 1.95e-01 8.23e-03 1.77e-07 δ2.3
EOMES 1.57e-01 3.8e-01 2.64e-02 2.88e-07 δ2.3
IL7R 1.94e-01 2.38e-01 1.89e-03 4.32e-07 δ2.3
TNFRSF25 3.16e-01 3.86e-01 1.11e-04 6.09e-07 δ2.3
YWHAH 2.6e-01 3.81e-01 1.8e-03 7.82e-07 δ2.3
RPLP0 2.25e-01 1.8e-01 7.25e-06 1.21e-06 δ2.3
GPR65 2.23e-01 3.8e-01 6.33e-03 1.22e-06 δ2.3
PTGER2 2.11e-01 3.44e-01 1.58e-03 1.47e-06 δ2.3
RPL12 1.19e-01 1.55e-01 1.2e-03 1.64e-06 δ2.3
RPL10A 1.49e-01 1.41e-01 8.82e-06 5.37e-06 δ2.3
ALOX5AP 1.81e-01 2.92e-01 8.69e-04 5.99e-06 δ2.3
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CAMK4 1.58e-01 3.18e-01 2.67e-01 9.63e-06 δ2.3
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Table A.4: List of differentially expressed genes between γδ-T cell subtypes in breast
tumour samples (BC1 and BC2). Associated with Figure X.
gene BC1 avg logFC BC2 avg logFC max pval min pval cluster
FGFBP2 2.04e+00 1.85e+00 2.04e-20 1.72e-86 γδ-T.1
RAP1GAP2 1.72e+00 1.37e+00 6.33e-05 2.35e-52 γδ-T.1
BC043356 1.32e+00 8.21e-01 6.99e-03 1.32e-44 γδ-T.1
GNLY1 1.46e+00 2.23e+00 7.53e-12 1.56e-36 γδ-T.1
SPON2 1.07e+00 1.58e+00 4.82e-07 4.12e-33 γδ-T.1
PLAC8 1.14e+00 1.35e+00 1.1e-06 8.31e-27 γδ-T.1
GZMB1 1.17e+00 1.97e+00 5.97e-08 3.33e-25 γδ-T.1
GZMH 1.06e+00 1.27e+00 2.06e-07 1.29e-23 γδ-T.1
LINC00299 1.28e+00 1.26e+00 4.88e-04 6.11e-23 γδ-T.1
UBE2F 1.11e+00 9.15e-01 4.58e-04 3.3e-19 γδ-T.1
KLRF1 1.13e+00 1.9e+00 5.78e-09 7.38e-18 γδ-T.1
GPR56 5.64e-01 4.28e-01 2.28e-02 1.61e-17 γδ-T.1
PDGFD1 1.39e+00 1.85e+00 4.45e-08 1.92e-17 γδ-T.1
KLRD11 8.65e-01 1.52e+00 5.26e-07 5.21e-17 γδ-T.1
BNC2 1.1e+00 1.29e+00 6.63e-07 1.15e-16 γδ-T.1
FAM53B 9.37e-01 2.55e-01 2.52e-01 2.23e-16 γδ-T.1
FCGR3A 6.2e-01 7.64e-01 1.21e-04 5.92e-16 γδ-T.1
TGFBR31 1e+00 9.78e-01 3.97e-03 2.86e-15 γδ-T.1
ZEB21 7.37e-01 1.34e+00 2.31e-05 8.84e-15 γδ-T.1
RAP2B 8.22e-01 6.45e-01 1.33e-01 5.33e-14 γδ-T.1
TTC38 7.48e-01 8.74e-01 8.72e-05 1.19e-13 γδ-T.1
PTPN12 9.16e-01 1.97e+00 1.19e-11 1.29e-13 γδ-T.1
KLHDC4 7.14e-01 4.3e-01 4.66e-01 2.62e-12 γδ-T.1
BCR 7.11e-01 1.34e+00 4.54e-05 4.52e-12 γδ-T.1
PLEKHF1 6.51e-01 6.25e-01 1.48e-02 8.68e-12 γδ-T.1
GK5 8.35e-01 9.58e-01 5.15e-04 1.07e-11 γδ-T.1
ITGB21 6.58e-01 6.07e-01 1.12e-01 6.66e-11 γδ-T.1
CX3CR1 4.68e-01 4.86e-01 2.03e-02 7.09e-11 γδ-T.1
DGKD 7.75e-01 4.26e-01 3.49e-02 1.18e-10 γδ-T.1
ARPC2 5.1e-01 4.37e-01 1.82e-01 2.97e-10 γδ-T.1
MYBL11 5.9e-01 7.93e-01 3.48e-03 3.61e-10 γδ-T.1
PTGDS 5.54e-01 1.26e+00 8.67e-05 3.86e-10 γδ-T.1
SLCO4C1 4.43e-01 6.32e-01 1.64e-05 1.39e-09 γδ-T.1
MYL12A 5.5e-01 9.19e-01 8.17e-05 1.51e-09 γδ-T.1
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ABI3 6.7e-01 9.78e-01 2.44e-02 1.68e-09 γδ-T.1
C12ORF75 6.39e-01 5.96e-01 1.3e-03 1.9e-09 γδ-T.1
TYROBP1 7.1e-01 1.35e+00 4.4e-06 1.97e-09 γδ-T.1
DOCK51 1.02e+00 2.79e-01 1.49e-01 2.01e-09 γδ-T.1
RASA3 7.52e-01 8.89e-01 9.18e-03 3.63e-09 γδ-T.1
HCST1 5.61e-01 7.89e-01 2.37e-02 3.97e-09 γδ-T.1
PTPN7 7.59e-01 4.4e-01 1.46e-01 4.21e-09 γδ-T.1
PXN 5.66e-01 3.15e-01 1.84e-01 6.03e-09 γδ-T.1
MYO1F1 7.32e-01 1.45e+00 1.68e-06 6.1e-09 γδ-T.1
B3GNT71 7.43e-01 4.81e-01 4.87e-03 6.58e-09 γδ-T.1
AKR1C3 4.04e-01 7.33e-01 5.73e-05 7.51e-09 γδ-T.1
ITGAL 7.43e-01 5.48e-01 3.68e-02 7.92e-09 γδ-T.1
SYTL31 5.34e-01 1.44e+00 5.02e-06 8.26e-09 γδ-T.1
HAVCR21 7.56e-01 1.15e+00 9.18e-03 1.82e-08 γδ-T.1
SSBP3 7.13e-01 3.11e-01 5.99e-01 2.94e-08 γδ-T.1
BIN21 6.95e-01 6.2e-01 3.44e-02 4.82e-08 γδ-T.1
NFE2L21 6.4e-01 5.05e-01 1.65e-01 4.83e-08 γδ-T.1
AOAH1 4.99e-01 1.29e+00 1.26e-05 5.66e-08 γδ-T.1
FOXK2 7.68e-01 6.3e-01 3.95e-01 7.92e-08 γδ-T.1
DSTN 6.47e-01 6.1e-01 6.7e-03 8.16e-08 γδ-T.1
LINGO21 1.43e+00 1.88e+00 2.61e-03 1.62e-07 γδ-T.1
ACTB 5.19e-01 7.92e-01 6.93e-04 1.67e-07 γδ-T.1
PFN1 5.34e-01 6.49e-01 2.11e-02 1.83e-07 γδ-T.1
LPCAT1 6.01e-01 7.77e-01 5.66e-03 2.13e-07 γδ-T.1
CCL4 5.89e-01 1.84e+00 1.75e-04 3.27e-07 γδ-T.1
TNFRSF1B 5.65e-01 3.27e-01 6.58e-02 5.64e-07 γδ-T.1
GZMA1 2.65e-01 1.52e+00 1.08e-04 5.72e-07 γδ-T.1
ITGAM 3.98e-01 6.78e-01 3.56e-02 6.06e-07 γδ-T.1
PLEKHA21 5.69e-01 3.89e-01 6.34e-02 6.31e-07 γδ-T.1
TMEM181 5.27e-01 8.88e-01 2.69e-02 6.63e-07 γδ-T.1
TSPAN32 4.8e-01 8.66e-01 6.37e-03 7.09e-07 γδ-T.1
PTPRE 5.48e-01 5.22e-01 3.1e-01 7.67e-07 γδ-T.1
ST3GAL4 4.08e-01 3.6e-01 3.47e-02 8.03e-07 γδ-T.1
UPP1 5.16e-01 4.11e-01 2.27e-02 8.95e-07 γδ-T.1
SETBP1 6.69e-01 6.04e-01 1.39e-01 1e-06 γδ-T.1
DDIT4 6.81e-01 3.4e-01 4.64e-01 1.1e-06 γδ-T.1
S100A4 4.21e-01 7.37e-01 5.4e-03 1.34e-06 γδ-T.1
SYNE1 5.95e-01 9.99e-01 1.27e-02 1.52e-06 γδ-T.1
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CCND3 4.57e-01 3.37e-01 2.89e-01 1.64e-06 γδ-T.1
BHLHE401 5.63e-01 7.19e-01 3.35e-02 1.94e-06 γδ-T.1
DIP2A 5.63e-01 1.11e+00 4.06e-04 2.85e-06 γδ-T.1
HLA.C 3.53e-01 7.54e-01 1.48e-03 3.22e-06 γδ-T.1
CLIC3 2.59e-01 9.91e-01 2.32e-03 3.25e-06 γδ-T.1
SAMD31 3.85e-01 1.4e+00 9.82e-05 4.02e-06 γδ-T.1
PLCB11 2.67e-01 1.39e+00 9.7e-04 5.58e-06 γδ-T.1
TRAPPC10 4.76e-01 7.27e-01 7.42e-02 6.49e-06 γδ-T.1
RNF168 4.66e-01 1.11e+00 2.56e-04 9.11e-06 γδ-T.1
FNDC3B1 6.65e-01 7.43e-01 1.16e-02 1.02e-05 γδ-T.1
HIPK2 6.66e-01 6.73e-01 1.04e-01 1.04e-05 γδ-T.1
ARL4C 4.53e-01 8.8e-01 2.31e-02 1.23e-05 γδ-T.1
SPN 5.18e-01 8.99e-01 2.93e-03 1.3e-05 γδ-T.1
ST8SIA6 3.62e-01 4.07e-01 1.92e-02 1.31e-05 γδ-T.1
RHBDF2 4.23e-01 3.29e-01 6.42e-02 1.36e-05 γδ-T.1
EMP3 4.47e-01 9.16e-01 1.66e-05 1.42e-05 γδ-T.1
CD38 4.63e-01 1.71e+00 5.9e-05 1.46e-05 γδ-T.1
ACTG1 4.73e-01 4.5e-01 2.02e-01 1.82e-05 γδ-T.1
STK38 5.35e-01 7.23e-01 5.48e-02 1.84e-05 γδ-T.1
CMIP1 4.92e-01 9.12e-01 1.49e-02 2.42e-05 γδ-T.1
PAFAH2 2.9e-01 7.4e-01 3.67e-03 2.44e-05 γδ-T.1
IGF1R 8.57e-01 8.51e-01 6.79e-02 2.64e-05 γδ-T.1
GFOD11 4.29e-01 1.27e+00 3.71e-03 2.66e-05 γδ-T.1
VAV3 4.96e-01 9.81e-01 2.03e-02 2.66e-05 γδ-T.1
VPS37B 4.78e-01 4.18e-01 6.23e-01 2.76e-05 γδ-T.1
CCND2 3.47e-01 1.18e+00 1.46e-03 2.8e-05 γδ-T.1
IL21R 4.16e-01 2.74e-01 3.81e-01 3.22e-05 γδ-T.1
FGR 3.02e-01 7.06e-01 9.55e-05 4.68e-05 γδ-T.1
NFATC2 3.5e-01 9.35e-01 3.35e-04 4.82e-05 γδ-T.1
SLA21 5.93e-01 8.07e-01 1.45e-02 4.89e-05 γδ-T.1
AK5 3.6e-01 8.13e-01 1.72e-04 5.49e-05 γδ-T.1
F2R 3.94e-01 5.93e-01 4.65e-03 5.64e-05 γδ-T.1
ADRB21 4.32e-01 4.69e-01 1.99e-01 5.68e-05 γδ-T.1
GZMM1 3.73e-01 9.38e-01 8.41e-04 5.7e-05 γδ-T.1
SLC39A10 3.1e-01 7.58e-01 2.54e-02 6.15e-05 γδ-T.1
SUSD1 3.46e-01 9.2e-01 9.76e-04 6.42e-05 γδ-T.1
LINC00861 4.14e-01 8e-01 9.52e-02 6.57e-05 γδ-T.1
CASP10 4.34e-01 3.59e-01 3.52e-01 6.82e-05 γδ-T.1
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SH3GLB1 3.09e-01 3.01e-01 4.34e-01 7.29e-05 γδ-T.1
CCDC88C 3.62e-01 4.37e-01 3.25e-01 7.48e-05 γδ-T.1
SUN2 3.61e-01 5.3e-01 1.97e-01 7.94e-05 γδ-T.1
LOC284757 5.47e-01 1.15e+00 1e-02 9.36e-05 γδ-T.1
GNAL 5.92e-01 5.96e-01 1.26e-01 1.02e-04 γδ-T.1
GSTP11 3.95e-01 5.04e-01 1.07e-01 1.46e-04 γδ-T.1
KLRB11 6.92e-01 1.27e+00 3.82e-04 1.49e-04 γδ-T.1
PITPNC1 3.52e-01 1.36e+00 1.43e-03 1.5e-04 γδ-T.1
AXIN1 5.95e-01 8.86e-01 4.7e-03 1.54e-04 γδ-T.1
LLGL2 4.29e-01 3.67e-01 1.42e-01 1.55e-04 γδ-T.1
SLC1A4 6.23e-01 5.85e-01 1.32e-01 1.79e-04 γδ-T.1
BCL2 3.95e-01 2.88e-01 5.06e-01 1.96e-04 γδ-T.1
YAF2 5.02e-01 8.13e-01 3.38e-02 1.98e-04 γδ-T.1
HOPX1 3.54e-01 1.43e+00 1.32e-03 2.16e-04 γδ-T.1
PHF20 4.27e-01 3.41e-01 5.55e-01 2.36e-04 γδ-T.1
SSX2IP 2.64e-01 8.55e-01 7.78e-04 2.4e-04 γδ-T.1
GSAP 4.6e-01 9.5e-01 1.4e-02 2.47e-04 γδ-T.1
TES 3.8e-01 5.51e-01 7.69e-02 2.64e-04 γδ-T.1
BPGM 4.89e-01 7.82e-01 4.89e-02 2.76e-04 γδ-T.1
HSPA5 3.35e-01 5.58e-01 5.25e-03 2.79e-04 γδ-T.1
RALGAPA1 3.69e-01 7.92e-01 8.28e-03 2.83e-04 γδ-T.1
ITGA5 2.92e-01 7.33e-01 4.93e-03 3.08e-04 γδ-T.1
TMEM50B.1 3.92e-01 3.8e-01 5.78e-02 3.1e-04 γδ-T.1
PTGER2 3.5e-01 5.31e-01 1.4e-01 3.11e-04 γδ-T.1
PRR5L1 4.71e-01 8.32e-01 8.32e-02 3.72e-04 γδ-T.1
GNG2 4.04e-01 1.08e+00 3.39e-03 3.89e-04 γδ-T.1
MCTP21 4.09e-01 1.11e+00 8.98e-04 4.6e-04 γδ-T.1
B4GALT51 2.59e-01 4.71e-01 4.33e-01 4.67e-04 γδ-T.1
PPP2R5C 2.7e-01 7.44e-01 5.61e-03 4.69e-04 γδ-T.1
PIK3CD 3.78e-01 6.38e-01 1.65e-01 4.75e-04 γδ-T.1
PCSK7 3.2e-01 6.62e-01 1.06e-02 5.16e-04 γδ-T.1
PPM1L 5.65e-01 8.89e-01 8.27e-04 5.55e-04 γδ-T.1
CDC42SE1 6.1e-01 7.62e-01 4.43e-02 6.14e-04 γδ-T.1
GNPTAB 4.86e-01 4.27e-01 1.16e-01 7.4e-04 γδ-T.1
STARD3NL1 2.97e-01 8.57e-01 2.08e-02 8.88e-04 γδ-T.1
EFHD2 4.24e-01 7.16e-01 1.17e-03 1.02e-03 γδ-T.1
CYBA 2.98e-01 5.42e-01 1.2e-02 1.02e-03 γδ-T.1
NAPA 3.48e-01 3.55e-01 4.61e-01 1.05e-03 γδ-T.1
APPENDIX A. Supplementary Tables for Chapter 3 219
HCP5 3.02e-01 9.13e-01 4.88e-03 1.06e-03 γδ-T.1
FAM49B 3.53e-01 9.32e-01 5.6e-03 1.06e-03 γδ-T.1
ARSG 4.18e-01 1.24e+00 1.35e-03 1.11e-03 γδ-T.1
BRD7 3.89e-01 5.28e-01 2.89e-01 1.24e-03 γδ-T.1
MSL2 3.7e-01 5.59e-01 9.86e-02 1.27e-03 γδ-T.1
CEP78 4.05e-01 8.37e-01 1.01e-03 1.49e-03 γδ-T.1
NDUFA12 3.67e-01 4.43e-01 1.94e-01 1.52e-03 γδ-T.1
RNF167 3.13e-01 4.47e-01 3.16e-01 1.63e-03 γδ-T.1
FOSL21 3.6e-01 3.86e-01 5.3e-01 1.83e-03 γδ-T.1
CNOT21 4.51e-01 7.78e-01 3.07e-01 2.01e-03 γδ-T.1
CARD11 4.27e-01 7.47e-01 2.26e-01 2.16e-03 γδ-T.1
ST3GAL5 3.5e-01 4.17e-01 3.93e-01 2.24e-03 γδ-T.1
RUNX3 2.99e-01 8.89e-01 1.41e-01 2.29e-03 γδ-T.1
TBCB 3.76e-01 3.68e-01 1.39e-01 2.35e-03 γδ-T.1
C5ORF56 2.99e-01 5.39e-01 2.13e-01 2.4e-03 γδ-T.1
ST3GAL2 3.72e-01 3.26e-01 2.44e-01 2.5e-03 γδ-T.1
AES 3.2e-01 9.71e-01 2.47e-02 2.79e-03 γδ-T.1
ADAM10 4.55e-01 4.63e-01 3.97e-01 2.86e-03 γδ-T.1
ZBTB2 3.66e-01 3.52e-01 4.56e-01 2.89e-03 γδ-T.1
IFITM11 3.01e-01 8.21e-01 5.91e-03 2.97e-03 γδ-T.1
GPR651 2.88e-01 1.14e+00 1.12e-02 3.22e-03 γδ-T.1
OSTF1 2.97e-01 4.58e-01 4.06e-02 3.33e-03 γδ-T.1
CALM1 2.58e-01 2.97e-01 8.97e-02 3.35e-03 γδ-T.1
ESYT2 3.94e-01 5.04e-01 9.51e-02 3.65e-03 γδ-T.1
JAK1 2.57e-01 3.03e-01 3e-01 3.8e-03 γδ-T.1
UBN2 3.37e-01 5.83e-01 1e-01 3.83e-03 γδ-T.1
LNPEP 3.27e-01 3.86e-01 3.97e-01 4.03e-03 γδ-T.1
ABL1 4.13e-01 7.52e-01 6.64e-02 4.07e-03 γδ-T.1
PDE7A 2.57e-01 5.22e-01 6.69e-01 4.13e-03 γδ-T.1
DDOST 3.18e-01 4.97e-01 1.31e-02 4.38e-03 γδ-T.1
C1ORF56 6.17e-01 7.11e-01 2.51e-02 4.51e-03 γδ-T.1
GTF3C1 3.48e-01 4.56e-01 2.03e-01 4.72e-03 γδ-T.1
JAZF1 3.7e-01 2.53e-01 6.49e-01 4.79e-03 γδ-T.1
SAE1 3.4e-01 4.69e-01 2.11e-01 4.85e-03 γδ-T.1
CFL1 2.98e-01 6.38e-01 6.07e-03 5.77e-03 γδ-T.1
RBM22 2.93e-01 2.81e-01 5.39e-01 5.98e-03 γδ-T.1
FANCA 2.73e-01 5.42e-01 1.93e-01 5.98e-03 γδ-T.1
AES.1 3.38e-01 9.11e-01 1.8e-02 6.02e-03 γδ-T.1
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RAP1B 2.63e-01 2.93e-01 5.89e-01 6.08e-03 γδ-T.1
HIRA 3.49e-01 3.26e-01 5.07e-01 6.09e-03 γδ-T.1
PHAX 3.04e-01 4.64e-01 2.11e-01 6.9e-03 γδ-T.1
REV3L 3.21e-01 4.85e-01 2e-01 7.4e-03 γδ-T.1
WDR37 4.06e-01 7.28e-01 7.39e-02 8.03e-03 γδ-T.1
VTI1B 2.91e-01 2.89e-01 2.08e-01 8.24e-03 γδ-T.1
LAT 3.76e-01 5.1e-01 4.05e-01 8.35e-03 γδ-T.1
AP2M1 3.21e-01 2.57e-01 5.12e-01 8.66e-03 γδ-T.1
HSH2D 3.72e-01 4.52e-01 2.62e-01 8.66e-03 γδ-T.1
OXSR1 3.08e-01 5.01e-01 3.36e-01 8.94e-03 γδ-T.1
SYAP1 3.85e-01 3.95e-01 1.77e-01 9.31e-03 γδ-T.1
ARRB1 3.14e-01 3.29e-01 9.83e-02 9.83e-03 γδ-T.1
TMEM71 5.11e-01 9.13e-01 8.89e-03 1.08e-02 γδ-T.1
LPP 2.71e-01 5.19e-01 4.77e-02 1.34e-02 γδ-T.1
LDHA 3.17e-01 2.77e-01 1.69e-01 1.37e-02 γδ-T.1
EIF4G3 3.61e-01 4.09e-01 3.02e-01 1.53e-02 γδ-T.1
TRAPPC8 2.63e-01 3.31e-01 6.02e-01 1.59e-02 γδ-T.1
GAB3 4.08e-01 3.72e-01 3.09e-02 1.74e-02 γδ-T.1
MED14 2.71e-01 4.35e-01 1.05e-01 1.85e-02 γδ-T.1
PPP3R1 2.8e-01 7.92e-01 2.32e-02 1.96e-02 γδ-T.1
JA700183 2.75e-01 4.74e-01 3.31e-01 1.98e-02 γδ-T.1
FKBP111 2.79e-01 5.79e-01 1.62e-02 2.01e-02 γδ-T.1
CCL31 5.23e-01 8.41e-01 9.35e-02 2.05e-02 γδ-T.1
ABHD21 3.31e-01 5.17e-01 3.33e-02 2.1e-02 γδ-T.1
KANSL1 2.72e-01 4.51e-01 2.32e-01 2.22e-02 γδ-T.1
NPIPL1.1 2.71e-01 3.48e-01 1.54e-01 2.29e-02 γδ-T.1
PTPN41 2.62e-01 5.99e-01 6.02e-02 2.34e-02 γδ-T.1
ITCH 2.72e-01 8.06e-01 1.87e-02 2.42e-02 γδ-T.1
CD226 2.54e-01 9.45e-01 5.23e-02 2.45e-02 γδ-T.1
DOK6 2.85e-01 5.44e-01 2.41e-01 2.61e-02 γδ-T.1
RIN31 2.8e-01 5.9e-01 5.14e-02 2.64e-02 γδ-T.1
UCK2 2.73e-01 2.65e-01 1.53e-01 2.65e-02 γδ-T.1
IL2RG 2.88e-01 3.8e-01 2.68e-01 2.76e-02 γδ-T.1
TG1 2.73e-01 8.06e-01 3.23e-02 2.81e-02 γδ-T.1
MANF 3.31e-01 4.17e-01 3.51e-01 2.84e-02 γδ-T.1
UBR1 3.32e-01 4.39e-01 3.7e-01 2.88e-02 γδ-T.1
STRN 3.56e-01 6.54e-01 3.78e-02 2.93e-02 γδ-T.1
PAPD5 3.66e-01 8.45e-01 2.1e-02 3.09e-02 γδ-T.1
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MECP2 3.21e-01 3.84e-01 2.39e-01 3.19e-02 γδ-T.1
MTF2 3.1e-01 6.58e-01 2.03e-01 3.26e-02 γδ-T.1
RIPK2 2.6e-01 4.17e-01 3.88e-01 3.33e-02 γδ-T.1
PCED1B 2.81e-01 5.65e-01 3.88e-02 3.34e-02 γδ-T.1
SIRT2 3.26e-01 2.92e-01 6.09e-01 3.43e-02 γδ-T.1
GRAP2 2.65e-01 5.76e-01 9.8e-02 3.69e-02 γδ-T.1
TARS 3.21e-01 5.25e-01 1.66e-01 3.72e-02 γδ-T.1
MYO1G 2.84e-01 4.76e-01 2.28e-01 3.76e-02 γδ-T.1
RAD9A 2.59e-01 3.12e-01 6.06e-01 3.94e-02 γδ-T.1
JMJD6 2.81e-01 5.15e-01 6.9e-02 4.27e-02 γδ-T.1
SMAD5 2.51e-01 7.76e-01 2.97e-02 4.4e-02 γδ-T.1
KDM2A 2.5e-01 5.98e-01 5.77e-02 4.42e-02 γδ-T.1
C18ORF8 2.85e-01 4.28e-01 1.01e-01 4.45e-02 γδ-T.1
SECISBP2L 2.8e-01 3.06e-01 5.47e-02 4.69e-02 γδ-T.1
ETFA 3.11e-01 6.03e-01 3.89e-01 4.75e-02 γδ-T.1
POMP 2.67e-01 4.56e-01 5.95e-02 4.9e-02 γδ-T.1
SET 2.63e-01 3.83e-01 3.21e-01 4.9e-02 γδ-T.1
MED15 2.62e-01 4.32e-01 5.94e-02 5.18e-02 γδ-T.1
C2CD5 3.21e-01 4.02e-01 4.85e-02 5.28e-02 γδ-T.1
IRF2BPL 3.16e-01 3.4e-01 3.31e-01 5.75e-02 γδ-T.1
DDX52 2.78e-01 4.43e-01 4.08e-01 6.07e-02 γδ-T.1
LUZP6 2.83e-01 6.79e-01 1.24e-01 6.4e-02 γδ-T.1
GLCCI1 3.51e-01 4e-01 2.88e-01 6.55e-02 γδ-T.1
USP28 2.6e-01 4.44e-01 4.29e-02 7.04e-02 γδ-T.1
KIAA2018 2.69e-01 3.24e-01 4.15e-01 7.2e-02 γδ-T.1
PSEN1 3.17e-01 2.81e-01 3.63e-01 7.43e-02 γδ-T.1
MADD 3.05e-01 3.75e-01 4.82e-01 7.46e-02 γδ-T.1
CHMP1B 3.34e-01 4.14e-01 3.34e-01 7.61e-02 γδ-T.1
PDIA6 2.64e-01 4.58e-01 2.43e-01 7.7e-02 γδ-T.1
FAM65B 3.15e-01 3.2e-01 3.4e-01 7.82e-02 γδ-T.1
PPP1R18 2.59e-01 6.24e-01 8.57e-02 7.9e-02 γδ-T.1
AK097472 2.64e-01 3.49e-01 2.38e-01 8.23e-02 γδ-T.1
MAZ 2.57e-01 3.42e-01 2.54e-01 9.79e-02 γδ-T.1
CPQ 3.23e-01 4.91e-01 1.76e-01 9.91e-02 γδ-T.1
CDK6 2.58e-01 8.25e-01 2.08e-01 1e-01 γδ-T.1
THOC7 2.58e-01 3.21e-01 2.23e-01 1.06e-01 γδ-T.1
RBBP4 2.64e-01 3.11e-01 2.81e-01 1.19e-01 γδ-T.1
ZNF710 3.1e-01 7.43e-01 7.72e-02 1.2e-01 γδ-T.1
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SLC12A2 2.53e-01 5.43e-01 3.39e-01 1.22e-01 γδ-T.1
SLK 2.65e-01 6.7e-01 1.07e-01 1.23e-01 γδ-T.1
RAB18 2.6e-01 3.18e-01 6.78e-01 1.33e-01 γδ-T.1
KPNA3 2.74e-01 6.19e-01 1.22e-01 1.34e-01 γδ-T.1
PACSIN21 2.76e-01 3.72e-01 5.12e-01 1.47e-01 γδ-T.1
PAK1 3.21e-01 6.06e-01 2.42e-01 1.74e-01 γδ-T.1
RNF115 2.59e-01 3.9e-01 6.2e-01 1.91e-01 γδ-T.1
PPP2R3A 2.85e-01 5.93e-01 1.09e-01 1.95e-01 γδ-T.1
C16ORF54 3.04e-01 3.71e-01 4.48e-01 2e-01 γδ-T.1
CPEB4 2.77e-01 3.13e-01 5.98e-01 2.96e-01 γδ-T.1
GNLY 3.16e+00 3.2e+00 4.13e-90 6.23e-246 γδ-T.2
ATP8B4 2.02e+00 1.49e+00 2.68e-26 2.14e-177 γδ-T.2
NCAM1 1.97e+00 1.39e+00 8.63e-27 2.16e-163 γδ-T.2
TYROBP 1.41e+00 1.99e+00 5.27e-55 2.69e-130 γδ-T.2
PLCG2 2.02e+00 5.93e-01 1.8e-04 1.07e-123 γδ-T.2
LOC285972 1.26e+00 7.94e-01 5.33e-08 2.78e-106 γδ-T.2
KLRD1 1.45e+00 1.44e+00 1.01e-25 2.13e-101 γδ-T.2
AV4S11 1.42e+00 1.95e+00 4.09e-41 2.23e-90 γδ-T.2
RIN3 1.35e+00 1.21e+00 1.3e-15 6.64e-73 γδ-T.2
KLRC1 1.2e+00 1.35e+00 2.89e-25 1.51e-72 γδ-T.2
GZMB 1.68e+00 1.69e+00 6.35e-24 9.31e-70 γδ-T.2
FCER1G 9.3e-01 1.14e+00 6.53e-28 6.87e-68 γδ-T.2
CLNK 1e+00 4.53e-01 5.32e-03 1.17e-61 γδ-T.2
MCTP2 1.15e+00 1e+00 1.97e-12 3.25e-61 γδ-T.2
LINGO2 1.88e+00 1.08e+00 6.05e-11 4.47e-60 γδ-T.2
HAVCR2 1.25e+00 7.36e-01 1.26e-06 9.06e-60 γδ-T.2
CD7 1.04e+00 1.5e+00 3.39e-26 3.75e-57 γδ-T.2
B3GNT7 7.5e-01 1.56e+00 5.29e-27 4.14e-53 γδ-T.2
CNOT2 1.15e+00 8.66e-01 9.03e-12 1.12e-50 γδ-T.2
CD63 9.39e-01 1.24e+00 9.69e-19 2.1e-50 γδ-T.2
AK096314 8.39e-01 1.72e+00 3.3e-37 1.89e-49 γδ-T.2
KLRK1 8.22e-01 1.67e+00 1.21e-32 2.26e-48 γδ-T.2
DOCK5 1.1e+00 9.88e-01 3.87e-12 8.43e-48 γδ-T.2
WIPF3 6.41e-01 2.28e+00 1.41e-33 3.39e-46 γδ-T.2
GAS7 1.1e+00 1.34e+00 9.4e-15 1.36e-44 γδ-T.2
APBA2 1.03e+00 3.28e-01 1.81e-02 2.59e-42 γδ-T.2
PRKX 8.38e-01 8.5e-01 4.34e-09 4.85e-42 γδ-T.2
PDGFD 1.06e+00 1.17e+00 5.62e-11 1.45e-39 γδ-T.2
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CCL5 5.67e-01 1.79e+00 4.51e-27 2.07e-39 γδ-T.2
ABCB11 9.09e-01 9.44e-01 4.29e-09 5.07e-39 γδ-T.2
SAMD3 8.4e-01 1.08e+00 2.53e-13 1.04e-38 γδ-T.2
HOPX 9.69e-01 1.37e+00 7.35e-24 2.94e-38 γδ-T.2
KRT81 4.67e-01 1.19e+00 6.45e-22 5.21e-38 γδ-T.2
GEM 1.12e+00 5.04e-01 5.92e-03 1.5e-37 γδ-T.2
GALNT2 9.14e-01 1.36e+00 7.56e-19 1.63e-37 γδ-T.2
PPP1R9A 7.12e-01 8.01e-01 1.83e-06 3.94e-37 γδ-T.2
KRT86 5.12e-01 1.78e+00 5.55e-33 8.78e-36 γδ-T.2
SRGAP3 8.84e-01 1.06e+00 7.1e-11 9.44e-34 γδ-T.2
ABHD2 8.46e-01 7.15e-01 7.61e-08 1.51e-33 γδ-T.2
AHI1 8.92e-01 8.33e-01 9.21e-07 8.9e-33 γδ-T.2
ITGB1 7.9e-01 8.66e-01 1.33e-08 2.09e-32 γδ-T.2
AOAH 4.19e-01 1.62e+00 1.58e-19 1.22e-31 γδ-T.2
LOC100506776 7.94e-01 6.4e-01 2.83e-05 6.17e-31 γδ-T.2
ZNF683 7.92e-01 1.01e+00 1.76e-11 2.57e-30 γδ-T.2
LAT2 5.96e-01 6.88e-01 2.02e-04 5.05e-29 γδ-T.2
SYTL3 3.64e-01 1.31e+00 2.83e-09 5.47e-29 γδ-T.2
LDB2 7.59e-01 1.08e+00 3.2e-16 4.87e-28 γδ-T.2
IFITM2 7.06e-01 6.64e-01 9.64e-06 1.16e-27 γδ-T.2
GZMA 5.42e-01 1.63e+00 1.53e-12 1.92e-27 γδ-T.2
ITGA1 7.6e-01 1.73e+00 4.42e-27 1.97e-27 γδ-T.2
GPR97 4.5e-01 9.41e-01 1.44e-17 8.92e-26 γδ-T.2
L3MBTL4 8e-01 4.36e-01 2.62e-02 3.1e-24 γδ-T.2
DFNB311 6.75e-01 8.71e-01 1.69e-09 4.75e-23 γδ-T.2
KCNQ5 9.67e-01 2.84e-01 3.62e-02 1.55e-21 γδ-T.2
CBLB 4.29e-01 1.23e+00 2.85e-16 3.56e-21 γδ-T.2
CMC1 9.59e-01 1.61e+00 9.03e-19 7.01e-20 γδ-T.2
PRR5L 3.89e-01 1.38e+00 1.68e-04 2.42e-19 γδ-T.2
GFOD1 6.96e-01 6.19e-01 1.16e-03 3.35e-19 γδ-T.2
CMIP 4.91e-01 1e+00 4.66e-17 8.53e-19 γδ-T.2
TNFRSF18 5.86e-01 1.37e+00 1.53e-16 1.03e-17 γδ-T.2
PLXNA4 6.2e-01 8.69e-01 5.01e-11 1.45e-17 γδ-T.2
EPHA41 6.11e-01 8.24e-01 2.05e-05 8.71e-17 γδ-T.2
GAB1 5.31e-01 5.92e-01 6.74e-04 2.78e-16 γδ-T.2
CHST12 5.5e-01 9.84e-01 2.3e-09 2.8e-16 γδ-T.2
ZEB2 4.75e-01 7.25e-01 3.37e-07 3.61e-16 γδ-T.2
IL2RB 5.13e-01 6.84e-01 2.58e-06 8.12e-16 γδ-T.2
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LRMP 6.34e-01 5.95e-01 3.33e-03 4.5e-15 γδ-T.2
HCST 2.85e-01 1.01e+00 5.5e-06 4.68e-15 γδ-T.2
MAFF1 2.9e-01 1.12e+00 1.59e-05 5.89e-15 γδ-T.2
LYST 5.26e-01 2.88e-01 2.01e-01 1.18e-14 γδ-T.2
ATP8A1 4.41e-01 8.05e-01 4.42e-08 1.21e-14 γδ-T.2
PELO 4.67e-01 7.77e-01 2.02e-08 1.73e-14 γδ-T.2
NCR31 3.34e-01 3.1e-01 3.28e-02 2.48e-12 γδ-T.2
MAFF.1 2.5e-01 8.58e-01 6.31e-06 2.84e-12 γδ-T.2
CHN2 5.02e-01 1.06e+00 3.02e-11 3.46e-12 γδ-T.2
HIP1 5.6e-01 7.2e-01 1.5e-04 1.43e-11 γδ-T.2
CLEC2B 2.53e-01 1.04e+00 3.65e-05 3.92e-11 γδ-T.2
RBPJ 2.66e-01 1.03e+00 2.21e-02 4.08e-11 γδ-T.2
MCF2L2 2.95e-01 1.18e+00 1.92e-03 5.69e-11 γδ-T.2
ZNF611 4.76e-01 3.86e-01 3.48e-02 8.44e-11 γδ-T.2
ITGAE 2.57e-01 1.01e+00 5.07e-03 1.74e-10 γδ-T.2
ABTB2 8.52e-01 6.85e-01 2.35e-05 1.99e-10 γδ-T.2
FOSL2 4.84e-01 5.56e-01 2.65e-04 2.79e-10 γδ-T.2
LITAF1 4.82e-01 7.09e-01 1.2e-06 3.5e-10 γδ-T.2
SLA2 3.64e-01 9.96e-01 3.92e-06 5.01e-10 γδ-T.2
MRPS6 2.58e-01 8.5e-01 1.32e-04 6.98e-10 γδ-T.2
DOCK8 3.41e-01 5.93e-01 5.87e-07 9.11e-10 γδ-T.2
TFDP2 4.4e-01 3.08e-01 4.41e-01 2.01e-09 γδ-T.2
TCTN3 4.96e-01 4.38e-01 2.64e-02 2.77e-09 γδ-T.2
IFITM1 3.66e-01 5.81e-01 1.48e-06 3.95e-09 γδ-T.2
PARP8 2.99e-01 7.8e-01 4.52e-07 4.34e-09 γδ-T.2
PACSIN2 3.68e-01 3.4e-01 4.84e-02 6.38e-09 γδ-T.2
TIGIT 3.65e-01 6.08e-01 1.04e-04 7.23e-09 γδ-T.2
SLC16A3 3.92e-01 7.26e-01 4.48e-07 9.16e-09 γδ-T.2
CCL3 3.45e-01 1.36e+00 1.89e-03 1.04e-08 γδ-T.2
PTPN4 2.64e-01 7.99e-01 2.8e-04 1.26e-08 γδ-T.2
CAPN12 3.58e-01 3.53e-01 2.14e-02 3.36e-08 γδ-T.2
FNDC3B 3.32e-01 8.92e-01 6.6e-05 3.51e-08 γδ-T.2
BHLHE40 2.93e-01 8.12e-01 5.83e-05 4.22e-08 γδ-T.2
GSTP1 3.65e-01 5.86e-01 5.84e-04 4.54e-08 γδ-T.2
ERGIC1 3.82e-01 5.85e-01 5.73e-04 5.79e-08 γδ-T.2
LGALS1 3.35e-01 1.11e+00 9.03e-06 5.98e-08 γδ-T.2
CTNNB1 4.11e-01 3.57e-01 4.35e-03 6.46e-08 γδ-T.2
TPST2 3.56e-01 2.79e-01 1.38e-01 8.14e-08 γδ-T.2
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PTPRJ 2.62e-01 3.46e-01 1.02e-04 8.97e-08 γδ-T.2
PLEKHA2 3.72e-01 4.22e-01 7.34e-03 9.33e-08 γδ-T.2
BIN2 4.1e-01 4.05e-01 1.62e-02 9.51e-08 γδ-T.2
PIK3R1 3.73e-01 8e-01 2.38e-07 1.3e-07 γδ-T.2
SLAMF7 3.07e-01 2.66e-01 1.58e-02 1.92e-07 γδ-T.2
CD971 3.19e-01 7.93e-01 7.3e-05 3.05e-07 γδ-T.2
SOS2 4.27e-01 4.53e-01 2.33e-03 3.8e-07 γδ-T.2
CASK 3.25e-01 2.74e-01 8.37e-02 4.34e-07 γδ-T.2
CTSD 2.57e-01 7.91e-01 4.76e-06 4.58e-07 γδ-T.2
GALNT111 2.61e-01 7.17e-01 2.61e-04 5.02e-07 γδ-T.2
TMX4 3.95e-01 5.38e-01 1.08e-02 6.04e-07 γδ-T.2
SKI 3.21e-01 6.96e-01 3.78e-06 6.58e-07 γδ-T.2
SFMBT2 2.92e-01 7.64e-01 7.27e-05 6.73e-07 γδ-T.2
C20ORF112 3.44e-01 8.26e-01 9.57e-07 7.4e-07 γδ-T.2
ID2 2.85e-01 9.32e-01 2.81e-04 7.99e-07 γδ-T.2
MNAT1 3.16e-01 2.97e-01 7.18e-02 9.49e-07 γδ-T.2
SLFN5 3.69e-01 4.37e-01 5.19e-03 2.06e-06 γδ-T.2
SACM1L 2.66e-01 5.04e-01 2.51e-03 2.2e-06 γδ-T.2
B3GNT5 3.14e-01 8.42e-01 3.85e-04 2.38e-06 γδ-T.2
BRF1 3.12e-01 3.54e-01 4.38e-02 3.43e-06 γδ-T.2
TG 2.53e-01 7.15e-01 1.57e-04 5.14e-06 γδ-T.2
SPECC1 3.41e-01 4.15e-01 7.56e-03 6.9e-06 γδ-T.2
PON2 3.21e-01 6.73e-01 2.34e-04 7.18e-06 γδ-T.2
MPG 3.09e-01 4.57e-01 9.15e-03 7.47e-06 γδ-T.2
LY6E 3.34e-01 4.5e-01 2.77e-02 7.68e-06 γδ-T.2
KDM5B 3.21e-01 5.86e-01 2.91e-03 1.75e-05 γδ-T.2
PYHIN1 2.67e-01 4.51e-01 1.19e-02 1.9e-05 γδ-T.2
BTN3A1 2.72e-01 3.12e-01 3.26e-03 2.49e-05 γδ-T.2
STARD9 2.67e-01 4.33e-01 4.66e-03 3.35e-05 γδ-T.2
ZNF827 3.46e-01 2.67e-01 1.48e-01 3.87e-05 γδ-T.2
CRIM1 2.67e-01 7.12e-01 6.48e-05 5.23e-05 γδ-T.2
MIPEPP3 2.83e-01 3.38e-01 5.46e-02 7.3e-05 γδ-T.2
MYO1F 3.25e-01 4.27e-01 2.58e-02 7.32e-05 γδ-T.2
ITGB2 2.7e-01 3.09e-01 8.62e-02 1.12e-04 γδ-T.2
40787 3.06e-01 3.75e-01 3.05e-02 1.86e-04 γδ-T.2
PREX1 2.51e-01 2.62e-01 1.3e-01 3.71e-04 γδ-T.2
STARD3NL 2.75e-01 3.98e-01 3.01e-02 3.92e-04 γδ-T.2
DENND1B 3.41e-01 3.11e-01 1.77e-02 3.96e-04 γδ-T.2
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ASXL2 2.76e-01 3.23e-01 2.6e-02 5.2e-04 γδ-T.2
GBE1 2.67e-01 7.04e-01 2.71e-03 5.71e-04 γδ-T.2
GLIPR2 2.64e-01 5.53e-01 6.8e-04 9.11e-04 γδ-T.2
37681 3.6e-01 6.33e-01 3.49e-03 1.55e-03 γδ-T.2
ADCY3 2.54e-01 3.16e-01 6.09e-02 3.5e-03 γδ-T.2
SNTB1 2.61e-01 5.52e-01 1.91e-03 3.61e-03 γδ-T.2
ZNF767 2.54e-01 4.07e-01 4.71e-02 9.51e-03 γδ-T.2
A2M 1.3e+00 1.57e+00 4.2e-17 5.7e-148 γδ-T.3
PLCB1 1.22e+00 1.58e+00 1.39e-13 8.61e-139 γδ-T.3
AV4S1 1.49e+00 1.88e+00 1.09e-21 1e-128 γδ-T.3
KLRB1 1.34e+00 1.89e+00 1.55e-17 2.46e-128 γδ-T.3
PZP 1.13e+00 9.43e-01 1.36e-06 2.62e-114 γδ-T.3
S100B 1.09e+00 1.08e+00 2.59e-13 1.26e-77 γδ-T.3
CEBPD 8.84e-01 5.46e-01 1.49e-02 3.33e-71 γδ-T.3
RGS2 9.03e-01 4.24e-01 1.19e-01 1.74e-69 γδ-T.3
PDE4D 8.17e-01 6.06e-01 8.48e-04 4.59e-58 γδ-T.3
KLRG1 7.68e-01 9.31e-01 6.04e-06 1.21e-56 γδ-T.3
ME1 6.58e-01 5.04e-01 6.24e-05 1.56e-56 γδ-T.3
CYTH3 8.5e-01 9.19e-01 4.78e-06 7.95e-56 γδ-T.3
RORA 7.24e-01 1.11e+00 1.82e-06 5.56e-52 γδ-T.3
SLC4A10 6.32e-01 8.68e-01 1.73e-06 2.44e-47 γδ-T.3
IL12RB2 8.11e-01 1.14e+00 1.2e-07 1.86e-44 γδ-T.3
GZMK 2.63e-01 9.87e-01 6.66e-08 3.15e-40 γδ-T.3
SLC7A5 6.11e-01 8.57e-01 2e-06 1.48e-38 γδ-T.3
RASGRF2 6.18e-01 3.76e-01 5.95e-02 1.77e-36 γδ-T.3
ABCB1 5.55e-01 7.6e-01 8.7e-03 4.62e-36 γδ-T.3
TARP 4.96e-01 1.04e+00 8.4e-12 2.59e-34 γδ-T.3
STAT4 4.8e-01 1.05e+00 1.95e-07 7.92e-34 γδ-T.3
BC035094 5.86e-01 9.56e-01 4.13e-05 1.31e-33 γδ-T.3
PHACTR2 6.3e-01 1.18e+00 1.37e-09 2.21e-33 γδ-T.3
ARHGAP26 4.54e-01 1.07e+00 1.1e-12 2.89e-33 γδ-T.3
REL 5.6e-01 3.3e-01 8.35e-02 8.42e-32 γδ-T.3
NFE2L2 5.71e-01 3.8e-01 1.02e-01 7.43e-31 γδ-T.3
SPOCK2 4.73e-01 6.11e-01 3.03e-03 1.34e-29 γδ-T.3
IFNGR1 5.69e-01 6.82e-01 8.89e-04 2.89e-29 γδ-T.3
CADM1 5.18e-01 2.9e-01 3.42e-02 6.33e-29 γδ-T.3
SATB1 5.99e-01 2.51e-01 3.44e-01 4.39e-28 γδ-T.3
NFKB1 6.07e-01 4.43e-01 3.09e-02 1.52e-26 γδ-T.3
APPENDIX A. Supplementary Tables for Chapter 3 227
PIK3AP1 5.44e-01 4.83e-01 2.56e-02 1.67e-24 γδ-T.3
DHRS3 5.58e-01 4.03e-01 2.55e-02 2.6e-24 γδ-T.3
DUSP2 4.48e-01 8.2e-01 1.25e-07 4.66e-24 γδ-T.3
NCR3 3.9e-01 4.9e-01 1.79e-02 3.21e-23 γδ-T.3
IL18RAP 4.42e-01 7.49e-01 5.86e-09 4.39e-22 γδ-T.3
TTC39C 3.95e-01 7.27e-01 1.91e-04 7.68e-22 γδ-T.3
LONRF3 4.76e-01 5.51e-01 1.76e-02 2.54e-21 γδ-T.3
MYBL1 5.03e-01 5.59e-01 6.22e-04 5.41e-21 γδ-T.3
PBX4 4.82e-01 1.11e+00 2.43e-10 9.5e-21 γδ-T.3
TMEM117 5.78e-01 6.6e-01 1.4e-02 5.63e-20 γδ-T.3
ERN1 4.34e-01 3.06e-01 3.48e-03 1.7e-19 γδ-T.3
NEO1 3.77e-01 6.54e-01 2.3e-05 3.43e-19 γδ-T.3
MAFF 3.85e-01 5.13e-01 2.41e-02 1.87e-18 γδ-T.3
TANC2 4.57e-01 5.61e-01 5.34e-04 4.48e-18 γδ-T.3
FKBP11 4.14e-01 9.52e-01 1.01e-06 5.42e-18 γδ-T.3
DPP4 4.04e-01 6.72e-01 7.47e-06 8.08e-18 γδ-T.3
SVIL 6.46e-01 6.66e-01 2.07e-02 9.86e-18 γδ-T.3
CRY1 4.59e-01 9.03e-01 4.17e-06 1.04e-16 γδ-T.3
LITAF 4.79e-01 6.27e-01 2.8e-04 1.19e-16 γδ-T.3
PDE8A 4.55e-01 3.79e-01 2.91e-02 1.27e-16 γδ-T.3
NFKBIA 4.42e-01 8.21e-01 8.01e-05 1.52e-16 γδ-T.3
BC127952 3.92e-01 3.67e-01 1.15e-01 4.67e-16 γδ-T.3
MICAL2 4.49e-01 4.55e-01 6.21e-02 5.71e-16 γδ-T.3
TGFBR3 3.14e-01 7.16e-01 9.79e-04 9.59e-15 γδ-T.3
BTBD11 4.12e-01 5.01e-01 3.8e-02 2.63e-14 γδ-T.3
LBH 3.54e-01 5.16e-01 5.87e-03 3.03e-14 γδ-T.3
GCHFR 3.58e-01 9.74e-01 8.81e-09 4.9e-14 γδ-T.3
GALNT11 3.86e-01 8.85e-01 6.4e-05 4.76e-13 γδ-T.3
ATF7IP2 4.33e-01 3.09e-01 3.6e-02 1.77e-12 γδ-T.3
TC2N 3.83e-01 6.36e-01 5.89e-03 2.56e-12 γδ-T.3
CD97 4.26e-01 8.72e-01 2.44e-05 2.85e-12 γδ-T.3
LOC285740 3.44e-01 5.02e-01 1.77e-03 3.74e-12 γδ-T.3
GPR65 3.7e-01 7.32e-01 9.37e-04 4.41e-12 γδ-T.3
EVA1C 3.97e-01 8.61e-01 9.12e-07 4.67e-12 γδ-T.3
FBXO34 3.92e-01 6.54e-01 1.08e-03 7.29e-12 γδ-T.3
DUSP10 3.71e-01 5.45e-01 5.07e-02 9.4e-12 γδ-T.3
ZNF331 2.67e-01 2.63e-01 5.4e-02 1.75e-11 γδ-T.3
CDK17 2.97e-01 8.34e-01 1.62e-08 3.85e-11 γδ-T.3
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ADRB2 2.73e-01 3.93e-01 1.44e-03 6.46e-11 γδ-T.3
ZFYVE9 2.83e-01 4.6e-01 3.35e-04 1.42e-10 γδ-T.3
SLC38A1 2.67e-01 4.9e-01 1.08e-02 2.89e-10 γδ-T.3
XBP1.1 2.95e-01 7.27e-01 3.26e-04 6.88e-10 γδ-T.3
SIK1 2.96e-01 2.51e-01 2.61e-01 9.25e-10 γδ-T.3
LYAR 2.5e-01 1.15e+00 3.02e-06 9.75e-10 γδ-T.3
CEP112 3.75e-01 4.89e-01 1.05e-03 3.12e-09 γδ-T.3
LUZP1 3.12e-01 5.39e-01 4.46e-02 3.87e-09 γδ-T.3
SBF2 3.84e-01 3.84e-01 5.23e-02 5.94e-09 γδ-T.3
TESK2 3.5e-01 2.68e-01 1.45e-01 7.09e-09 γδ-T.3
ARNTL 2.83e-01 5.81e-01 8.1e-03 7.78e-09 γδ-T.3
CERK 2.97e-01 7.62e-01 3.93e-05 1.11e-08 γδ-T.3
FAM19A1 3.5e-01 2.79e-01 1.01e-01 1.9e-08 γδ-T.3
TM9SF1 2.72e-01 4.35e-01 3.33e-02 1.92e-08 γδ-T.3
EPHA4 2.77e-01 1.22e+00 1.34e-07 3.16e-08 γδ-T.3
B4GALT5 3.73e-01 1.11e+00 5.44e-06 4.6e-08 γδ-T.3
SND1 2.51e-01 3.55e-01 1.01e-01 8.54e-08 γδ-T.3
GZMM 2.54e-01 4.41e-01 1.9e-02 1.14e-07 γδ-T.3
GYG1 2.78e-01 8.46e-01 2.43e-05 3.22e-07 γδ-T.3
SLA 2.58e-01 4.39e-01 3.58e-02 3.28e-07 γδ-T.3
ZCCHC14 3.12e-01 3.87e-01 7.6e-02 4.63e-07 γδ-T.3
SESN1 2.73e-01 4.96e-01 3.79e-02 6.35e-07 γδ-T.3
MAP3K4 3.13e-01 4.33e-01 7.27e-03 6.93e-07 γδ-T.3
MPZL3 3.13e-01 4e-01 6.24e-03 3.94e-06 γδ-T.3
PDK3 2.66e-01 2.78e-01 2.37e-01 7.78e-06 γδ-T.3
DFNB31 2.64e-01 2.77e-01 3.11e-01 1.71e-05 γδ-T.3
GALNT10 2.62e-01 3.56e-01 1.85e-01 1.72e-05 γδ-T.3
VCL 2.58e-01 3.3e-01 1.15e-01 5.41e-05 γδ-T.3
EPB41L2 3.03e-01 2.92e-01 3.94e-01 1.24e-04 γδ-T.3
TGFB1 2.61e-01 6.94e-01 1.48e-03 3.22e-04 γδ-T.3
FOS 3.06e-01 3.56e-01 3.43e-01 3.22e-04 γδ-T.3
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Table A.5: List of differentially expressed genes between each of the γδ-T cell subtype
and all other immune cell types in breast tumour sample BC1.
gene BC1 avg logFC p-value cluster
FGFBP2 2.04e+00 9.66e-87 γδ-T.1
PRF1 1.72e+00 8.51e-53 γδ-T.1
RAP1GAP2 1.72e+00 1.2e-52 γδ-T.1
NKG7 1.5e+00 1.02e-43 γδ-T.1
GNLY 1.46e+00 7.8e-37 γδ-T.1
SPON2 1.07e+00 2.25e-33 γδ-T.1
S1PR5 9.44e-01 8.76e-30 γδ-T.1
PLAC8 1.14e+00 4.22e-27 γδ-T.1
GZMB 1.17e+00 1.67e-25 γδ-T.1
GZMH 1.06e+00 6.46e-24 γδ-T.1
LYN 1.17e+00 1.29e-19 γδ-T.1
UBE2F 1.11e+00 1.7e-19 γδ-T.1
KLRF1 1.13e+00 3.73e-18 γδ-T.1
PDGFD 1.39e+00 9.68e-18 γδ-T.1
KLRD1 8.65e-01 2.61e-17 γδ-T.1
BNC2 1.1e+00 5.8e-17 γδ-T.1
FAM53B 9.37e-01 1.13e-16 γδ-T.1
CD247 8.49e-01 1.49e-16 γδ-T.1
TGFBR3 1e+00 1.44e-15 γδ-T.1
ZEB2 7.37e-01 4.42e-15 γδ-T.1
TMCC3 9.45e-01 8.42e-15 γδ-T.1
RAP2B 8.22e-01 2.68e-14 γδ-T.1
TTC38 7.48e-01 6.37e-14 γδ-T.1
PTPN12 9.16e-01 6.46e-14 γδ-T.1
TFDP2 8.86e-01 2.84e-13 γδ-T.1
KLHDC4 7.14e-01 1.31e-12 γδ-T.1
BCR 7.11e-01 2.26e-12 γδ-T.1
GK5 8.35e-01 5.38e-12 γδ-T.1
AUTS2 8.48e-01 2.5e-11 γδ-T.1
DGKD 7.75e-01 5.93e-11 γδ-T.1
NCAM1 8.34e-01 1.47e-10 γδ-T.1
SGCD 7.69e-01 1.95e-10 γδ-T.1
TYROBP 7.1e-01 9.85e-10 γδ-T.1
DOCK5 1.02e+00 1.01e-09 γδ-T.1
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RASA3 7.52e-01 1.82e-09 γδ-T.1
PTPN7 7.59e-01 2.11e-09 γδ-T.1
MYO1F 7.32e-01 3.06e-09 γδ-T.1
B3GNT7 7.43e-01 3.35e-09 γδ-T.1
ITGAL 7.43e-01 3.97e-09 γδ-T.1
MTSS1 7.03e-01 7.21e-09 γδ-T.1
HAVCR2 7.56e-01 9.11e-09 γδ-T.1
SSBP3 7.13e-01 1.47e-08 γδ-T.1
YES1 9.44e-01 3.04e-08 γδ-T.1
CADM1 7.55e-01 3.63e-08 γδ-T.1
FOXK2 7.68e-01 3.97e-08 γδ-T.1
LINGO2 1.43e+00 8.16e-08 γδ-T.1
IGF1R 8.57e-01 1.33e-05 γδ-T.1
GNLY 3.16e+00 3.98e-246 γδ-T.2
ATP8B4 2.02e+00 1.71e-177 γδ-T.2
NCAM1 1.97e+00 1.48e-163 γδ-T.2
TYROBP 1.41e+00 1.35e-130 γδ-T.2
PLCG2 2.02e+00 6.43e-124 γδ-T.2
KLRD1 1.45e+00 1.4e-101 γδ-T.2
NKG7 1.37e+00 1.19e-89 γδ-T.2
CTSW 1.13e+00 1.85e-75 γδ-T.2
RIN3 1.35e+00 4.1e-73 γδ-T.2
SH2D1B 8.52e-01 4.95e-73 γδ-T.2
KLRC1 1.2e+00 8e-73 γδ-T.2
GZMB 1.68e+00 5.05e-70 γδ-T.2
NCR1 7.35e-01 1.75e-68 γδ-T.2
FCER1G 9.3e-01 3.56e-68 γδ-T.2
CLNK 1e+00 6.41e-62 γδ-T.2
MCTP2 1.15e+00 1.89e-61 γδ-T.2
LINGO2 1.88e+00 2.57e-60 γδ-T.2
HAVCR2 1.25e+00 5.47e-60 γδ-T.2
NCALD 1.16e+00 3.73e-58 γδ-T.2
CD7 1.04e+00 2.2e-57 γδ-T.2
KLRF1 9.29e-01 1.76e-55 γδ-T.2
B3GNT7 7.5e-01 2.24e-53 γδ-T.2
CNOT2 1.15e+00 6.03e-51 γδ-T.2
CD63 9.39e-01 1.12e-50 γδ-T.2
KLRK1 8.22e-01 1.16e-48 γδ-T.2
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DOCK5 1.1e+00 4.37e-48 γδ-T.2
PRF1 1.06e+00 7.6e-48 γδ-T.2
GOLIM4 7.73e-01 1.88e-45 γδ-T.2
GAS7 1.1e+00 6.99e-45 γδ-T.2
APBA2 1.03e+00 1.39e-42 γδ-T.2
PRKX 8.38e-01 2.56e-42 γδ-T.2
VAV3 1.04e+00 2.95e-41 γδ-T.2
LYN 8.57e-01 3.52e-41 γδ-T.2
HSH2D 9.75e-01 9.18e-41 γδ-T.2
PDGFD 1.06e+00 7.29e-40 γδ-T.2
ABCB1 9.09e-01 2.6e-39 γδ-T.2
SAMD3 8.4e-01 5.55e-39 γδ-T.2
TXK 8.87e-01 1.13e-38 γδ-T.2
HOPX 9.69e-01 1.75e-38 γδ-T.2
GEM 1.12e+00 7.84e-38 γδ-T.2
GALNT2 9.14e-01 8.88e-38 γδ-T.2
PPP1R9A 7.12e-01 2.47e-37 γδ-T.2
ADAM28 8.03e-01 3.11e-37 γδ-T.2
SRGAP3 8.84e-01 5.02e-34 γδ-T.2
ABHD2 8.46e-01 8.79e-34 γδ-T.2
AHI1 8.92e-01 4.68e-33 γδ-T.2
ITGB1 7.9e-01 1.12e-32 γδ-T.2
PDE7B 1.14e+00 2.87e-32 γδ-T.2
ZNF683 7.92e-01 1.31e-30 γδ-T.2
PIK3AP1 8.8e-01 1.75e-30 γδ-T.2
LARGE 9.12e-01 4.08e-30 γδ-T.2
LDB2 7.59e-01 2.5e-28 γδ-T.2
IFITM2 7.06e-01 6.28e-28 γδ-T.2
ITGA1 7.6e-01 4.48e-27 γδ-T.2
LOC374443 7.05e-01 2.23e-25 γδ-T.2
L3MBTL4 8e-01 1.71e-24 γδ-T.2
AGPAT4 7.38e-01 4.34e-23 γδ-T.2
KCNQ5 9.67e-01 7.78e-22 γδ-T.2
CMC1 9.59e-01 3.89e-20 γδ-T.2
DAPK2 7.77e-01 2.25e-18 γδ-T.2
ABTB2 8.52e-01 1.02e-10 γδ-T.2
A2M 1.2e+00 1.28e-84 γδ-T.3
ZBTB16 1.09e+00 3.84e-77 γδ-T.3
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PLCB1 1.09e+00 5.28e-76 γδ-T.3
PZP 1.05e+00 7.8e-64 γδ-T.3
KLRB1 9.95e-01 4.99e-54 γδ-T.3
IL12RB2 1.07e+00 3.59e-52 γδ-T.3
CEBPD 8.32e-01 7.24e-41 γδ-T.3
KLRD1 7.88e-01 1.26e-40 γδ-T.3
RGS2 8.16e-01 4.34e-36 γδ-T.3
CYTH3 8.78e-01 5.25e-36 γδ-T.3
S100B 7.63e-01 4.4e-27 γδ-T.3
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Table A.6: List of GO Biological Process and KEGG pathway terms significantly
enriched in the γδ-T cell clusters in PBMC.
Term Fold Enrichment Bonferroni cluster
GO:0006614 SRP-dependent






GO:0045047 protein targeting to ER 5.77e+01 6.94e-29 δ1.1
GO:0072599 establishment of protein






GO:0070972 protein localization to
endoplasmic reticulum
4.69e+01 7.9e-27 δ1.1
GO:0019083 viral transcription 3.47e+01 2.95e-25 δ1.1




GO:0006413 translational initiation 3.18e+01 4.38e-23 δ1.1
GO:0006612 protein targeting to
membrane
3.16e+01 4.92e-23 δ1.1




GO:0006402 mRNA catabolic process 2.72e+01 1.29e-21 δ1.1
GO:0006401 RNA catabolic process 2.41e+01 1.65e-20 δ1.1
GO:0006364 rRNA processing 2.23e+01 8.54e-20 δ1.1
GO:0016072 rRNA metabolic process 2.18e+01 1.47e-19 δ1.1
GO:0042254 ribosome biogenesis 1.79e+01 8.59e-18 δ1.1
GO:0019058 viral life cycle 1.44e+01 9.99e-18 δ1.1
GO:0072657 protein localization to
membrane
1.34e+01 5.05e-17 δ1.1
GO:0090150 establishment of protein
localization to membrane
1.63e+01 6.05e-17 δ1.1





GO:0043043 peptide biosynthetic process 1.06e+01 1.76e-16 δ1.1
GO:0034470 ncRNA processing 1.46e+01 5.92e-16 δ1.1
GO:0046700 heterocycle catabolic process 1.46e+01 5.92e-16 δ1.1
GO:0044270 cellular nitrogen compound
catabolic process
1.44e+01 8.37e-16 δ1.1
GO:0019439 aromatic compound catabolic
process
1.42e+01 1.07e-15 δ1.1
GO:0043604 amide biosynthetic process 9.64e+00 1.85e-15 δ1.1












GO:0006518 peptide metabolic process 8.68e+00 2.26e-14 δ1.1
GO:0072594 establishment of protein
localization to organelle
9.84e+00 4.71e-14 δ1.1











GO:0061024 membrane organization 7.18e+00 3.96e-13 δ1.1
GO:0034660 ncRNA metabolic process 1.05e+01 3.96e-13 δ1.1
GO:0043603 cellular amide metabolic
process
7.14e+00 2.38e-12 δ1.1




GO:0033365 protein localization to
organelle
7.26e+00 3.51e-11 δ1.1











GO:0015031 protein transport 4.11e+00 6.5e-08 δ1.1
GO:0045184 establishment of protein
localization
3.92e+00 7e-08 δ1.1
GO:0046907 intracellular transport 4.28e+00 6.36e-07 δ1.1







GO:0008104 protein localization 3.34e+00 1.16e-06 δ1.1
GO:0051649 establishment of localization
in cell
3.68e+00 2.16e-06 δ1.1
GO:0033036 macromolecule localization 2.91e+00 3.21e-05 δ1.1
GO:0044085 cellular component biogenesis 2.81e+00 6.99e-05 δ1.1
GO:0051641 cellular localization 3.01e+00 7.08e-05 δ1.1
GO:0044248 cellular catabolic process 3.72e+00 1.62e-04 δ1.1
GO:0032774 RNA biosynthetic process 2.24e+00 3.44e-03 δ1.1













GO:0048534 hematopoietic or lymphoid
organ development
4.56e+00 3.09e-02 δ1.1
GO:0002520 immune system development 4.32e+00 5.2e-02 δ1.1
GO:0002181 cytoplasmic translation 2.58e+01 6.74e-02 δ1.1
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GO:0016337 single organismal cell-cell
adhesion
4.52e+00 8.24e-02 δ1.1
GO:0098609 cell-cell adhesion 3.52e+00 8.7e-02 δ1.1
GO:0030097 hemopoiesis 4.43e+00 9.71e-02 δ1.1
GO:0016337 single organismal cell-cell
adhesion
6.35e+00 7.03e-04 δ1.2
GO:0001775 cell activation 5.45e+00 1.12e-03 δ1.2
GO:0098602 single organism cell adhesion 5.91e+00 1.51e-03 δ1.2
GO:0030217 T cell differentiation 1.39e+01 2.22e-03 δ1.2
GO:0030098 lymphocyte differentiation 1.03e+01 3.1e-03 δ1.2
GO:0042110 T cell activation 7.94e+00 4.97e-03 δ1.2
GO:0070489 T cell aggregation 7.94e+00 4.97e-03 δ1.2
GO:0071593 lymphocyte aggregation 7.93e+00 5.07e-03 δ1.2
GO:0070486 leukocyte aggregation 7.8e+00 5.75e-03 δ1.2
GO:0048534 hematopoietic or lymphoid
organ development
5.46e+00 1.06e-02 δ1.2
GO:0007159 leukocyte cell-cell adhesion 7.21e+00 1.08e-02 δ1.2
GO:0046649 lymphocyte activation 6.06e+00 1.32e-02 δ1.2
GO:0002520 immune system development 5.18e+00 1.77e-02 δ1.2
GO:0030097 hemopoiesis 5.27e+00 4.34e-02 δ1.2
GO:0045321 leukocyte activation 5.22e+00 4.75e-02 δ1.2
GO:0002521 leukocyte differentiation 6.73e+00 6.6e-02 δ1.2
GO:0042127 regulation of cell proliferation 3.42e+00 7.73e-02 δ1.2
GO:0098609 cell-cell adhesion 3.96e+00 8.61e-02 δ1.2
GO:0006955 immune response 4.6e+00 1.76e-14 δ2.1
GO:0002252 immune effector process 6.41e+00 2.17e-11 δ2.1
GO:0048584 positive regulation of
response to stimulus
3.26e+00 3.27e-08 δ2.1
GO:0050776 regulation of immune
response
4.84e+00 1.33e-07 δ2.1
GO:0006909 phagocytosis 9.81e+00 1.76e-07 δ2.1
GO:0001775 cell activation 4.67e+00 7.74e-07 δ2.1
GO:0006897 endocytosis 5.37e+00 3.31e-06 δ2.1
GO:0002682 regulation of immune system
process
3.58e+00 7.03e-06 δ2.1
GO:0006928 movement of cell or
subcellular component
3.12e+00 9.11e-06 δ2.1
GO:0016192 vesicle-mediated transport 3.41e+00 9.52e-06 δ2.1
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GO:0006952 defense response 3.36e+00 1.37e-05 δ2.1
GO:0007155 cell adhesion 3.1e+00 4.24e-05 δ2.1
GO:0022610 biological adhesion 3.09e+00 4.59e-05 δ2.1
GO:0007166 cell surface receptor signaling
pathway
2.48e+00 9.21e-05 δ2.1
GO:0016477 cell migration 3.59e+00 1.36e-04 δ2.1
GO:0002433 immune response-regulating
cell surface receptor signaling pathway
involved in phagocytosis
1.34e+01 1.45e-04 δ2.1
GO:0038096 Fc-gamma receptor signaling
pathway involved in phagocytosis
1.34e+01 1.45e-04 δ2.1
GO:0002431 Fc receptor mediated
stimulatory signaling pathway
1.31e+01 1.77e-04 δ2.1
GO:0038094 Fc-gamma receptor signaling
pathway
1.3e+01 1.9e-04 δ2.1
GO:0050778 positive regulation of immune
response
4.72e+00 1.94e-04 δ2.1
GO:0040011 locomotion 3.11e+00 2.85e-04 δ2.1
GO:0051674 localization of cell 3.32e+00 2.9e-04 δ2.1
GO:0048870 cell motility 3.32e+00 2.9e-04 δ2.1












GO:0098602 single organism cell adhesion 4.14e+00 1.33e-03 δ2.1
GO:0002253 activation of immune
response
4.94e+00 1.74e-03 δ2.1
GO:0016337 single organismal cell-cell
adhesion
4.22e+00 2.36e-03 δ2.1
GO:0045321 leukocyte activation 4.09e+00 3.56e-03 δ2.1
GO:0002429 immune response-activating










cell surface receptor signaling pathway
5.54e+00 9.34e-03 δ2.1
GO:0043207 response to external biotic
stimulus
3.69e+00 1.44e-02 δ2.1
GO:0051707 response to other organism 3.69e+00 1.44e-02 δ2.1
GO:0098609 cell-cell adhesion 3.07e+00 2.71e-02 δ2.1
GO:0009607 response to biotic stimulus 3.5e+00 2.83e-02 δ2.1
GO:0050900 leukocyte migration 5.42e+00 3.15e-02 δ2.1
GO:0038093 Fc receptor signaling pathway 6.99e+00 3.24e-02 δ2.1
hsa04810:Regulation of actin cytoskeleton 6.3e+00 2.9e-03 δ2.1
GO:0046649 lymphocyte activation 3.96e+00 5.44e-02 δ2.1
GO:0007159 leukocyte cell-cell adhesion 4.5e+00 7.25e-02 δ2.1
GO:0006968 cellular defense response 1.64e+01 7.85e-02 δ2.1
GO:0019835 cytolysis 2.74e+01 7.87e-02 δ2.1
GO:0009605 response to external stimulus 2.29e+00 9.28e-02 δ2.1
GO:0002576 platelet degranulation 1.11e+01 9.72e-02 δ2.1
hsa05131:Shigellosis 1.24e+01 1.5e-02 δ2.1
hsa04015:Rap1 signaling pathway 5.67e+00 2.02e-02 δ2.1
hsa05140:Leishmaniasis 1.12e+01 2.45e-02 δ2.1
hsa04142:Lysosome 7.65e+00 3.63e-02 δ2.1
hsa05132:Salmonella infection 9.56e+00 5.03e-02 δ2.1
GO:0007166 cell surface receptor signaling
pathway
4.68e+00 1.1e-03 δ2.2




GO:0002682 regulation of immune system
process
6.8e+00 6.99e-03 δ2.2
GO:0071345 cellular response to cytokine
stimulus
1.03e+01 1.74e-02 δ2.2
GO:0006968 cellular defense response 6.71e+01 1.84e-02 δ2.2
GO:1903039 positive regulation of
leukocyte cell-cell adhesion
2.39e+01 2.95e-02 δ2.2
GO:0034097 response to cytokine 9.08e+00 3.56e-02 δ2.2
GO:0022409 positive regulation of cell-cell
adhesion
2.1e+01 4.82e-02 δ2.2
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GO:0045047 protein targeting to ER 5.18e+01 5.12e-12 δ2.3
GO:0072599 establishment of protein






GO:0070972 protein localization to
endoplasmic reticulum
4.21e+01 4.31e-11 δ2.3
GO:0019083 viral transcription 2.98e+01 1.43e-09 δ2.3
GO:0006413 translational initiation 2.85e+01 2.21e-09 δ2.3
GO:0006612 protein targeting to
membrane
2.84e+01 2.33e-09 δ2.3
GO:0019080 viral gene expression 2.81e+01 2.59e-09 δ2.3







GO:0006402 mRNA catabolic process 2.44e+01 1.05e-08 δ2.3
GO:0006401 RNA catabolic process 2.16e+01 3.43e-08 δ2.3
GO:0006364 rRNA processing 2e+01 7.34e-08 δ2.3
GO:0016072 rRNA metabolic process 1.95e+01 9.44e-08 δ2.3
GO:0042254 ribosome biogenesis 1.61e+01 6.26e-07 δ2.3
GO:0019058 viral life cycle 1.29e+01 6.79e-07 δ2.3






GO:0046700 heterocycle catabolic process 1.31e+01 4.5e-06 δ2.3
240
GO:0034470 ncRNA processing 1.31e+01 4.5e-06 δ2.3
GO:0044270 cellular nitrogen compound
catabolic process
1.29e+01 5.29e-06 δ2.3
GO:0019439 aromatic compound catabolic
process
1.27e+01 5.93e-06 δ2.3






GO:0072657 protein localization to
membrane
1.1e+01 2.36e-05 δ2.3
GO:0006412 translation 9.17e+00 2.42e-05 δ2.3
GO:0006518 peptide metabolic process 7.78e+00 2.67e-05 δ2.3
GO:0043043 peptide biosynthetic process 8.81e+00 3.64e-05 δ2.3
GO:0016071 mRNA metabolic process 8.74e+00 3.93e-05 δ2.3
GO:0043604 amide biosynthetic process 7.98e+00 9.94e-05 δ2.3
GO:0034660 ncRNA metabolic process 9.45e+00 9.96e-05 δ2.3



















GO:0006605 protein targeting 7.68e+00 6.75e-04 δ2.3







GO:0033365 protein localization to
organelle
5.97e+00 6.54e-03 δ2.3







GO:0061024 membrane organization 5.25e+00 2.03e-02 δ2.3
GO:0070489 T cell aggregation 8.78e+00 2.34e-02 δ2.3
GO:0042110 T cell activation 8.78e+00 2.34e-02 δ2.3
GO:0071593 lymphocyte aggregation 8.76e+00 2.37e-02 δ2.3
GO:0070486 leukocyte aggregation 8.63e+00 2.62e-02 δ2.3
GO:0001913 T cell mediated cytotoxicity 6.53e+01 2.93e-02 δ2.3








GO:0002682 regulation of immune system
process
4.26e+00 4.4e-02 δ2.3
GO:0098609 cell-cell adhesion 4.63e+00 5.85e-02 δ2.3
GO:0045321 leukocyte activation 5.9e+00 8.3e-02 δ2.3
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Table A.7: List of GO Biological Process and KEGG pathway terms differentially
enriched between δ1.1 and δ1.2 γδ-T cell subtypes in PBMC.
Term Fold Enrichment Bonferroni cluster
GO:0006614 SRP-dependent






GO:0045047 protein targeting to ER 1.28e+02 1.37e-94 δ1.1
GO:0072599 establishment of protein






GO:0070972 protein localization to
endoplasmic reticulum
1.04e+02 3.52e-89 δ1.1
GO:0019083 viral transcription 7.36e+01 9.29e-81 δ1.1
GO:0006413 translational initiation 7.05e+01 9.57e-80 δ1.1
GO:0006612 protein targeting to
membrane
7.01e+01 1.27e-79 δ1.1







GO:0006402 mRNA catabolic process 6.03e+01 3.89e-76 δ1.1
GO:0006401 RNA catabolic process 5.35e+01 1.96e-73 δ1.1
hsa03010:Ribosome 4.34e+01 3.45e-74 δ1.1
GO:0006364 rRNA processing 4.95e+01 1.05e-71 δ1.1
GO:0016072 rRNA metabolic process 4.83e+01 3.93e-71 δ1.1
GO:0042254 ribosome biogenesis 3.98e+01 7.31e-67 δ1.1






GO:0019058 viral life cycle 2.99e+01 1.89e-62 δ1.1
GO:0034470 ncRNA processing 3.24e+01 1.98e-62 δ1.1
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GO:0046700 heterocycle catabolic process 3.24e+01 1.98e-62 δ1.1
GO:0044270 cellular nitrogen compound
catabolic process
3.19e+01 4.56e-62 δ1.1
GO:0019439 aromatic compound catabolic
process
3.15e+01 8.22e-62 δ1.1






GO:0072657 protein localization to
membrane
2.72e+01 1.03e-58 δ1.1
GO:0006412 translation 2.16e+01 4.16e-57 δ1.1
GO:0043043 peptide biosynthetic process 2.08e+01 3.09e-56 δ1.1
GO:0034660 ncRNA metabolic process 2.34e+01 1.83e-55 δ1.1
GO:0043604 amide biosynthetic process 1.89e+01 4.38e-54 δ1.1
GO:0072594 establishment of protein
localization to organelle
2e+01 3.41e-52 δ1.1
GO:0016071 mRNA metabolic process 1.98e+01 5.25e-52 δ1.1





















GO:0033365 protein localization to
organelle
1.48e+01 6.9e-46 δ1.1
GO:0006396 RNA processing 1.46e+01 1.05e-45 δ1.1

















GO:0046907 intracellular transport 8.36e+00 2.88e-34 δ1.1




GO:0044248 cellular catabolic process 8.24e+00 5.43e-34 δ1.1
GO:0015031 protein transport 7.31e+00 1.11e-32 δ1.1
GO:0051649 establishment of localization
in cell
6.79e+00 3.74e-31 δ1.1
GO:0045184 establishment of protein
localization
6.73e+00 5.56e-31 δ1.1
GO:0008104 protein localization 5.55e+00 4.39e-27 δ1.1
GO:0051641 cellular localization 5.35e+00 2.49e-26 δ1.1
GO:0033036 macromolecule localization 4.83e+00 2.95e-24 δ1.1













GO:0016070 RNA metabolic process 2.99e+00 1.72e-15 δ1.1
GO:0010467 gene expression 2.72e+00 5.02e-15 δ1.1
GO:0042255 ribosome assembly 5.09e+01 1.1e-11 δ1.1
GO:0042273 ribosomal large subunit
biogenesis
4.56e+01 3.56e-11 δ1.1
GO:0002181 cytoplasmic translation 4.71e+01 1.42e-08 δ1.1
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GO:0000028 ribosomal small subunit
assembly
7.93e+01 1.1e-05 δ1.1






GO:0070925 organelle assembly 5.1e+00 1.85e-02 δ1.1
GO:0030490 maturation of SSU-rRNA 2.89e+01 2.91e-02 δ1.1
GO:0000462 maturation of SSU-rRNA
from tricistronic rRNA transcript (SSU-
rRNA, 5.8S rRNA, LSU-rRNA)
3e+01 3.03e-01 δ1.1
GO:0000470 maturation of LSU-rRNA 3.33e+01 9.85e-01 δ1.1
GO:0097421 liver regeneration 2.87e+01 9.97e-01 δ1.1





cell surface receptor signaling pathway
7.14e+00 5.11e-04 δ1.2
hsa04810:Regulation of actin cytoskeleton 8.58e+00 3.09e-05 δ1.2
GO:0098602 single organism cell adhesion 4.78e+00 7.29e-04 δ1.2
GO:0001775 cell activation 4.33e+00 1.11e-03 δ1.2
GO:0050776 regulation of immune
response
4.32e+00 1.14e-03 δ1.2
GO:0016337 single organismal cell-cell
adhesion
4.83e+00 1.66e-03 δ1.2
GO:0038093 Fc receptor signaling pathway 9.02e+00 3.53e-03 δ1.2
GO:0007159 leukocyte cell-cell adhesion 5.8e+00 4.58e-03 δ1.2






GO:0042110 T cell activation 5.89e+00 1.18e-02 δ1.2
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GO:0070489 T cell aggregation 5.89e+00 1.18e-02 δ1.2
GO:0071593 lymphocyte aggregation 5.88e+00 1.2e-02 δ1.2
GO:0046649 lymphocyte activation 4.77e+00 1.31e-02 δ1.2
GO:0002429 immune response-activating
cell surface receptor signaling pathway
6.57e+00 1.39e-02 δ1.2
GO:0070486 leukocyte aggregation 5.79e+00 1.39e-02 δ1.2






GO:0098609 cell-cell adhesion 3.39e+00 3.08e-02 δ1.2
GO:0007015 actin filament organization 6.54e+00 4.65e-02 δ1.2
GO:0002684 positive regulation of immune
system process
3.65e+00 4.98e-02 δ1.2
GO:0045321 leukocyte activation 4.11e+00 6.31e-02 δ1.2
GO:0038094 Fc-gamma receptor signaling
pathway
1.17e+01 6.62e-02 δ1.2
GO:0006928 movement of cell or
subcellular component
2.69e+00 6.99e-02 δ1.2
GO:0008219 cell death 2.57e+00 7.9e-02 δ1.2
GO:0006909 phagocytosis 7.12e+00 8.21e-02 δ1.2




GO:0030217 T cell differentiation 8.59e+00 8.8e-02 δ1.2
GO:0030029 actin filament-based process 4.24e+00 1.02e-01 δ1.2
GO:0007155 cell adhesion 2.71e+00 1.03e-01 δ1.2
GO:0022610 biological adhesion 2.7e+00 1.08e-01 δ1.2
GO:0050778 positive regulation of immune
response
4.16e+00 1.2e-01 δ1.2
hsa04520:Adherens junction 1.38e+01 6.31e-03 δ1.2
GO:0007166 cell surface receptor signaling
pathway
2.22e+00 1.39e-01 δ1.2
GO:0006915 apoptotic process 2.63e+00 1.49e-01 δ1.2
GO:0002252 immune effector process 3.84e+00 2.43e-01 δ1.2
GO:0071822 protein complex subunit
organization
2.62e+00 2.53e-01 δ1.2
hsa05132:Salmonella infection 1.18e+01 1.33e-02 δ1.2




GO:0012501 programmed cell death 2.48e+00 3.06e-01 δ1.2






GO:0038096 Fc-gamma receptor signaling
pathway involved in phagocytosis
1.04e+01 4.91e-01 δ1.2
GO:0002433 immune response-regulating
cell surface receptor signaling pathway
involved in phagocytosis
1.04e+01 4.91e-01 δ1.2
GO:0002521 leukocyte differentiation 4.62e+00 4.92e-01 δ1.2
GO:0002431 Fc receptor mediated
stimulatory signaling pathway
1.01e+01 5.28e-01 δ1.2
GO:0010941 regulation of cell death 2.61e+00 5.48e-01 δ1.2
GO:0042981 regulation of apoptotic
process
2.66e+00 6.51e-01 δ1.2
GO:0042127 regulation of cell proliferation 2.54e+00 6.68e-01 δ1.2
GO:0043067 regulation of programmed cell
death
2.64e+00 6.89e-01 δ1.2




GO:0048013 ephrin receptor signaling
pathway
1.26e+01 7.98e-01 δ1.2
GO:0035567 non-canonical Wnt signaling
pathway
8.48e+00 8.14e-01 δ1.2
GO:0016477 cell migration 2.78e+00 8.4e-01 δ1.2
GO:0016192 vesicle-mediated transport 2.49e+00 8.83e-01 δ1.2
GO:0060491 regulation of cell projection
assembly
8.02e+00 8.86e-01 δ1.2
GO:0044087 regulation of cellular
component biogenesis
3.26e+00 9.03e-01 δ1.2
GO:0008064 regulation of actin
polymerization or depolymerization
7.73e+00 9.22e-01 δ1.2




GO:0051128 regulation of cellular
component organization
2.07e+00 9.34e-01 δ1.2
hsa05100:Bacterial invasion of epithelial
cells
1.05e+01 1.18e-01 δ1.2
GO:0008283 cell proliferation 2.24e+00 9.58e-01 δ1.2
GO:0048584 positive regulation of
response to stimulus
2.16e+00 9.65e-01 δ1.2
hsa04015:Rap1 signaling pathway 5.46e+00 1.43e-01 δ1.2
GO:0021762 substantia nigra development 1.79e+01 9.7e-01 δ1.2
GO:0008284 positive regulation of cell
proliferation
3.1e+00 9.7e-01 δ1.2
GO:0031328 positive regulation of cellular
biosynthetic process
2.28e+00 9.76e-01 δ1.2
GO:0043254 regulation of protein complex
assembly
4.6e+00 9.83e-01 δ1.2
GO:0030097 hemopoiesis 3.26e+00 9.86e-01 δ1.2
GO:0006461 protein complex assembly 2.43e+00 9.87e-01 δ1.2
GO:0022407 regulation of cell-cell adhesion 4.54e+00 9.88e-01 δ1.2
GO:0070271 protein complex biogenesis 2.42e+00 9.88e-01 δ1.2
GO:0071103 DNA conformation change 5.4e+00 9.88e-01 δ1.2
GO:0033043 regulation of organelle
organization
2.66e+00 9.88e-01 δ1.2
GO:0009891 positive regulation of
biosynthetic process
2.24e+00 9.89e-01 δ1.2
GO:0001649 osteoblast differentiation 6.74e+00 9.91e-01 δ1.2
GO:0022607 cellular component assembly 1.92e+00 9.95e-01 δ1.2
GO:0048870 cell motility 2.47e+00 9.96e-01 δ1.2
GO:0051674 localization of cell 2.47e+00 9.96e-01 δ1.2
GO:0051881 regulation of mitochondrial
membrane potential
1.51e+01 9.97e-01 δ1.2
GO:0050863 regulation of T cell activation 5.13e+00 9.97e-01 δ1.2
GO:0030155 regulation of cell adhesion 3.41e+00 9.97e-01 δ1.2
GO:0048534 hematopoietic or lymphoid
organ development
3.1e+00 9.98e-01 δ1.2
GO:0051249 regulation of lymphocyte
activation
4.26e+00 9.98e-01 δ1.2
GO:0033151 V(D)J recombination 3.87e+01 9.99e-01 δ1.2
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GO:0006977 DNA damage response,
signal transduction by p53 class mediator
resulting in cell cycle arrest
1.41e+01 9.99e-01 δ1.2
GO:0006952 defense response 2.31e+00 9.99e-01 δ1.2




transduction involved in G1 DNA damage
checkpoint
1.39e+01 9.99e-01 δ1.2
GO:0072413 signal transduction involved
in mitotic cell cycle checkpoint
1.39e+01 9.99e-01 δ1.2
GO:1902402 signal transduction involved
in mitotic DNA damage checkpoint
1.39e+01 9.99e-01 δ1.2
GO:1902403 signal transduction involved
in mitotic DNA integrity checkpoint
1.39e+01 9.99e-01 δ1.2
GO:0072431 signal transduction involved
in mitotic G1 DNA damage checkpoint
1.39e+01 9.99e-01 δ1.2
GO:0006897 endocytosis 3.29e+00 9.99e-01 δ1.2
GO:0010628 positive regulation of gene
expression
2.2e+00 1e+00 δ1.2
GO:0072401 signal transduction involved
in DNA integrity checkpoint
1.35e+01 1e+00 δ1.2
GO:0072422 signal transduction involved
in DNA damage checkpoint
1.35e+01 1e+00 δ1.2
GO:0072395 signal transduction involved





GO:2000045 regulation of G1/S transition
of mitotic cell cycle
7.77e+00 1e+00 δ1.2





Table A.8: List of GO Biological Process and KEGG pathway terms differentially
enriched between δ2.2 and δ2.3 γδ-T cell subtypes in PBMC.
Term Fold Enrichment Bonferroni cluster
GO:0019835 cytolysis 7.67e+01 4.69e-01 δ2.2
GO:0002703 regulation of leukocyte
mediated immunity
2.03e+01 5.64e-01 δ2.2













GO:0045047 protein targeting to ER 5.86e+01 1.48e-18 δ2.3
GO:0072599 establishment of protein






GO:0070972 protein localization to
endoplasmic reticulum
4.76e+01 3.12e-17 δ2.3
GO:0019083 viral transcription 3.37e+01 4.57e-15 δ2.3
GO:0006413 translational initiation 3.22e+01 8.46e-15 δ2.3
GO:0006612 protein targeting to
membrane
3.21e+01 9.12e-15 δ2.3







hsa03010:Ribosome 2.53e+01 1.51e-15 δ2.3
GO:0006402 mRNA catabolic process 2.76e+01 1.47e-13 δ2.3
GO:0006401 RNA catabolic process 2.45e+01 4.42e-13 δ2.3
GO:0006364 rRNA processing 2.26e+01 1.18e-12 δ2.3
GO:0016072 rRNA metabolic process 2.21e+01 1.77e-12 δ2.3
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GO:0090150 establishment of protein
localization to membrane
1.77e+01 3.53e-12 δ2.3
GO:0042254 ribosome biogenesis 1.82e+01 2.61e-11 δ2.3






GO:0072657 protein localization to
membrane
1.33e+01 2.29e-10 δ2.3
GO:0046700 heterocycle catabolic process 1.48e+01 4.3e-10 δ2.3
GO:0034470 ncRNA processing 1.48e+01 4.3e-10 δ2.3
GO:0044270 cellular nitrogen compound
catabolic process
1.46e+01 5.41e-10 δ2.3
GO:0019439 aromatic compound catabolic
process
1.44e+01 6.36e-10 δ2.3




GO:0006412 translation 1.01e+01 1.12e-08 δ2.3
GO:0072594 establishment of protein
localization to organelle
9.76e+00 1.93e-08 δ2.3
GO:0043043 peptide biosynthetic process 9.74e+00 1.98e-08 δ2.3
GO:0016071 mRNA metabolic process 9.67e+00 2.2e-08 δ2.3
GO:0006518 peptide metabolic process 8.44e+00 2.74e-08 δ2.3
GO:0034660 ncRNA metabolic process 1.07e+01 3.51e-08 δ2.3







GO:0043603 cellular amide metabolic
process
6.95e+00 4.95e-07 δ2.3








GO:0033365 protein localization to
organelle
7.2e+00 1.35e-06 δ2.3
GO:0006396 RNA processing 7.14e+00 1.52e-06 δ2.3




















GO:0046907 intracellular transport 4.33e+00 4.14e-04 δ2.3




GO:0044248 cellular catabolic process 4.27e+00 5e-04 δ2.3
GO:0015031 protein transport 3.71e+00 3.32e-03 δ2.3
GO:0051649 establishment of localization
in cell
3.44e+00 8.84e-03 δ2.3
GO:0045184 establishment of protein
localization
3.42e+00 9.86e-03 δ2.3
GO:0042110 T cell activation 8.19e+00 1.19e-02 δ2.3
GO:0070489 T cell aggregation 8.19e+00 1.19e-02 δ2.3
GO:0071593 lymphocyte aggregation 8.18e+00 1.21e-02 δ2.3
GO:0070486 leukocyte aggregation 8.05e+00 1.35e-02 δ2.3
GO:0098609 cell-cell adhesion 4.54e+00 1.51e-02 δ2.3
GO:0042255 ribosome assembly 3.38e+01 1.66e-02 δ2.3
GO:0046649 lymphocyte activation 6.32e+00 2.21e-02 δ2.3
GO:0007159 leukocyte cell-cell adhesion 7.44e+00 2.37e-02 δ2.3
GO:0001913 T cell mediated cytotoxicity 5.41e+01 6.4e-02 δ2.3
GO:0045321 leukocyte activation 5.44e+00 7.01e-02 δ2.3
GO:0002250 adaptive immune response 7.74e+00 7.17e-02 δ2.3
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GO:0008104 protein localization 2.82e+00 1.06e-01 δ2.3
GO:0030217 T cell differentiation 1.19e+01 1.49e-01 δ2.3
GO:0051641 cellular localization 2.72e+00 1.62e-01 δ2.3
GO:0033993 response to lipid 4.72e+00 1.93e-01 δ2.3
GO:0070887 cellular response to chemical
stimulus
2.61e+00 2.51e-01 δ2.3
GO:0001775 cell activation 4.46e+00 2.79e-01 δ2.3




involved in immune response
1.36e+01 4.41e-01 δ2.3
GO:0048534 hematopoietic or lymphoid
organ development
4.7e+00 4.46e-01 δ2.3
GO:0098602 single organism cell adhesion 4.69e+00 4.49e-01 δ2.3
GO:0007155 cell adhesion 3.11e+00 4.49e-01 δ2.3
GO:0033036 macromolecule localization 2.45e+00 4.5e-01 δ2.3
GO:0022610 biological adhesion 3.1e+00 4.6e-01 δ2.3
GO:0042273 ribosomal large subunit
biogenesis
2.42e+01 5.2e-01 δ2.3
GO:0002460 adaptive immune response
based on somatic recombination of immune
receptors built from immunoglobulin
superfamily domains
8.52e+00 5.37e-01 δ2.3
GO:0002520 immune system development 4.45e+00 5.7e-01 δ2.3
GO:0044085 cellular component biogenesis 2.37e+00 5.86e-01 δ2.3
GO:0010467 gene expression 1.84e+00 6.11e-01 δ2.3
GO:0006954 inflammatory response 5.1e+00 6.15e-01 δ2.3
GO:0032774 RNA biosynthetic process 2.08e+00 6.25e-01 δ2.3
GO:0048535 lymph node development 7.17e+01 6.29e-01 δ2.3
GO:0030098 lymphocyte differentiation 7.86e+00 6.7e-01 δ2.3
GO:0002521 leukocyte differentiation 6e+00 6.85e-01 δ2.3

















GO:0001914 regulation of T cell mediated
cytotoxicity
5.3e+01 8.4e-01 δ2.3
GO:0000027 ribosomal large subunit
assembly
4.87e+01 8.85e-01 δ2.3






GO:0002263 cell activation involved in
immune response
9.49e+00 8.94e-01 δ2.3




GO:0016070 RNA metabolic process 1.83e+00 9.63e-01 δ2.3
GO:0051249 regulation of lymphocyte
activation
5.93e+00 9.78e-01 δ2.3
GO:0046651 lymphocyte proliferation 7.72e+00 9.91e-01 δ2.3
GO:0032943 mononuclear cell proliferation 7.66e+00 9.92e-01 δ2.3
GO:0071310 cellular response to organic
substance
2.42e+00 9.96e-01 δ2.3
GO:0070661 leukocyte proliferation 7.25e+00 9.97e-01 δ2.3
GO:0010033 response to organic substance 2.16e+00 9.97e-01 δ2.3
GO:0002694 regulation of leukocyte
activation
5.21e+00 9.99e-01 δ2.3
GO:0050863 regulation of T cell activation 6.79e+00 9.99e-01 δ2.3
GO:0002293 alpha-beta T cell
differentiation involved in immune
response
2.44e+01 1e+00 δ2.3
GO:0002287 alpha-beta T cell activation
involved in immune response
2.44e+01 1e+00 δ2.3
GO:1903037 regulation of leukocyte cell-
cell adhesion
6.49e+00 1e+00 δ2.3
GO:0001910 regulation of leukocyte
mediated cytotoxicity
2.39e+01 1e+00 δ2.3
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GO:0050865 regulation of cell activation 4.86e+00 1e+00 δ2.3
GO:0002709 regulation of T cell mediated
immunity
2.34e+01 1e+00 δ2.3
GO:1901700 response to oxygen-
containing compound
2.77e+00 1e+00 δ2.3
GO:0002684 positive regulation of immune
system process
3.38e+00 1e+00 δ2.3
GO:0002440 production of molecular
mediator of immune response
9.73e+00 1e+00 δ2.3
GO:0002292 T cell differentiation involved
in immune response
2.18e+01 1e+00 δ2.3
GO:0031341 regulation of cell killing 2e+01 1e+00 δ2.3




Table A.9: List of GO Biological Process and KEGG pathway terms differentially
enriched γδ-T cell subtypes in breast tumour.
Term Fold Enrichment Bonferroni cluster
GO:0001775 cell activation 3.47e+00 4.64e-09 γδ-T.1
GO:0007166 cell surface receptor signaling
pathway
2.1e+00 2.24e-07 γδ-T.1











cell surface receptor signaling pathway
4.32e+00 3.47e-05 γδ-T.1
GO:0002252 immune effector process 3.1e+00 1.68e-04 γδ-T.1
GO:0002429 immune response-activating
cell surface receptor signaling pathway
4.3e+00 1.81e-04 γδ-T.1
GO:0048584 positive regulation of
response to stimulus
2.09e+00 1.82e-04 γδ-T.1




protein tyrosine kinase signaling pathway
3.21e+00 4.03e-04 γδ-T.1
hsa04650:Natural killer cell mediated
cytotoxicity
6.75e+00 2.14e-05 γδ-T.1
GO:0009966 regulation of signal
transduction
1.84e+00 8.07e-04 γδ-T.1
GO:0036211 protein modification process 1.65e+00 1.14e-03 γδ-T.1
GO:0006464 cellular protein modification
process
1.65e+00 1.14e-03 γδ-T.1
GO:0006909 phagocytosis 4.66e+00 1.37e-03 γδ-T.1
GO:0007167 enzyme linked receptor
protein signaling pathway
2.63e+00 1.56e-03 γδ-T.1
GO:0016310 phosphorylation 1.93e+00 1.94e-03 γδ-T.1
GO:0007155 cell adhesion 2.11e+00 2.05e-03 γδ-T.1
GO:0022610 biological adhesion 2.1e+00 2.28e-03 γδ-T.1




GO:0010646 regulation of cell
communication
1.73e+00 3.99e-03 γδ-T.1
GO:0050778 positive regulation of immune
response
2.94e+00 4.08e-03 γδ-T.1
GO:0046649 lymphocyte activation 3.01e+00 4.21e-03 γδ-T.1
GO:0008219 cell death 1.98e+00 4.52e-03 γδ-T.1
GO:0012501 programmed cell death 2.02e+00 4.59e-03 γδ-T.1
GO:0006915 apoptotic process 2.05e+00 4.64e-03 γδ-T.1
GO:0023051 regulation of signaling 1.71e+00 7.45e-03 γδ-T.1







GO:0006793 phosphorus metabolic process 1.7e+00 9.39e-03 γδ-T.1
GO:0051674 localization of cell 2.21e+00 1.02e-02 γδ-T.1
GO:0048870 cell motility 2.21e+00 1.02e-02 γδ-T.1







GO:0042127 regulation of cell proliferation 2.08e+00 1.4e-02 γδ-T.1
GO:0010647 positive regulation of cell
communication
2.08e+00 1.47e-02 γδ-T.1






GO:2000145 regulation of cell motility 2.73e+00 1.64e-02 γδ-T.1
GO:0023056 positive regulation of
signaling
2.07e+00 1.67e-02 γδ-T.1
GO:0098609 cell-cell adhesion 2.28e+00 1.88e-02 γδ-T.1
GO:0009967 positive regulation of signal
transduction
2.11e+00 2.35e-02 γδ-T.1
GO:0002274 myeloid leukocyte activation 5.86e+00 2.61e-02 γδ-T.1
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GO:0051270 regulation of cellular
component movement
2.6e+00 2.68e-02 γδ-T.1
GO:0038093 Fc receptor signaling pathway 4.43e+00 3.11e-02 γδ-T.1
GO:0042981 regulation of apoptotic
process
2.1e+00 3.48e-02 γδ-T.1
GO:0040012 regulation of locomotion 2.62e+00 3.49e-02 γδ-T.1
GO:0002684 positive regulation of immune
system process
2.39e+00 3.96e-02 γδ-T.1
GO:0043067 regulation of programmed cell
death
2.08e+00 4.31e-02 γδ-T.1
GO:0098602 single organism cell adhesion 2.58e+00 4.47e-02 γδ-T.1
GO:0006468 protein phosphorylation 1.9e+00 5.24e-02 γδ-T.1
GO:0040011 locomotion 2.02e+00 5.26e-02 γδ-T.1
GO:0007159 leukocyte cell-cell adhesion 3.07e+00 6.88e-02 γδ-T.1
GO:0006897 endocytosis 2.7e+00 7.3e-02 γδ-T.1
GO:0010941 regulation of cell death 2e+00 8.49e-02 γδ-T.1
hsa04510:Focal adhesion 4e+00 7.76e-03 γδ-T.1
hsa04015:Rap1 signaling pathway 3.92e+00 9.48e-03 γδ-T.1
hsa05416:Viral myocarditis 7.22e+00 7.05e-02 γδ-T.1
hsa04650:Natural killer cell mediated
cytotoxicity
1.21e+01 3.33e-07 γδ-T.2
GO:0051674 localization of cell 3.23e+00 1.03e-05 γδ-T.2
GO:0048870 cell motility 3.23e+00 1.03e-05 γδ-T.2
GO:0040011 locomotion 2.98e+00 2.21e-05 γδ-T.2
GO:0046649 lymphocyte activation 4.45e+00 5.12e-05 γδ-T.2
GO:0007166 cell surface receptor signaling
pathway
2.29e+00 7.04e-05 γδ-T.2
GO:0006928 movement of cell or
subcellular component
2.68e+00 1.03e-04 γδ-T.2
GO:0045321 leukocyte activation 4.01e+00 1.42e-04 γδ-T.2
GO:0001775 cell activation 3.43e+00 1.06e-03 γδ-T.2
GO:0050776 regulation of immune
response
3.28e+00 4.3e-03 γδ-T.2
GO:0016477 cell migration 2.86e+00 8.34e-03 γδ-T.2
GO:0002252 immune effector process 3.51e+00 1.04e-02 γδ-T.2
GO:0030334 regulation of cell migration 3.61e+00 1.35e-02 γδ-T.2
GO:0002228 natural killer cell mediated
immunity
1.52e+01 1.89e-02 γδ-T.2
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GO:0007155 cell adhesion 2.37e+00 2.66e-02 γδ-T.2
GO:0022610 biological adhesion 2.37e+00 2.85e-02 γδ-T.2
GO:2000145 regulation of cell motility 3.36e+00 3.57e-02 γδ-T.2
GO:0040012 regulation of locomotion 3.22e+00 6.24e-02 γδ-T.2
GO:0031589 cell-substrate adhesion 5.1e+00 6.68e-02 γδ-T.2
GO:0007159 leukocyte cell-cell adhesion 3.97e+00 6.77e-02 γδ-T.2
hsa05100:Bacterial invasion of epithelial
cells
9.45e+00 5.54e-02 γδ-T.2
GO:0080134 regulation of response to
stress
3.99e+00 2.54e-05 γδ-T.3






GO:0009966 regulation of signal
transduction
2.35e+00 1.56e-02 γδ-T.3
GO:0033993 response to lipid 3.97e+00 2.16e-02 γδ-T.3
GO:0048585 negative regulation of
response to stimulus
3.12e+00 3e-02 γδ-T.3
GO:0010646 regulation of cell
communication
2.19e+00 3.92e-02 γδ-T.3
GO:0023051 regulation of signaling 2.16e+00 5.41e-02 γδ-T.3
GO:1902531 regulation of intracellular
signal transduction
2.74e+00 6.11e-02 γδ-T.3
GO:0002684 positive regulation of immune
system process
3.56e+00 7.7e-02 γδ-T.3
GO:0048584 positive regulation of
response to stimulus
2.52e+00 7.73e-02 γδ-T.3
GO:0010033 response to organic substance 2.19e+00 8.87e-02 γδ-T.3
hsa05142:Chagas disease (American
trypanosomiasis)
9.23e+00 5.29e-02 γδ-T.3
